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ABSTRACT
In recent years, the understanding of the structure and functions of biological
macromoleculcs has advanced rapidly, the result of which is a better mechanistic
understanding of many biological processes. As an outgrowth of this understanding,
organic molecules that react with biological macromolecules (DNA) or adopt
conformations responsible for specific functions in biological macromolecules (peptides
and proteins) have been synthesized and computational modeling studies performed.
Polycyclic aromatic hydrocarbons (PAHs) and p-peptides are among synthetic organic
compounds known to interact with natural biological macromolecules. This interaction
may affect the specific biological functions of the biomacromolecules.

A variety of

synthetic methodologies have been employed in the synthesis of benzo[c]phenanthrene
derivatives, single electron oxidation nucleoside adducts and deoxynucleoside derivatives
(Part 1). In Part 2 heterogeneous backbone oligomers containing the p-amino acid, trans2-aminocyclohexanecarboxylic acid (ACHC). and a-amino acids Ala, Phe, Val, Lys, and
Tyr in an alternating sequence have been synthesized. Computational modeling studies
have been applied in studying the diastereoselectivity of reaction intermediates in the
PAH syntheses (Part 1), the interaction between the organic compounds and
biomacromoleculcs (P-peptides with proteins Fos and Jun, Part 2), and the
conformational preference (conformations of a/p-peptides, Part 2).

Computational

modeling based on molecular and quantum mechanical techniques were applied to
complement the syntheses in Parts 1 and 2.

xxi
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GENERAL INTRODUCTION TO PARTS ONE AND TWO
The majority of the work presented in this dissertation is synthetic, with
computational modeling studies performed to better understand the kinds of organic
molecules that react with biological macromolccules and their conformations.
The synthesis in Part I involves PAHs and nucleoside derivatives. Members of
the environmentally ubiquitous class of polycyclic aromatic hydrocarbons are thought to
undergo metabolic activation to carcinogens either via oxidative metabolism to diol
epoxides or through radical cations.

Both species have been shown to cause DNA

alkylation through covalent modification of DNA. Diastereoseleclive synthesis of the
diol epoxide and some derivatives of bcn/o[ciphenanthrene have been developed. Single
electron oxidation of PAHs produces radical cations that then react with a variety of
nucleophilic sites in deoxyadenosine and deoxyguanosine producing adducted
nuclcobascs and nucleosides. For the first time, stable adducts at the cxocyclic amino
groups of nucleosides produced by single electron oxidation of PAHs have been
synthesized via a palladium-catalyzed carbon-nitrogen bond formation. A convenient
and concise strategy for the synthesis of nucleoside derivatives has also been
demonstrated.
The synthesis in Part 2 involves heterogeneous backbone oligomers.
Heterogeneous oligomers arc synthetic oligomers containing both a- and P-amino acids,
capable of mimicking the secondary structures and folding arrangement of natural protein
molecules.

I
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A variety of synthetic strategies have been employed for coupling a- and P-amino
acids, in the synthesis of heterogeneous oligomers, making use of Z-, Boc- or Fmocprotcctcd amino groups, benzyl esters for the acid terminus and, carbodiimidc methods
for the coupling steps. A simple, practical, and scalable synthetic approach has been
applied in the synthesis of p-amino acid monomers in high enantiomeric purity, needed
for coupling with commercially available a-amino acids in the synthesis of heterogeneous
oligomers. For the first lime, heterogeneous oligomers containing a- and P-amino acids
in an alternating sequence have been synthesized by both solid phase and solution phase
methodologies. Oligomers have been fully characterized and preliminary conformational
analysis performed indicating some ordered conformation in solution.
Both synthetic projects (Parts 1 and 2) are complemented with computational
modeling.

In Part 1, computational modeling studies based on the use of molecular

mechanics (MM) and quantum mechanics (QM) calculations to evaluate the
diastereoselectivity of synthetic intermediates have been performed. Computationally,
the diastereoselectivity of some synthetic steps encountered in the case of
bcnzo[c]phcnanthrene and reported for the case of benzo[a]pyrene have been evaluated.
In Part 2, conformational search methods based on Monte Carlo (MC) and torsion driving
have been applied to evaluate molecular conformations and to study the interactions
between a- and P-peptide helices held by flexible linkers. The sections that follow
describe some of the general methods used in modeling.
General Methods in Molecular Modeling
Computational chemistry generally attempts to predict the properties of molecules
without much experimental information. Computational chemistry has been growing for
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more than 40 years, and in recent times it is commonly been used in collaboration with
experiment in most research laboratories. The knowledge of the preferred geometry of a
molecule and of its corresponding energy is of critical importance. From this information
one may infer the relation between structure and activity. As the cost of computers and
computer time drops, the simulation of molecules and their properties becomes more
competitive with experimentation.
The most stable conformation of a molecule can be determined by model building
the desired structure and optimizing the structure either (a) classically or (b) quantum
mechanically by minimization using first- or second- derivative techniques. Different
conformations can be modeled.

Combining molecular modeling techniques with

experimental information provides a powerful tool for research purposes. Determining
the difference in stability between two isomers requires finding the lowest energy
conformation (global minimum) of each isomer. Molecular mechanics (MM) can be
used for finding the low-energy conformations, while quantum mechanics (QM) can be
used to assess the relative energies and equilibrium geometries for the conformers.1 It
becomes increasingly difficult, however, to model large flexible molecules because of the
large number of degrees of freedom. Two pertinent issues are the determination of the
most stable conformation (global minimum) and the location of other minima on the
potential energy surface, otherwise known as the multiple minima problem.2 In molecular
modeling studies, most of the quantities of interest, such as conformations, equilibrium
geometries and heats of reaction, come from the construction of a potential energy
surface, which is a plot of the energy against the reaction coordinate (Figure 1).'
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Figure 1 One dimensional potential energy surface.
On the potential energy surface, the energy minima and maxima are collectively
referred to as stationary points. An energy minimum is referred to as a local minimum
and corresponds to a stable molecule although some unstable intermediates may be
situated at a local minimum. The lowest energy local minimum is referred to as the
global minimum.

Random search methods such as the Monte Carlo (MC)

conformational search are able to facilitate easy treatment of systems with large numbers
of degrees of freedom."7
Molecular Mechanics
Molecular mechanics (MM) is based on a classical approach to calculate the
energy of a system.8 MM seeks to achieve a reasonably good description of the
conformational behavior of molecules with a relatively simple mathematical model. MM
treats a molecule as a set of charged point masses (atoms) connected together with
springs. MM is used to assess individual molecular structures, the number of minima and
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the energy differences between these minima.

MM calculates the total energy of a

molecule by using an empirical function which sums various individual energy terms.8
The energy terms of a particular conformation of a molecule include bond stretching,
valence angle bending, torsion, and nonbond interaction terms, such as van der Waals and
electrostatic interactions (equation 1 ).
total #l>t
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The energy components are broken down into bonded and non-bonded energies as
described below. Most of the computational work described in part one of this thesis
uses the MMFF94 force field,1’ and so the form of this force field will be used to
exemplify force fields in general. While elegant MM force fields have been and are still
being developed for the treatment of all elements,8 most of the force fields for the
treatment of organic molecules have similar general forms, known as the bonded- and
non-bonded-energy terms.
Bonded Energies
Bonded interactions among atoms arc broken down into two-, three-, and fouratom interactions. The bond term (involving two atoms) is referred to as a 1-2 interaction
term, the angle bending term (involving three atoms) is referred to as a 1-3 interaction
term, and the torsion term (involving four atoms) is referred to as a 1-4 interaction term.
The first three summations (Equation 1) represent all the bonds, bond angles and dihedral
angles of a particular molecule.

Generally, classical, all-atom force fields include

stretching, bending, and torsional interactions. Some force fields may also include the
effects of interactions between two or more of these components.

For example the

MMFF94 force field includes stretching, bending, torsional and other composite
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interactions (stretch bending and out-of-plane bending interactions).9 These composite
interactions can give better approximate descriptions of molecular conformations but are
generally smaller in magnitude than stretches, bends, and torsional effects. The bond
term is a summation over all the bonds in a structure, with the energy of each bond
evaluated depending on how far it is distorted from its equilibrium value. The bond
stretching and valence angle bending terms arc represented in the form of quadratic
equations.8
(2 )

£w <a) = { * w ( « - « . ) 3

(3)

The bond distance and angle are represented respectively by r and a while r0 and do arc
the equilibrium bond length and angle. The parameters Kanwh and K w are the stretch
and bond force constants respectively. The equilibrium bond length and angle are the
preferred values, and any deviation from this value by compression or expansion leads to
an energetic penalty. The force constant parameters determine the amount by which the
energy of a system increases for a given deviation from the ideal value.

A good

approximation for the energetic effects of deviations in the bond length or angle, within
about 0.10 A or 10 degrees, is provided by these mathematical descriptions.
In practice, torsional parameters are added to the non-bonded terms so as to give a
more accurate fit to experimental data. Torsional parameters are also key to the utility of
a force field, and the accuracy of simulations carried with the force field.9 The MMFF949
force field uses a torsional energy function of the form shown in equation (4).
Elmum = j{V1(l + cosO) + V,J(l-cos2c&) + V',(l + cos3<h))

ced with permission of the copyright owner. Further reproduction prohibited without permission.

(4)

7
Equation (4) is a threefold representation where 0 is the torsion angle between four
atoms, while V|, V;, and V3 are constants depending on the atom types (Figure 2).10'"
b
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Figure 2 The one (a)-, two (b)-, and threefold (c) components of the torsional energy
function.
The last two terms in Equation (4) represent the two- and threefold components of
the torsional energy (Figure 2 b and c). The twofold energy function forms the largest
part of the torsional energy functions and describes double bonds. The double bonds
prefer one of two specific orientations (0 and 180°), and are distorted from having all
substituents coplanar only with a large increase in energy.

The threefold torsional

expression describes typical interactions between substituents on sp3-sp3 bonds. In this
case, substituents prefer to assume staggered (±60 or 180°) instead of eclipsed
orientations.

The onefold torsional potential has no exact analogue to a specific

molecular interaction, but rather modifies the effects of the two- and threefold torsional
potentials (Figure 2 a).
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Non-bonded Energies
The non-bonded energies of a molecule typically include van der Waals (VDW)
and coulombic interactions. Some force fields contain a hydrogen bonding component as
well (e.g. AMBER).,0I> The energy of solvation is not treated as part of the force field,
but rather solvent is treated as a background continuum at a set dielectric constant.9 A
continuum solvent treatment, while being less computationally expensive than the use of
explicit solvent, can still reproduce effects of solvation.1' Generally, nonbonded
interactions involving van der Waals (VDW) interactions and electrostatic interactions
are represented as a sum of both energy terms (equation 5).
Fm m b on dtd —E
+E
^ \< 1 W T ^ n m U tm b u

(5)

The van der Waals interaction between two non-bonded atoms i and j is defined by a
Lennard-Jones potential (equation 6 ).

The nonbonded distance between the atoms is represented by /fy, while A#, By, and £y are
constants. The (A,/Ry)12 term deals with atom-atom repulsions whereas the (By/Ry)6
term treats the atom-atom attractions.
The coulombic (electrostatic) interactions take into account the interaction of
charges. As a result each atom is assigned a partial charge, depending on the charges of
the atom, and the interaction of these charges can either be attractive or repulsive. The
electrostatic energy between two atoms i and j is defined by the equation below (equation
7).
Erl„ 0 . j) = Of, x ? / )/(* * K,j)
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The nonbonded distance is represented by R,j, the dielectric constant by e, and the atomic
charges by q, and qr In MMFF94, the Lennard-Jones potential (equation 6 ), and the
Coulombic terms (equation 7) are replaced by fairly complex equations (not shown).9 For
calculations on larger structures, the nonbond interaction term dominates the computer
time required for energy evaluation, because the number of nonbonded atom pairs rises
with the square of the number of atoms 1 ’
Despite all the information that can be generated from molecular mechanics, it
does not provide any information on the electronic structure and so cannot be used when
a molecule is not in its ground state. The energies of two different molecules cannot be
accurately compared using molecular mechanics, because their respective energies are
built up from different combinations of the individual energy functions.

However,

molecular mechanics can be used to compare the relative energies of molecules with the
same connectivity, such as enantiomers and diastereomers. Computational techniques
based on molecular mechanics are most commonly used to compare different
conformations of a molecule or molecular complex, to determine energetic favorability.
Description of Force Field (MMFF94)
Many force fields have been designed for different purposes. It is not the goal of
this thesis to review the various force fields that are available, for excellent reviews exist
in the literature. However, a brief description of the force field that was used for our
calculation is presented. The Merck molecular mechanics force field (MMFF94)9 is able
to quantitatively account for the molecular geometry and conformation of common
organic systems. The MMFF94 force field was developed based on fitting experimental
variables to ab initio results for gas-phase molecules, ions, and biomolecular complexes.9
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MMFF94 is a classical, all-atom force field that is generally used for a variety of systems
and is carefully parameterized for structures and energetics in the gas-phase.u
Quantum Mechanics
The time-independent Schrodinger equation is given as equation 8.15
fTV = E>V
where // is the Hamiltonian operator and lF is a many-particlc wavefunction.

(8 )
The

Schrodinger equation for a many-particle system cannot be solved exactly without the
introduction of approximations.

One such approximation, the Bom-Oppenheimer

approximation, assumes that the nuclei do not move. The result is the generation of an
electron-based Schrodinger equation, which is still not solvable for more than one
electron (equation 9).
tf * * - =

(9)

The Bom Oppenheimcr approximation solves the Schrodinger equation for the
arrangement of electrons in a molecule moving in the field of fixed nuclei.15 The energy
of a molecule and the associated wave function, from which other electronic properties
can he calculated, are generated.
Approximation methods for determining the electronic structure include the
Hartree-Fock method, which is based on a separation of variables that replaces the manyelectron wavefunction by a product of one-electron wavefunctions known as spin
orbitals.16 The Hartree-Fock approximation generates a set of coupled differential
equations each involving a single electron. Further approximation methods have been
developed from the Hartree-Fock method such as the linear combination of atomic
orbitals (LCAO) approximation and the Roothaan-Hall equations.15 More advanced
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approximation methods include Moller-Plesset models.16 An alternative approach to the
treatment of correlation in many-electron systems is provided by the density functional
model.17 Density functional models take into account electron correlation in an explicit
manner.
Two major draw backs of quantum mechanical calculations, compared to
molecular mechanics, are their limitations to small molecules and the relative
requirement of additional computer time and money. For more efficiency and accuracy,
both molecular mechanics and quantum mechanics should be used complementarily. Due
to the flexible nature of the organic molecules treated herein (Chapter 3), MM and QM
are combined with a conformational search method, based on Monte Carlo, to address the
problem of multiple minima.
Description of Semi-empirical Module (AMD
AMI (Austin Model 1) is a parametric quantum mechanical molecular model
which is based on the neglect of diatomic differential overlap (NDDO) approximation."*
AMI has been parameterized for the treatment of a wide variety of compounds, including
those containing boron.10 Dewar el al. demonstrated the superiority of AMI compared to
other methods in predicting the heats of formation of boron-containing compounds.1'1 The
geometry and dipole moment calculated by AMI also agreed well with experiment much
better than results obtained by the ab initio Hartree-Fock method using a 4-31G* basis
set. Compared to ab initio methods which are in general more effective, semi-empirical
AMI methods are much more cost effective and can be used for rather large systems.20
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Conformational Search
Two general methods for exploring conformational space exist: conformational
search by torsion driving and conformational search using molecular dynamics.11 In
conformational search by torsion driving, the energy of the molecule is evaluated as the
conformation is systematically modified through rotation of each selected rotatable bond
by a given amount. Two different types of torsion driving calculations can be performed
in Insight II.'3 Both torsion driving methods are systematic search methods in which the
torsion angles of interest in the molecule are defined, and are then rotated through their
full range to generate trial structures for minimization.

For example to perform a

systematic search on a molecule with two torsion angles 0 and tg, the angles may be
rotated in 60° increment from 0 to 360°, producing (360/60)' = 36 trial structures to be
minimized. The number of trial structures for minimization can be increased by reducing
the angle increment and vice versa. The disadvantage of the systematic search method is
that it could be very time consuming especially for large molecules with many degrees of
freedom. A non systematic search method such as the Monte Carlo method2 is more
advantageous than the systematic search methods.
Monte Carlo Method
A Monte Carlo (MC) conformational search uses random alterations to the
molecule’s shape to explore possible conformations. Monte Carlo (MC) is based on a
stochastic method to explore conformational space. Stochastic techniques are based on
the use of random numbers and probability statistics to investigate problems. The use of a
stochastic method to explore conformational space, to solve the multiple-minima problem
in protein folding was first reported by Li and Scheraga.4 The Metropolis algorithm21 was
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used to sample potential conformations for allowed energy transitions.

Internal

coordinates (torsion angles) were randomly selected and rotated in random increments
giving a resulting structure that is optimized by energy minimization. The method was
successfully applied to locate the lowest energy conformer of a pentapeptide.4 An internal
coordinate, random-variation method has been successfully applied for searching the
conformational space of a variety of organic molecules.2 The method generally leads to
the global minimum and the location of all minima consistent with the energetic and
geometrical constraints for flexible organic molecules.
MC calculations simulate the dynamic behavior of a molecule by random changes
made to the system, such as the dihedral angle rotation or atom displacement." The
energy of the trial configuration of atoms is calculated and a choice whether to accept this
configuration is made. If the energy of a configuration has decreased from the previous
configuration, then that configuration is accepted. Otherwise, if the energy is higher after
the random change, then the MeUopolis algorithm is used to determine whether the new
configuration should be accepted.

The new configurations are accepted with a

probability given by the Boltzmann distribution (Equation 10).21
Nj
•V,

=e

A

t

( 10)

The Boltzmann constant is represented by k and the absolute temperature by T. A
random number is chosen between 0 and 1 and compared with the Boltzmann factor, and
if this number is smaller, then the configuration is accepted and the molecule is moved to
its new position. If the number is bigger, then the molecule is returned to its previous
configuration and again subjected to a random alteration.
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The MC program incorporated in PC Spartan Pro11 performs a conformational
search using the MMFF94 molecular mechanics force field for assigning the lowest
energy conformation.

The equilibrium geometry for each conformer is obtained by

performing AMI semi-empirical quantum mechanical calculations.1*
Molecular Dynamics
Molecular dynamics as a conformational search tool uses Newton's classical
equation of motion to compute the acceleration, and hence the velocity of the atoms from
the atomic forces.22 At the start of a molecular dynamics simulation, the atoms of the
molecule under consideration are assigned velocities. The behavior of the molecule is
then simulated through time. The new positions for the atoms after a short time step
(order of 1 fs) are calculated from the accelerations and the constraints of the molecular
mechanics force field. Each atom is then moved to a new position in space. Many
iteration of this process generates a series of new conformations of the structure known as
trajectories. 13 The temperature of the simulations and thus the thermal energy of the
system is directly related to the velocities of the atoms. Both low-temperature and hightemperature dynamic simulations can be performed in Insight II.'5 High-temperature
dynamics is more advantageous than low-temperature dynamics because at a higher
temperature, there is sufficient energy to climb both lower- and higher-energy barriers
faster. A molecular dynamics simulation can be allowed to run freely taking its own
unrestricted path through conformational space, or it can be controlled by imposing
restraints on parts of the molecule. The molecular dynamics simulation reported in Part 2
of this dissertation is based on unrestricted path through conformational space.
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PART ONE
SYNTHETIC AND COMPUTATIONAL STUDIES ON PAHs AND SYNTHESIS OF
NUCLEOSIDE DERIVATIVES
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CHAPTER I
OVERVIEW OF PAHs
Polycyclic aromatic hydrocarbons (PAHs) arc environmental contaminants,
formed from the incomplete combustion of organic matter. It is very common to find
these compounds in environmental sources such as air, water, and soil. Another form of
exposure to these contaminants is from societal activities such as smoking, grilling or
roasting of foods, and occupations involving the handling and manufacturing of PAHcontaining materials. The largest sources of PAHs in the air are open burning such as
burning of gasoline and diesel fuels (automobile pollution), and home heating with wood
and coal.24'25
PAHs are thought to undergo metabolic activation to carcinogens either via
oxidative metabolism to diol epoxides,25 or through single-electron oxidation to radical
cations.26'27 Both species have been shown to cause DNA alkylation through covalent
modification of DNA.25'27

Several PAHs that contain a bay- or fjord-region exhibit

cytotoxic, mutagenic and carcinogenic activity, primarily through metabolic activation to
diol epoxides.25 Two examples of PAHs containing these structural features are shown in
Figure 1.1.

16
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1.1 Structures of highly hindered PAHs: benzo[a]pyrene (BaP), and

benzo[c]phenanthrene (BcPh).
1.1 Historical Background and Carcinogenicity
The story goes that in 1666 after the great fire in London, people began building
homes with long and twisted chimneys.28 Coal was used for heating with the result that
deposits of black soot had to be removed periodically from the chimneys. In removing
these deposits, workers contracted a disease that later became known as cancer of the
scrotum. In 1775, Percivall Pott, a London-based surgeon, reported that coal dust was the
cause of this disease.'8 In 1892 Henry T. Butlin, also based in London, reported no
occurrence of the disease in countries where there was no accumulation of coal
deposits."18
In 1929, the first synthesis of a carcinogenic PAH. dibcnz[n./i]anthracene, was
reported.’9 Subsequently, within the same year, the synthesis of the 3-methyl derivative
of dibenz[a,/i]anthracene was reported.29 These compounds were tested and shown to
induce cancer in mice.29 In 1930, Hiegler and co-workers began research on the isolation
of carcinogenic hydrocarbons from tar.’°

They found that even at very low

concentration, a potent carcinogen isolated from tar was still carcinogenic on mouse skin.
In 1933, benzofalpyrene (BaP) was isolated, in a senes of experiments aimed at
identifying the chemical composition of the carcinogenic composition of coal tar/ 1 These
results sparked general interest in the study of PAH carcinogenesis. Also in 1933, Cook
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et al. reported that chemically synthesized benzo[a]pyrene and benzo[e]pyrene (BeP)
were identical to carcinogenic hydrocarbons from coal-tar.33 Cook and co-workers also
reported that the application of synthetic benzo[a]pyrene (BaP) to the backs of mice
resulted in tumors.

Their findings were later investigated and confirmed by other

groups.31-33'34
With the advances made in the correlation between PAH and carcinogenicity, it
became imperative to probe into the structural features underlying the difference between
carcinogenic and non-carcinogenic PAHs.

A number of theories were proposed to

explain the difference in carcinogenic behavior.

One of these theories is based on

reactive positions on the PAH structure. For example Fieser et al. hypothesized that the
most reactive position in BaP, carbon 6. was involved in its activation.35 36 This means
C -6 substituted derivatives of BaP will be expected to be more potent than unsubstituted
derivatives for the hypothesis to be valid. In contrast, all 6-substituted derivatives of BaP
tested for carcinogenicity were found to be less potent than the unsubstituted
derivatives.35'36 This result led to a theory that BaP. and not some metabolite, is directly
responsible for its carcinogenicity.

The inference from the above result was that

metabolism is a detoxifying event as further proven by Arcos and Argus/ 7 They showed
that with damaged livers, animals less able to metabolize BaP were more susceptible to
BaP carcinogenesis.37
The first generally persuasive theory on the relationship between carcinogenicity
and PAH structure was proposed by Pullman.’8

This theory, based on quantum

mechanical calculations, gave a new impetus to research on PAH carcinogenicity.
According to Pullman, the carcinogenicity of a PAH is related to the susceptibility of the
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‘K-rcgion’ and 'L-region' towards addition reactions (Figure 1.2). Based on the above
theory, Pullman proposed BaP to be an ideal carcinogen because it's "K- and ‘L-rcgions
are blocked and thus not exposed to oxidation.38’0 The 'K-rcgion' was proposed to be
the region of high reactivity while the ‘L-region’ that of low reactivity and detoxification.
This structure-activity relationship was widely tested with the hope that blocking of the
‘K-region’ should lead to inactivity while blocking of the ‘L-region’ should lead to
enhanced activity due to prevention of metabolic detoxification.

The results were

inconsistent among the compounds tested and so the theory was later abandoned.

• = ’K-region’
0 = 1,-region'

Figure 1.2 The ’K’ and L-rcgions’ of benzo[a]pyrcne.
Considerable progress was made towards understanding the mechanism of
carcinogenesis in the 1950s and 1960s.’10 The importance of epoxides in the metabolism
of polycyclic hydrocarbons was first recognized by Boyland.41 The work of Boyland.
contrary to earlier views that unmodified PAHs were responsible for carcinogenesis,
suggested that reactive epoxide intermediates might play a significant role in the
mechanism of carcinogenesis. The binding of PAHs to proteins in mouse skin was
reported by Miller.42 and later by Abell and Heidelberger.4’ These workers proposed that
an enzymatic step must be involved in the covalent binding of a PAH to proteins in
mouse skin. In 1964, Brookes and Lawley found that there was a better correlation with
carcinogenicity in the binding of polycyclic hydrocarbons to DNA than to protein.44
Brookes and Lawley further suggested that the reaction betw een polcyclic hydrocarbons
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and DNA was very critical in tumor initiation. The work of Brookes and Lawley was
later supported by in vitro DNA binding studies which suggested that metabolism was
vital to the process.-15'46 After an extensive study on a number of carcinogens, Miller
hypothesized that all carcinogens were generally metabolized to electrophiles which then
reacted with DNA.-17 A general hypothesis was made based on Pullman’s 'K-region’
theory3*'3*’ and Miller’s theory47 in which a given PAH is metabolized to an epoxide
followed by DNA alkylation The K-region’ epoxides were initially thought to be the
“ultimate carcinogens".

However, Baird el al. found that adducts formed from the

reaction of the “K-region” epoxides with DNA were different from those formed from
the parent hydrocarbons.4*
A significant contribution in the understanding of carcinogenesis by PAHs came
through the discovery of rra;u-7,8-dihydroxy-9,10-epoxy-7.8,9,10-tetrahydrobenzo[a]pyrene (BaPDE) as an intermediate in DNA binding (Figure 1.3).49,50 Following the
above discovery, several research groups subsequently showed that BaPDE was the
ultimate carcinogen from BaP.5153
12

1

Figure 1.3 Structure of tra/»-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tctrahydro BaP
With the discovery of BaPDE, it became possible to study the mechanism of
binding of BaP to DNA and the structure of the products.54 From these studies, it was
established that the bay-region diol epoxides were responsible for mediating the cellular
binding of PAH carcinogens to DNA. It is the goal of current research in the field to
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come out with a general theory on the chemistry of PAH-induced mutation and
carcinogenesis, which will shed some light into cancer, a disease society is plagued with.
1.2 Metabolic Activation of PAHs
Two mechanisms for metabolic activation of PAHs to carcinogens have been
proposed.25 One of these mechanisms, single-electron oxidation, leads to radical cations
as intermediates, which have been shown not to be associated with any biological activity
such as mutagenicity.55 The second mechanism, and which has been widely investigated,
involves oxidative metabolism to diol epoxides.
The pathway of oxidative metabolism of PAHs to diol epoxide involves two
phases, known as Phase I and Phase II metabolism.5’’ Phase I metabolism involves the
initial oxidation and hydroxylation, while Phase II metabolism involves the removal of
Phase 1 metabolites through conjugation, secondary metabolism and reduction.
Generally,

Phase

I transformations

are considered activating, and

Phase

II

transformations are considered detoxifying.57-00 Various enzymes, such as cytochrome
P-450 and epoxide hydrolase, are involved in the metabolic pathway (Scheme l . l ).61
Generally, four isomeric diol epoxides are produced from any PAH. These diol
epoxides have been classified as syn or series- 1 diol epoxides and anti or series-2 diol
epoxides (Figure 1.4).25 The classification of the diol epoxide as syn and anti is based on
the orientation of the benzylic hydroxyl group relative to the epoxide. When the bcnzylic
hydroxyl and epoxide are on the same side, the diol epoxides of series- 1 (syn) are formed.
On the other hand, the series-2 (anti) diol epoxides are formed when the benzylic
hydroxyl and epoxide are on opposite sides. The diol epoxides in each series have
different biological activities related to their stereochemistry.
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Cytochrome
P-450

Epoxide Hydrolase

Epoxide Hydrolase

j Cytochrome

I Cytochrome
I P-450

P-450
j________

OH

JCX

Scheme 1.1 Metabolic activation of PAHs. Heavy arrows represent the major pathways.

Figure 1.4 Structures of the four isomeric diol epoxide of any PAH.
For example the series-1 diol epoxides of planar PAHs have been shown to be
inactive as tumorigens except in the non-planar BcPh.62 In contrast, the serics-2 diol
epoxides are highly tumorigenic.02 In addition, the (R.S.S.R) diol epoxide isomer stands
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out unique in its tumorigcnicity of all the hydrocarbons studied so far.62 A large number
of diol epoxides have been studied and it has been found that reactivity, conformation,
and absolute configuration are among the factors that contribute to mutagenicity and
carcinogenicity.62
1.3 Reaction of PAHs with DNA
As previously mentioned, metabolic activation of PAHs, cither via oxidative
metabolism or single-electron oxidation, produces species which can cause DNA
alkylation through covalent modification of DNA. It is believed that these species react
with the exocyclic amino groups of deoxyadenosine (dA) and deoxyguanosine (dG) to
produce adducted DNA. Diol epoxides are thought to undergo a C-0 bond scission
producing a benzylic carbocation, which is trapped by the exocyclic amino groups of dA
and dG (Scheme 1.2A).63'66 Radical cations can also react at the exocyclic amino groups
of dG and dA to produce stable lesions (Scheme 1.2B), although apurinic sites in DNA
are also produced by this species.26 2' Metabolism and DNA binding of any PAH results
in a possible 16 nucleoside adducts (each diol epoxide reacting with deoxyadenosine and
deoxyguanosine through both cis and trans oxirane bond scission (Figure 1.5).67 The
respective hydrocarbon diol epoxides alkylate DNA to different extent and magnitudes.
They also differ in the ratio of dA to dG adduct formation.67 The current state of
knowledge in the field has revealed that the (R.S.S.R) diol epoxide of every hydrocarbon
is trapped to a greater extent by DNA than are the other isomers.
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Cytochrome P-450
Epoxide Hydrolase
DNA binding

Scheme 1.2 Binding of metabolically activated species to DNA.
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Figure 1.5 Adducts formed from epoxide ring opening of dihydrodiol epoxide
configurational isomers. 16 dA and dO (Nu) adducts formed (adapted from ref. 25).
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Hence, for detailed structure-biology studies it is necessary to generate
diastereoselective syntheses of each epoxide-nucleoside lesion.

These synthesized

lesions can then be incorporated into specific sites of biologically relevant
oligonucleotides. Structural and biological studies with these modified oligonucleotides
are expected to provide a better understanding of the events in chemical carcinogenesis.
1.4

Conformational Consideration of PAH Diol Epoxides

The reactivity and biological activity of diol epoxides is dictated by the
conformational preference of the hydroxyl groups.25 As previously mentioned, diol
epoxides are classified either as senes-1 or series-2 with the classification dependent on
the orientation of the epoxide ring relative to the benzylic hydroxyl group. A good
correlation between the conformational preferences with mutagenicities of diol epoxides
has been reported.611 Generally, in the absence of unusual factors, the hydroxyl groups of
scries- 1 diol epoxides are oriented quasi-diaxial, whereas in the serics-2 isomers these
prefer a quasi-diequatorial conformation, an arrangement in which the hydroxyl groups
are nearly in the plane of the remainder of the molecule. Study of a number of diol
epoxides has revealed that the absolute stereochemistry and conformation are important
factors in tumorigcnicity.t’,, An enhanced biological activity is generally observed when
the epoxide ring is located in a sterically hindered “bay region” with the hydroxyl groups
being trails quasi-diequatorial. An exception to this rule is the non-planar benzo[c]phenanthrene (BcPh),7IJ where high tumorigcnicity has been associated with the (S.R.S.R)
series-1 isomer (Figure 1.6) which has quasi-diequatorial hydroxyl groups. Based on the
results from numerous studies in PAH carcinogenesis, some general criteria have been
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proposed that a hydrocarbon diol epoxide must possess for high biological activity.68'6^
These criteria are listed below.
1. The presence of the epoxide ring in a bay or fjord region.
2. A irons quasi-dicquatorial orientation of hydroxyl groups.
3. An anti-onentation of benzylic hydroxyl relative to epoxide group.
4. An absolute configuration of (R,S,SJt) for the diol epoxide as read from the
benzylic carbinol carbon to the benzylic epoxide carbon.
1.5 Chemistry of PAH-DNA Interactions
The exact chemistry underlying the reaction of the active PAH metabolite, the
diol epoxides, with DNA is not fully understood. One school of thought however, based
on hydrolysis studies of benzo[a]pyrene diol epoxides (BaPDE).71 has suggested that a
carbocationic intermediate may be involved.

Such a carbocation would be prone to

reaction with a variety of nucleophiles. In an aqueous DNA environment, one would
expect the carbocation to be trapped predominantly by water.25
5-Ring PAH
Unhindered
bay region

4-Ring PAH
Hindered
bay region

OH

Scheme 1.3 Mechanistic rationalization of the difference in reactivity between different
diol epoxides and DNA.
A mechanism has been proposed involving an intermediate that is either partially
or completely ionized (Scheme 1.3).72 Thus the reaction of diol epoxides with
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nucleophiles, probably proceeds by protonation, followed by partial or complete
ionization, and then reaction with the nucleophile.

This mechanism implies that

alkylation by diol epoxides is acid-catalyzed, and the rate depends on the stability of the
intermediate carbocation.

The stability of the carbocation can be estimated from

theoretical charge distribution in the cation based on Hiickel theory."
The difference between the carbocation intermediate in relation to the structure of
the diol epoxide is explained by the different extent of charge delocalization around the
aromatic nucleus and steric hindrance at the bay region.’5 This might mean that the more
the charge around the aromatic nucleus is delocalized, the more stable the diol epoxide.
Also the less sterically congested the bay region, the more reactive the diol epoxide. In
fact it has been shown that unhindered bay region dihydrodiol epoxides having four
aromatic rings such as, benzo[o]pyrene and dibenz[a,j]anthracene are highly reactive
towards hydrolysis.72 With four aromatic rings there is greater charge delocalization
coupled with the uncongested bay region making the diol epoxides readily reactive and
therefore proceeding through a fully ionized intermediate (Scheme 1.3). On the other
hand, sterically congested and non planar diol epoxides from benzo[c]phenanthrcne,
having only three aromatic rings are less reactive.72

The non planar nature of

benzo[c]phenanthrenc and the presence of only three aromatic groups restricts the
effective delocalization of charge which could result in its diol epoxide reacting through a
partially ionized intermediate. 2 In the iight of all these, it was thought that the poor
trapping of benzo[c]phenanthrene diol epoxide by water could be due to reaction of the
diol epoxide via a partially ionized intermediate (Scheme I.3 ).72 The reaction of
benzo[c]phenanthrene diol epoxide through a partially ionized intermediate would then
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promote better competition between the more nucleophilic DNA and water, unlike in the
case of a fully ionized intermediate.7'

It was then shown that for the (R,S.S,R)

stereoisomer, the hindered diol epoxides were trapped more efficiently by DNA than the
unhindered diol epoxides. 2
1.6

Kinetics of PAH Diol Epoxide-DNA Binding

The general view in the literature proposes either an external binding site, in
which the hydrocarbon lies outside the stack of DNA bases, presumably in the narrow
groove, or it is intercalated.7,1'13 The kinetics based on the interaction of benzo[a]pyrene
diol epoxide with DNA that has been reported,7,173 is represented by two possible reaction
pathways shown in Figure 1.6.
BaP-tetrahydrotctrol

Complex 1 (intercalated)
BaPDE + DNA

H*
Complex 2 (externally bound)

Covalent binding

Figure 1.6 Two possible reaction pathways of PAH-DNA binding.
Hsu el al.

reported that the rale of covalent binding of //an.?-7,8-dihydroxy-anri-

9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (arm-BaPDE) was greater than that of
syn-BaPDE. It has been suggested that the decreased reactivity of syn-BaPDE relative to
rra/i.v-BaPDE is because the syn-isomcr is not in the right conformation to fit into the
DNA helix, possibly due to its diaxial hydroxyl groups.71 Even within the stable transBaPDE enantiomers, the relative extents of binding of (+)-(7/?,8S,9S,10/?)-BaPDE and
(-)-(75,8/f,9/?,105)-BaPDE with DNA have been investigated.'8 80 Although the isomers
have equal stability, and both binding to DNA and DNA-catalyzed hydrolysis occur at
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the same rate,81 the extent of binding favors the (+)-(7/?,8S,9S,10/f)-cnatiomer.78 80 A
possible explanation to this difference in extent of binding of the enantiomers is the way
in which they fit into DNA.
Computer modeling studies were carried out to study the intercalation of both
enantiomers into DNA.82 The complex with (+)-(7fi,8S,9S,10/?)-<wtfi-BaPDE was
energetically more favorable. With both enantiomers, it was found that the epoxide ring
was close to the amino group of guanine, which suggested that physical binding could be
followed by chemical reaction.82 88 Computational studies have also been carried out on
the c/s and trails adducts of anti-BaPDE.84'85 In the case of the A2-deoxyguanostne (dG)
adducts, it was shown that the cis adducts are less conformationally flexible than the
traits adducts due to steric crowding since the hydroxyl groups are on the same side of
the benzylic ring as guanine.84 The hydroxyl groups in the traits adducts are on the
opposite side of the benzylic ring, which makes the minor groove position in DNA
duplexes more favorable to the traits than cis adducts. Similar studies carried out on the
(+)-7/?,8S,9S,10/?- and (-)-7S,8/?,9/?,105-irans-aiiri-BaPDE-A'6-deoxyadenosine (dA)
adducts revealed that intercalation over a major groove results from steric and
hydrophobic effects.85'86 The hydrophobic pyrenyl moiety is not exposed in the major
groove but is rather buried within the helix. Computational calculations showed that the
(-)-lOI? isomer is more stable compared to the (+)-IOS isomer.86 Computational
investigation of the conformational preference of the (+)-W? and (-)-lS-trans-antiBcPhDE- .V2-dG adducts have recently been reported.87 Conformers that optimized
stacking interactions, contributing to the stability of intercalated BcPhDE-DNA duplex
structures, were highly favorable.87 Experimental studies, based on circular dichroism,
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fluorescence quenching, melting and electrophoresis, of anfr-BaPDE-DNA were carried
out showing the intercalation of the pyrenyl moiety into the DNA helix .88
Experimental evidence supporting an exterior binding site has also been reported
in the literature. In one report, it was found that the fluorescence of an//-BaPDE-DNA
was quenched readily by oxygen or iodide ions, implying that the pyrene nucleus was
exposed to molecules in solution and consequently not intercalated.89 Poulos et a l‘KI
measured the rate of oxygen quenching of a/i/t-BaPDE-DNA solutions by flash
photolysis. They found the rate of oxygen quenching to be faster than with intercalated
species, again supporting the view that the pyrene residues were easily accessible and
thus found in an exterior binding site. The binding of DNA to the syn isomer of BaPDE
has also been investigated.91 It was found that the pyrene residues were either intercalated
or bound externally in a ratio of 2 : 1 .
As already mentioned in the preceding paragraphs, the interaction between
polycyclic aromatic hydrocarbons and DNA has been studied by various analytical and
computational methods. Herein, molecular mechanics and quantum mechanics are used
to rationalize experimental results. Computer simulations have been carried out without
using any experimental constraints, except those incorporated in the force field, and it is
interesting that the results came close to experiment.

It is the hope that combining

computational chemistry with experimental chemistry will help to increase the
productivity of experimental labors.

In chapter 3, the objectives and results of the

computational studies are presented.
This part of the dissertation will focus on the synthetic and computational studies
on polycyclic aromatic hydrocarbon derivatives, and the synthesis of nucleoside analogs.
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Chapter 2 involves the synthesis of the fjord region

tctrahydroepoxide of

benzofrjphenanthrene and other derivatives of the non planar benzo[c]phenanthrene.
Chapter 3 involves computational evaluation of the diastereoselectivity in the synthesis of
hydroxylated derivatives of benzo[a]pyrene and benzo[c]phenanthrenc. In chapter 4, the
synthesis of nucleoside adducts corresponding to the binding of polycyclic aromatic
hydrocarbon radical cations, particularly from benzo[n]pyrene, to deoxyadenosine will be
reported. Importantly, we have applied our knowledge of palladium catalysis, based on
previous work in our laboratory, to synthesize single electron oxidation adducts for the
first time. In chapter 5, synthesis of compounds from other significant collaborative
group projects will be reported.
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CHAPTER 2
SYNTHESIS OF DIOL EPOXIDE AND DERIVATIVES OF THE FJORD REGION
BENZO[C]PHENANTHRENE

2.1 Introduction
Benzo[c]phenanthrene (BcPh) is a nonplanar molecule belonging to the class of
polycyclic aromatic hydrocarbons characterized by a highly congested fjord-region.
BcPh is a relatively weak carcinogen, ' and its metabolic activation leads to two pairs of
diastereomeric diol epoxides, namely syn and aiui benzo[c]phenanthrene diol epoxide
(Figure 2.1) ? ,,<)4 Each diastereomer consists of a pair of enantiomers.
Fjord region
11

2

7

6

BcPh

series 2 (anti)
BcPh 3,4-diol-1,2-epoxide

series 1 (syn)
BcPh 3,4-diol-1,2-epoxide

Figure 2.1 Structuresof BcPh and its series-1 and series-2 diol epoxides.
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Both diastereomers have been shown to be highly mutagenic and exhibit
exceptionally

high

tumorigenic

activity.95'06

Both

enantiomers

of

anti

benzo[c]phenanthrenc dio! epoxide can react with purines in DNA9394 through cis and
trans addition leading to the corresponding cis and traits adducts, w'ith a predominance of
trans addition.93
The congestion of the fjord-region diol epoxide metabolites of BcPh confers
specific and unusual properties to this class of polycyclic aromatic hydrocarbons unlike
their less congested bay-region counterparts. For example, ?rarw-3,4-dihydroxy-a/itr-1,2epoxy-1,2,3,4-tetrahydrobcnzo[c]phenanthrene (1/?,25,35,4/?) isomer, Figure 2.1 has
been reported to exhibit the greatest tumorigenic activity of all hydrocarbon diol epoxides
tested so far.70 The fjord-region diol epoxides of BcPh are highly efficient DN'A
alkylating agents compared to other polycyclics.92 In addition, the series 1 (syn) diol
epoxides show a conformational preference in which the hydroxyl groups have a quasidiequatorial orientation9 9S Generally among polycyclics. the syn isomer prefers a
conformation in which the hydroxyl groups are quasi-diaxial.98 This unusual
conformational preference of the hydroxyl groups in the syn isomer of BcPh diol epoxide
may be responsible for the high tumorigenic activity exhibited by the syn isomer
(1/?,25,3R,45) isomer, Figure 2.1, not common among other bay-region diol epoxide
metabolites.'0 Among other carcinogenic PAHs, only the series-2 (anti) stereoisomer
(l/?,2S,35,4/f) isomer, Figure 2.1 has been shown to exhibit high tumorigenicity.62
The diol epoxides of BcPh also differ from other PAHs in the region at which
reaction occurs with DNA. Compared to the diol epoxides of benzo[rt]pyrene (BaP),
chrysene, and benzo[a]anthraccne. which largely alkylate the N~ amino group of
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deoxyguanosine residues, the diol epoxides of BcPh predominantly alkylate the A/6 amino
group of deoxyadenosine residues.25 00 Reaction of the planar PAHs with DNA occurs in
the minor groove23 while with the diol epoxides of BcPh, reaction with DNA occurs in
the major groove.25'09 Thus, the diol epoxides of BcPh are distinguished by their
exceptionally high level of covalent binding to DNA in vitro and the relatively high ratio
of deoxyadenosine to deoxyguanosine adducts. High-resolution NMR solution structures
of adducts of the series-2 isomers of BcPh, (+)-lf? and (-)-lS-tranx-anri-BcPh with dA
and dG, in DNA have been studied.100 102 These studies have shown that the BcPh moiety
adopts an intercalated position in the DNA duplex. The (+)-l/? isomer is intercalated on
the 5’-side of the modified adenine and on the 3'-side of the modified guanine. The (-}IS isomer on the other hand is intercalated on the 3’-position of the modified adenine and
on the 5'-position of the modified guanine. All adducts cause changes that can lead to
mutagenesis and cancer initiation through distortion in function of key oncogenes or
tumor suppressor genes.103105
It is important to synthesize stereochemically defined PAH-DNA adducts for
biological studies.

The first step is to synthesize enanliomerically pure BcPh diol

epoxides in order that the biological activity of individual isomers can be accessed. In
this chapter, the syntheses of the diol epoxide and other derivatives of the fjord region
BcPh are reported.
2.2 Synthesis
Synthesis of diol epoxide was mostly accomplished following literature
procedures with some modifications where necessary pertaining to the chemistry of
benzo[c]phenanthrcnc. The key step in the synthesis is the photochemical ring closure of
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l-(2,3-dimethoxyphenyl)-2-(2-naphthyl)ethylene to 3,4-dimethoxybenzo[c]phenanthrene.
Photochemical ring closure of the appropriate olefins to PAHs in general and to the fjordregion BcPh in particular is well documented in the literature.1™’ 110 In all cases reported,
photocyclization appeared to offer a convenient general synthetic route to PAH
derivatives since the required olefins can be readily synthesized via the Wittig or
Grignard reactions.
2.2.1 Synthesis of Benzofclphenanthrenc Diol Epoxide
A retrosynthetic analysis for the synthesis of the diol epoxide of BcPh is shown
below (Figure 2.2).

Figure 2.2 Retrosynthetic analysis for the synthesis of tran.v-3,4-dihydroxy-au/i-1,2epoxy-l,2,3,4-tetrahydrobenzo[c]phenanthrene (2-7).
The required naphthylstyrene substrate 2-3 (Figure 2.2) for the photolysis reaction
was readily synthesized as follows. Commercially available 2-bromomethyinaphthalene
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2 -1 was converted to the methylnaphthalene triphenylphosphonium salt 2-2 by reacting

with triphenylphosphine under reflux in toluenefScheme 2.1).

Scheme 2.1 Synthesis of methylnaphthalenctriphenylphosphonium bromide.
A Wittig condensation reaction of 2-2 with 2,3-dimethoxybenzaldehyde with
sodium methoxide in methanol afforded a cis-trans mixture of styrene 2-3 in 97% yield
(Scheme 2.2).

Scheme 2.2 Synthesis of 1(2,3 dimethoxyphenyl)-2-(2-naphthyl)ethylene (2-3).
The ratio of cis- to rranx-isomer was assigned based on 'H NMR integration of
the methoxy singlets corresponding to cis and irons olefin. A ratio of approximately
1:1.5 (cis.trans) was obtained for the mixture. Once the alkene 2-3 was obtained, the
next step was the photolytic ring closure.
Photocyclization reactions for the conversion of alkenes to polycyclic systems are
well

known.

Naget

bcnzo[c]phcnanthrene

and

el

al.

reported

chrysenes

by

the

synthesis

photocyclization

of

alkyl-substituted

of

the

requisite

naphthylstyrene.106 Amin and co-workers107 and subsequently Utermochlen and co
workers'08 reported an improved photochemical synthesis of chrysene derivatives. The
photocyclization reaction for the synthesis of polycyclic systems through ultraviolet
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irradiation of a styrene moiety in solution in the presence of catalytic iodine and
dissolved oxygen has proven to be a valuable synthetic method.109 An improved
photocyclization methodology involving the use of stoichiometric iodine and propylene
oxide in the absence of air has also been reported." 0 Liu el al. reported a general
improvement in yield and purity of products formed from the improved methodology.110
Both photocyclization methods were used in the synthesis of the benzo[c]phcnanthrcne
derivatives, with an overall improvement in the yield and purity of the product noticed, as
had been reported for the improved methodology involving the use of stoichiometric
iodine and propylene oxide." 11
Photochemical ring closure was carried out by the two methods mentioned in the
previous paragraph. The first method involved the use of catalytic iodine and oxygen.
The second method (modified method) involved the use of stoichiometric iodine and
propylene oxide in the absence of air. Photolytic oxidative ring closure of 2-3 in benzene
with a 450 W medium-pressure Hg lamp, and a catalytic amount of iodine under oxygen
proceeded smoothly giving a low 37% yield of 2-4. To improve the yield for this step of
the synthesis, the modified method" 0 described above was implemented.

When the

photolysis reaction was carried out with excess propylene oxide and stoichiometric
iodine, in the absence of air, a much improved yield %% of 2-4 was obtained (Scheme
2.3).

Scheme 2.3 Synthesis of 3,4-dimethoxybcnzo[c]phenanthrene (2-4).
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The possible reasons for the difference in yield and purity of products from both
methodologies have been reported.1111 In the first method, catalytic amounts of iodine
plus air were used as oxidant while in the second method stoichiometric amounts of
iodine was used as oxidant with propylene oxide serving to consume the HI formed. The
presence of HI can lead to photoreduction of double bonds thereby lowering the product
yield.

But in the presence of propylene oxide, the HI formed is consumed and

photorcduction is prevented leaving the double bonds to photocyclize to the desired
product. Photooxidative side reactions that would otherwise be common in the presence
of air arc also prevented in the absence of air. Stoichiometric iodine therefore, is a good
oxidizing agent in photocyclization reactions but it must be used in conjunction with
propylene oxide which is needed to remove the reducing agent HI generated from
oxidation by iodine.
Once 3,4-dimethoxybenzo[r]phcnanthrenc 2-4 was obtained, the next step was
the conversion to 3,4-diacetoxybenzo[c]phenanthrene 2-5. The methoxy groups in 2-4
were cleaved by a two step process involving treatment with boron tribromide in
methylene chloride followed by acetylation of the resulting catechol with acetic
anhydride in the presence of 4-AW-dimethylamino pyridine and pyridine in ether to
afford 2-5 in 88% yield (Scheme 2.4).
1. BBr3, CH2CI2,-5 aC— - r.t.
2. Ac20, Py. DMAP, Et20
2-4

88%

2-5

Scheme 2.4 Synthesis of 3,4-diacetoxybenzo[c]phenanthrenc (2-5).
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Reduction of 2-5 with sodium borohydridc in ethanol under an oxygen
atmosphere

afforded

stereospecifically

the

desired

(+)-fra/i.s-3,4-dihydroxy-3.4-

dihydrobcnzo[<']phenanthrenc (2-6) in 51% yield (Scheme 2.5). 'H NMR confirmed the
formation of only the traits isomer.
NaBH4, EtOH
02
51%
2-5

2-6

Scheme 2.5 Synthesis of (±)-rra/i.v-3,4-dihydroxy-3,4-dihydrobenzo[c]phenanthrene (26).
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Figure 2.3 Partial 'H NMR spectrum (in DMSO-<4) of the saturated ring protons 1-4 of 26. Viewed from left to right, peaks correspond to H-l, H-2,0-H, O-H, H-4 and H-3.

The NMR chemical shifts and couplings of the saturated ring protons of 2-6 were
in good agreement with literature values. " 1 The aliphatic resonances of BcPh dihydrodiol
have been reported in which only one set of signals is observed, indicating fast
interconversion of potential P and M helical isomers on the NMR time scale.112 Figure
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2.3 shows the aliphatic resonances of 2-6 with only one set of signals observed,
confirming the existence of only one isomer.

A large coupling constant also exist

between the carbinol protons of 2-6 C/3,4 = 10.1 Hz), which is indicative of a diequatorial
orientation of the hydroxyl groups.
The final step involved the epoxidation of 2-6 with m-chloroperbenzoic acid. It is
known that PAH dihydrodiols having a quasi-dicquatorial arrangement of hydroxyl
groups undergo stereoselective epoxidation with m-chloroperbenzoic acid from the same
side as the allylic hydroxyl group:” Thus, dihydrodiol 2-6 was stereoselectively
converted to the anti-diol epoxide 2-7, in which the epoxide oxygen atom is on the
opposite face to the benzylic hydroxyl group, by treatment with m-chloroperbenzoic acid
(Scheme 2.6).

Scheme

2.6

Synthesis

of (±)-3a,4p-dihydroxy-la,2a-epoxy-l,2,3,4-tetrahydroben-

zo[c]phenanthrene (2-7).
The epoxidation reaction of 2-6 proceeded smoothly affording 2-7 in 67% yield as
a single isomer as determined by !H NMR. The 'H NMR spectrum and the physical
property of the diol epoxide 2-7 was consistent with the structural assignment and was in
good agreement with that reported in the literature98 The coupling constant for the
carbinol protons of 2-7 was 7.9 Hz, which is an indication that the conformational
preference of the hydroxyls 2-7 in solution favors the diequatorial orientation.
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2.2.2

Synthesis of Derivatives of Benzolrlphenanthrene

The syntheses of other derivatives of benzo[c]phenanthrene were accomplished
from frans-3,4-dihydro.xy-3.4-dihydrobenzo[c]phcnanthrene 2-6. Two protective groups
were employed for protection of the hydroxyl groups. The choice of the protecting group
was made taking into account that a critical step in the reaction sequence involved
oxidation. Ester groups are especially useful for protection during oxidations and are
quite stable, compared to other groups. Acetates and benzoates were used as the ester
derivatives.

Acetylation was accomplished by treating 2-6 with pyridine, acetic

anhydride, and 4-A,,A'-dimethylaminopyridine to afford 2-8 in 80% yield (Scheme 2.7).

Ac20 , Pyr. DMAP
80 %
2-6

2-8

Scheme 2.7 Synthesis of (±)-frans-3,4-diacetoxy-3,4-dihydrobenzo[c]phenanthrene (2-8).
Several reagent combinations were tried to form the benzoate ester derivative. In
one case the dihydrodiol 2-6 was reacted with benzoyl chloride in pyridine in the
presence of DMAP. After stirring for 24 hours, reaction did not show any product
formation as judged by TLC.

The initial reaction conditions were modified by

substituting DMAP with a stronger base, namely NaH. Although product was formed
upon modification of reaction condition, 'H NMR of product still showed inseparable
impurities with a modest yield of 60% obtained for the product.

The best reaction

condition was the use of benzoyleyanide, DMF, and EtjN. When reaction was carried
out under this condition, the product 2-9 was obtained with a yield of 92%, containing a
trace of inseparable impurities (Scheme 2.8).
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PhCOCN, Et3N,
DMF

92%

Scheme 2.8 Synthesis of (±)-/ra/K-3,4-dibenzoy!oxy-3,4-dihydrobenzo[c]phenanthrene
(2-9).
Osmium-catalyzed dihydroxylation of olefins remains one of the most reliable
methods for the synthesis of vicinal alcohols. " ’ 115 The standard Upjohn dihydroxylation
procedure uses the NMO/OsOj system, with water needed to remove osmium from the
diolate.1 The standard Upjohn dihydroxylation reactions are generally carried out in
aqueous solvent. Dihydroxylation of polyenes using the Narasaka’s modification of the
Upjohn procedure has been reported.117 Standard Narasaka dihydroxylation procedure
uses the NMO/OsO* system with phenylboromc acid to remove osmium from the
diolate.118 Dihydroxylations using the Narasaka conditions are generally carried out in
anhydrous solvent. Narasaka boronate-capture offers an added advantage of allowing a
wider range of reaction conditions." 1 It has been shown that catalytic OsOj
dihydroxylation of BaP dihydrodibenzoate using the Upjohn procedure proceeded with
reasonably high facial selectivity and produced the 7(5, 8a, 9a. 10a tetraol dibenzoate as
the major product (Figure 2.4).110

Major (7p. 8a, 9a, 10a)

Minor (7(t. 8a, 9P, 103)

Figure 2.4 Tetraol dibenzoates of BaP from dihydroxylation procedures.
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However, the Narasaka dihydroxylation using catalytic 0 s 0 4 and phenylboronic
acid afforded the 7f), 8a, 9a. 10a tetraol dibenzoate boronate exclusively which upon
oxidation provided the diastereomerically pure diol.m Similar chemistry was tested on
the more sterically congested benzo[c]phenanthrene.

Both acetate and benzoate

protected BcPh derivatives were used for this.
Reaction of 2-8 with 1 equivalent each of NMO and phenylboronic acid provided
the oxidation product, boronate ester 2-10 in 58% yield (Scheme 2.9). The product was
analyzed by 'H NMR and electrospray ionization mass spectrometry.

Proton NMR

showed that only one tetraol diacetate boronate isomer was formed. A similar reaction
was performed with the more bulky benzoate protective group in which an increase in
yield was noticed.

Scheme

2.9 Synthesis

of (±)-3a,4[)-diacetoxy-la,2a-di hydroxy-1 .2,3,4-tetrahydro-

benzo[c]phenanthrene bis(phcnylboronate) (2 - 10 ).
Reaction of 2-9 with 1 equivalent each of NMO and phenylboronic acid provided
the oxidation product, boronate ester 2-11 in 72% yield (Scheme 2.10). The product was
analyzed by !H NMR and high resolution mass spectrometry. Proton NMR showed that
only one tetraol dibenzoate boronate isomer was formed.
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Ph

Scheme 2.10 Synthesis of (±)-3a,4p-dibenzoyloxy-la,2a-dihydroxy-1,2,3,4-tetrahydrobenzo[c]phenanthrcne bis(phenylboronate) (2 - 1 1 ).
The deprotection of the boronales was achieved by oxidative cleavage using
aqueous hydrogen peroxide. The byproducts (phenol and boric acid) were separated
from the product by column chromatography. Treatment of 2-10 with a 50% aqueous
solution of hydrogen peroxide in a 1:2 mixture of ethyl acetate in acetone at room
temperature afforded a 44% yield of 2-12 (Scheme 2.11). The product was characterized
by 'H NMR and electrospray ionization mass spectrometry.
Ph

Scheme 2.11 Synthesis of (±)-3u,4[i-diacetoxy-l u,2«-dihydroxy-l ,2,3,4-telrahydrobenzo[c]phenanthrcnc (2 - 1 2 ).
Similarly, treatment of 2-11 with a 50% aqueous solution of hydrogen peroxide in
a 1:2 mixture of ethyl acetate in acetone at room temperature afforded a 58% yield of 213 (Scheme 2.12). The product was characterized by 'H NMR and high resolution mass
spectrometry.

Proton NMR showed that two products were formed.

The aliphatic

protons were assigned on the basis of the COSY spectrum of 2-13. Attempts were made
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to synthesize 2-13 directly from 2-9 using the Upjohn procedure and in all cases a
mixture of products was formed with very low yield, the best being 26%. Details of the
synthesis are presented in the experimental section.

Scheme 2.12 Synthesis of (±)-3a,4P-dibenzoyloxy-la,2a-dihydroxy-1,2,3,4-tetrahydrobenzo[c]phcnanthrene (2-13).
2.2.3

Towards the Synthesis of a Benzofclphenanthrene Amino Triol

The main goal in the synthesis of derivatives of benzofclphenanthrene, reported in
the preceding section, was to obtain the amino triol of benzofclphenanthrene (Scheme
2.13).

Such amino tnols upon reaction with fluoro nucleosides will provide

stereochemically defined nucleoside lesions that can be incorporated into biologically
pertinent DNA sequences.
OH

OH

2-13: COCbH5

Scheme 2.13 A plausible pathway to benzofclphenanthrene amino triol.
Regio- and stereo-controlled synthesis of aryl cis aminoalcohols from cis glycols
using Mattocks chloride has been reported.1"" The chemistry developed1"0 was applied in
an attempt to synthesize the amino triol of benzofclphenanthrene (Scheme 2.13). The
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route to the amino triol is a four step process involving reaction of the tetraol with uacetoxyisobutyryl chloride (Mattocks chloride) resulting in the formation of a trails
vicinal chlorohydrin acetate with the halide in the benzylic position. This is subsequently
followed by displacement of the chloride with an azide ion. deprotection of the ester and
reduction of the azido group by catalytic hydrogenation. Initial attempts at synthesizing
the amino triol were unsuccessful.

However, much effort was not invested in the

synthesis to find out why initial attempts were unsuccessful because the project was
halted when Dr. Lakshman moved to CUNY.
2.3 Summary
The synthesis of the active metabolite of benzo[c]phenanthrene, (+)-rrans-3,4dihydroxy-um;'-1 .2 -epoxy-1 ,2,3.4-ietrahydrobenzo[r]phenanthrene

(2-7).

has

been

accomplished. Proton NMR showed that the pattern of the aromatic protons of 2-7 was
consistent with that reported for benzo[c]phenanthrene ring system. This compound was
sent to a collaborator for DNA binding studies.
Several derivatives of benzo[e]phenanthrenc have also been synthesized. We
have shown that the Narasaka in situ boronate-capture modification of the Upjohn
catalytic dihydroxylation procedure can be applied for extended aromatic systems such as
benzo[c)phenanthrenc. The Narasaka dihydroxylation procedure gave only one boronate
isomer. Although deprotection of the boronate gave a mixture of products in the case of
the dibenzoates, overall the yield and purity of the reaction is better than dihydroxylation
using the standard Upjohn procedure. However, the acetates may be suitable for the
synthesis of the BcPh aminotriol.
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2.4 Experimental
Melting points (m.p.) were determined on a Thomas Hoover Capillary Melting
Point Apparatus and arc uncorrected. Proton nuclear magnetic resonance (*H NMR) was
recorded in deuterated solvents on cither a multi-nuclear Varian VXR-300 (300 MHz) or
a Bruker AVANCE-500 (500 MHz) spectrometer. Chemical shifts are reported in pans
per million (ppm, 6). 'H NMR splitting patterns are designated as singlet (s), doublet (d),
triplet (t), quartet (q), or quintet (quint). All first order splitting patterns arc assigned
based on the appearance of the multiplct. For those splitting patterns that could not be
easily visualized or interpreted, a designation of multiple! (m) or broad (br) was used.
Coupling constants are reported in Hertz (Hz). Analytical thin layer chromatography
(TLC) was carried out on glass-backed Analtech TLC plates precoated with silica gel
(250 pm layer thickness) containing a fluorescent indicator. Column chromatography
was performed using 200-300 mesh silica gel from Natland. Electrospray ionization
(ESI) mass spectra were determined on a Kratos MS-80 spectrometer.

Fast atom

bombardment mass spectra (FABMS) and high-resolution mass spectra (HRMS) were
determined on an AX505 spectrometer. Photochemical ling-closures were performed
with a Hanovia photoreactor equipped with a 450 W medium-pressure Hg lamp and a
Pyrcx filler. Monitoring the course of the photochemical reaction was accomplished by
gas chromatography (GC), thin layer chromatography (TLC) and proton nuclear
magnetic resonance ('H NMR).

The injector and detector were maintained at

temperatures of 200 and 250 °C respectively. All reactions were carried out in freshly
distilled and dried solvents. Unless otherwise stated, all other commercially available
reagents and solvents were used without further purification.
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Synthesis of 2-mcihvlnaphtlivItriplicnvlphosphonium Bromide (2-2)

2-2

To a stirred solution of 2-(bromomethyl)naphthalene 2-1 (5.0 g, 22.61 mmol) in
toluene (30 mL) was added triphenylpliosphine (6.5 g. 24.78 mmol). The mixture was
heated under reflux overnight. The mixture was cooled to room temperature and hexane
was added followed by filtration of the precipitated solid. The solid was washed three
times with hexane to afford the phosphonium salt 2-2 (10.22 g, 94%) as a white powder.
The phosphonium salt was then used in subsequent reactions without further purification.
Synthesis of l-(2.3-dimcihoxvpl)envl)-2-(2-naphthvl)ethene (2-3)

2-3

To a solution of 2-2 (10.22 g, 21.14 mmol) in MeOH (215 ml.) was added
NaOMe (2.28 g, 42.22 mmol). A slight color change from yellow to pale yellow was
observed. The mixture was stirred at room temperature for 1.5 hours followed by the
addition of 2,3-dimethoxybenzaidehyde (3.16 g, 19.02 mmol). The reaction was allowed
to proceed at room temperature for 48 hours. After completion of the reaction, as judged
by TLC. the mixture was diluted with CH2CI2 and washed with H2O. The organic layer
was dried over Na2SC>4 and the solvent was evaporated.

The crude product was

impregnated onto silica gel and the mixture loaded onto a dry-packed silica column.
Elution with CH2CI2 afforded 2-3 as a colorless powder (5.97 g, 97%). Integration of the
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methoxy singlets corresponding to cis- and trans-olefins showed a ratio of approximately
2:3: Rf = 0.28, 1:1 hexane/benzcnc; m.p. 70-72 °C; *11 NMR (300 MHz, CDCIj) 8 7.857.65, 7.62-7.37, 7.36-7.20 (m, 10H, ArH), 6.90-6.76 (m, 2H, CH=CH), 3.90, 3.89 (s, 3H.
OCll5), 3.88. 3.87 (s, 3H. OCH,); MS-ESl m/z 313.0 [M + Na]+.
Synthesis of 3.4-dimethoxvbenzolclphenanthrcne (2-4)

Photochemical ring closure of 2-3 to 2-4 was performed by using either catalytic
I2 in the presence of O2 or stoichiometric I2 and propylene oxide. A description of both
methods follows with the second method affording better yields.
Method 1: Using Catalytic E and Air
The alkene (4.86 g) was photolyzed in three equal batches. To a solution of the
alkene 2-3 (1.62 g, 5.59 mmol) in benzene (1 L) was added catalytic amount of iodine
(30 mg). The resulting mixture was subjected to photolysis while maintaining a sparge of
air through the mixture for the entire duration of the reaction. The reaction was complete
within 7 hours. The course of the reaction was monitored by GC (Ir(2.j )= 6.08 and 7.28
min; tau-n = 7.79 min). The reaction mixture was concentrated on a rotary evaporator.
The combined crude from the three runs was redissolved in CH2CI2, and washed with 2 %
aqueous Na2S2C>3. The organic layer was dried over anhydrous Na2-S0 4 and concentrated
by rotary evaporation. The crude product was impregnated onto silica gel, and the
mixture loaded onto a dry-packed silica column.

Elution with a mixture of 2:1

hexane:benzenc yielded 2-4 as a colorless solid (1.83 g, 37%).
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Method 2: Using Stoichiometric !■>and Propylene Oxide
The alkene (5.94 g, 20.48 mmol) was photolyzed in eight equal aliquots.
Nitrogen was bubbled through a solution of the alkene 2-3 (0.74 g, 2.55 mmol) and
iodine (0.72 g, 2.83 mmol) in benzene (963 mL) for 30 minutes followed by the addition
of propylene oxide (37 mL). The mixture was subjected to photolysis while maintaining
a constant flow of Nj throughout the entire duration of the reaction.

Reaction was

generally complete within 8 hours as judged by TLC and 'H NMR. The reaction mixture
was concentrated by rotary evaporation. The combined products from the eight equal
aliquots was redissolved in CH2CI2 and washed with 15% aqueous NajSjOi. The organic
layer was dried over NaaSOj and the solvent removed on a rotary evaporator. The crude
product was then subjected to column chromatography as described in Method I above,
yielding 2-4 as a colorless solid (5.68 g, 96%).
A sample of the product was rccrystallizcd from methanol giving 2-4 as white
crystals: Rf = 0.21, 1:1 hexane/benzene; m.p. 105-107 °C; 'l l NMR (500 MHz, CDCIj) 6
9.09 (d, J = 8.4 Hz, 1H, ArH), 8.89 (d, J = 9.4 Hz, 1H, ArH), 8.27 (d, J = 8.8 Hz, IH,
ArH), 8.02 (br d, J = 7.85 Hz, 1H, ArH), 7.88-7.82 (m, 3H, ArH), 7.69-7.61 (m, 2H,
ArH), 7.44 (d, J - 9.3 Hz, 1H, ArH), 4.09 (s, 6 H, 20CHj); MS-fiSI ni/z 311.0 (M + N a]\
599.1 [M + N af.
Synthesis of 3.4-diacctoxvbenzofdphcnanthrcnc (2-5)
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To a stirred solution of 2-4 (3.1 g, 10.75 mmol) in dry CH2CI2 (62.5 mL) was
added a solution of boron tribromide (23 mL of a l M solution in CH2G 2, 22.7 mmol) at
-5 °C, under N2 over a period of 10 minutes. The mixture was allowed to warm to room
temperature and stirred for 2 hours. The mixture was hydrolyzed with ice-cold H 2O and
diluted with CH2CI2. The organic layer was washed several times with distilled H2O to
neutrality and dried over anhydrous Na^SOj. The organic layer was then concentrated on
a rotary evaporator and dried further under vacuum. To the residue was added anhydrous
diethyl ether (269 mL) followed by pyridine (9 mL, 110 mmol), acetic anhydride (20.2
mL, 214 mmol), and 4-/V,A'-dimethyIaminopyndine (0.14 g, 1.15 mmol). The reaction
mixture was then stirred at room temperature overnight. The mixture was diluted with
Et20 and washed with 1 M HCI (100 mL), then with an aqueous saturated solution of
NaHCOj. The organic layer was dried over anhydrous NuiSOa and evaporated. The
crude product was purified by SiC>2 flash column chromatography using CH2CI2 as eluent
to afford 2-5 as a yellowish solid (3.24 g, 88%): Rr = 0.44, CH2CI2; ’ll NMR (300 MHz.
CDCI3) 6 9.07-9.03 (m, 2H, ArH), 8.04 (dd. J = 2.0. 8.0 Hz, IH, ArH), 7.96-7.88 (m, 3H,
ArH), 7.83 (app d, J,pp = 8.5 Hz, 1H, ArH). 7.74-7.62 (m, 2H. ArH), 7.54 (d, J = 9.3 Hz,
111, ArH), 2.53 (s, 3H, OCOCHj), 2.41 (s, 3H, OCOCH3); MS-ESI m/z 367.0 (M + N a]\
711.1 (2M + NaJ+.
Synthesis of (±)-/rw»-3.4-dihvdroxv-3.4-dihvdrohcnzofrlphcnanthrene (2-6)
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A portion of the diacctoxybenzo[c)phenathrene 2-5 (0.67 g. 1.95 mmol) was
dissolved in absolute ethanol (217 mL) and the mixture was sonicated.

This was

followed by the addition of NaBl i4 (0.74 g. 19.6 mmol) portionwise over a 30 minute
period, while 0 2 was bubbled into the reaction mixture. The reaction mixture was then
stirred tinder an 0 2 balloon for 48 hours. Dilution with water caused the precipitation of
a white solid which was filtered, washed with water and extracted into ethyl acetate. The
organic layer was dried over anhydrous NaiS0 4 and evaporated. The crude product was
punfied by column chromatography using ethyl acetate and recrystalli/.cd from hexane to
yield the pure diol 2-6 (0.26 g, 51%) as white crystals: Rf = 0.17, 1:1 benzene/hexane;
m.p. 192-194 °C; 'll NMR (300 MHz, Me2SO-4) 8 8.54-8.50 (m, 1 H, ArH,2), 8.01-7.97
(m, 1H, ArHi>), 7.91-7.84 (m. 2H, ArH78), 7.76 (app s, 2H. ArH,6). 7.66-7.60 (m, 2H,
Arllio.i i), 7.20 (dd, J = 10.1,2.1 Hz, 1H, H,), 6.23 (dd, / = 10.2, 2.2 Hz, 1H, Hj), 5.67 (d,
J = 5.8 Hz, 1H, OH), 5.35 (d,y = 4.7Hz, 1H. OH). 4.60-4.54 (m.y3.4= 10.1 Hz, 111, H.,),
4.51-4.44 (m, 1H, Hi); MS-ESI m/z 263.1 [M + H]*.
Synthesis of (±)-3a.4B-dihvdroxv-lu.2a-cpoxv-1.2.3.4-tctrahvdrobenzofclphcnanihrene

A solution of 2-6 (0.08 g, 0.30 mmol) in anhydrous THF (10 mL) was sparged
with N2 and cooled to -78 °C. To this solution was added m-chloroperbenzoic acid (0.42
g, 2.43 mmol) and the mixture was allowed to warm and stirred at room temperature for 1
hour under N2. The mixture was then diluted with diethyl ether and washed sequentially
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with ice-cold 0.5 M solution of NaOH, II20, and brine. Dilution with diethyl ether
caused the formation of an emulsion which persisted after adding brine. Dilution with
ethyl acetate followed by washing with ice-cold 0.5 M solution of NaOH and brine gave
a solution without emulsion. The organic layer was dried over anhydrous Na2S0 4 and
evaporated to provide a faint yellow solid. The resulting solid residue was dissolved in
cold diethyl ether and centrifuged, followed by trituration with cold 25% hexane in
diethyl ether. This afforded the diol epoxide 2-7 as a white powder (0.058 g, 67%): R( =
0.39, ethyl acetate; m.p. 183-185 °C; 'H NMK (500 MHz, Me2SO-<4) 6 8.67-8.64 (m,
1H, ArH,2), 8.05-8.03 (m, IH, ArH,>), 7.98 (app d,

= 8.2 Hz, 1H, ArHg), 7.91 (app d,

yapp = 8.2 Hz, 1H, A1H7), 7.81 (app q, Jw = 8.8 Hz, 2H, ArH5.6), 7.69-7.67 (m, 2H,
ArHio.n), 5.84 (d. J = 6.2 Hz, 1H, OH), 5.65 (d, J = 5.0 Hz, 1H. OH), 4.74 (d. J = 4.7 Hz,
1H, If,), 4.62-4.60 (m, JiA = 7.9 Hz, 1H, H„), 3.81-3.79 (m, IH, H3), 3.72-3.70 (m, IH,
II2); MS-ESI mJz 301.1 [M + Na]L
Synthesis of (±l-fra>i.v-3.4-diaectoxv-3.4-dili vdrobenzofclDhenanthrcne (2-8)

The dihydrodiol 2-6 (0.66 g, 2.52 mmol) was dissolved in diethyl ether (58 mL)
and sonicated. To the resulting solution was added pyridine (1.94 mL) followed by acetic
anhydride (4.4 mL, 46 mmol), and 4-ALV-dimethylaminopyridine (0.03 g, 0.25 mmol).
The mixture was stirred at room temperature overnight and was subsequently diluted with
EtiO and washed with 1 N HCI, followed by aqueous saturated solution of NaHCC>3. The
organic layer was dried in anhydrous Na2SQ4 and evaporated. The crude product was
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purified by Si0 2 column chromatography to afford 2-8 (0.70 g, 80%) as a pale brown
solid: Rr = 0.54, 2% acetone in CH2Ct2; m.p. 148-150 °C; 'H NMK (500 MHz. CDCh) 8
8.53 (d, 7 = 7.1 Hz, 1H, ArH), 7.94-7.92 (in. III, ArH), 7.82 (d, 7 = 8.0 Hz, 1H, ArH),
7.75 (app d, Jm = 8.7 Hz, 1H, ArH), 7.68-7.64 (m, 2H, ArH), 7.64-7.58 (m, 2H, ArH),
7.54 (app d, Jm = 8.0 Hz, 1H, Ht), 6.37 (d, 7 = 6.8 Hz, IH, R,), 6.27 (dd, 7 = 10, 4 Hz,
III, H3), 5.76-5.73 (m, 1H, H:), 2.18 (s, 3H, OCOCHj), 2.13 (s, 3H, OCOCH.,); MS-ESI
m/z 369.0 [M + Na]', 715.1 [2M + Na]+.
Svnthesis of (±)-mm.v-3,4-dihenzovloxv-3.4-dihvdrobcnzolclphenanthrene (2-9)

2-9

A sample of the dihydrodiol 2-6 (0.01 g, 0.04 mmol) was dissolved in DMF (0.60
mL) and Et3N (0.051 mL) was added. Benzoylcyanide (0.013 g, 0.10 mmol) dissolved in
DMF (0.3 mL) was added and the mixture was stirred at room temperature for 40
minutes. The mixture was diluted with ethyl acetate and washed with H20 followed by
brine. The organic layer was dried over anhydrous Na2S0 4 and evaporated to afford the
crude product. The crude product was purified by S i0 2 column chromatography using
30% ethyl acetate in hexane to yield the dibenzoate 2-9 (0.0165 g, 92%) as a yellowish
oil containing a trace of unseparated impurities: Rf = 0.76, ethyl acetate; 'l l NMR (300
MHz, CDCh) 5 8.59-8.54 (m, 1H, ArH), 8.18-7.36 (m, 18H. ArH & H,). 6.84 (d, 7= 8.5
Hz. 1H, H4), 6.40 (dd, 7 = 10.2, 3.5 Hz, 111, H3), 6.25-6.20 (m, HI, H2); I1RMS ealed for
C32H220 4 470.1518, found 470.1495.
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Synthesis, of (t)-3a,4B-diucctox y-1 a,3a-Jih vdrox v-1,3,14lctriihvdroben/.ofc|phenanlhrene hisfphenvlboronale) (2 - 10 )
Ph
> -Q
,,,OAc
’>*OAc
2-10

Into a 25 mL round-bottomed flask under a nitrogen atmosphere was added
0 s 0 4 (1.82 mg, 7.16 pmol) dissolved in CH2CI2 (1.5 mL). This was followed by the
addition of phenylboronic acid (38.5 mg, 0.32 mmol), solid NMO (37.0 mg, 0.32 mmol),
and 2-8 (0.10 g, 0.29 mmol) dissolved in CHjCb (1 mL). Additional CH2CI2 (3.2 mL)
was added to rinse reactants off the sides of the flask and to bring volume to the desired
amount. The reaction was stilted at room temperature under a nitrogen atmosphere for
17 hours. A 10 % aqueous solution of sodium sulfite (5 mL) was added to quench the
reaction mixture, and the two-phase mixture was stirred for 15 minutes. The layers were
separated, and the aqueous layer was extracted twice with CH2CI2 (100 mL, total
volume). The combined organic layers were dried over anhydrous NaiSOj, filtered, and
concentrated in vacuo. The crude product was purified by a trituration procedure in
which the product was dissolved in a minimum amount of diethyl ether and excess
hexane added followed by sonication until a precipitate formed. The resulting precipitate
was centrifuged, rinsed with more hexane, and dried under vacuum to afford 2-10 (0.08
g, 58%) as a gray powder: Rf = 0.37, 10% ethyl acetate in CH 2CI2; 'l l NMR (500 MHz,
CDClj) 6 9.27 (d, J = 8.3 Hz, 1H, ArH), 7.90-7.83 (m, 3H, ArH), 7.74-7.64 (m, 4H,
ArH), 7.48-7.46 (m, 3H, ArH), 7.34-7.32 (m, 2H, ArH), 6.61 (d, J = 8.0 Hz, 1H, H,)_
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6.48 (d, J = 8.6 Hz, 1H, H4), 5.28-5.26 (m. 1H, Hj), 5.09-5.07 (m, III, Hj), 2.15 (s, 3H,
OCOCHj), 1.96 (s, 3H. OCOCHj); MS-ESI

m Jz

491.1 [M + N af, 959.2 [2M + Na]+.

Synthesis of (±t-3a.4p-dibcnzovloxv-la.2u-dihvdroxv-1.2.3.4tetrahvdrobenzofclphenanthrene bis(phenvlboronate) (2 - 1 1 )
Ph

,0-0

Into a 25 mL round-bottomed flask under a nitrogen atmosphere, was added
0 s 0 4 (1.76 mg, 6.92 pmol) dissolved in CH2CI2 (1.5 mL). This was followed by the
addition of phcnylboronic acid (37 mg, 0.30 mmol), solid NMO (35.6 mg, 0,30 mmol),
and 2-9 (0.12 g, 0.26 mmol) dissolved in CH2CI2 (1 mL). Additional CH2CI2 (3.0 111L)
was added to rinse reactants off the sides of the flask and bring volume to the desired
amount. The reaction was stirred at room temperature under a nitrogen atmosphere for
19 hours. A 10% aqueous solution of sodium sulfite (5 mL) was added to quench the
reaction mixture, and the two-phase mixture was stirred for 25 minutes. The layers were
separated, and the aqueous layer was extracted twice with CH2CI2 (100 mL, total
volume). The combined organic layers were dried over anhydrous Na2S0 4, filtered, and
concentrated in vacuo. The crude product was purified by a trituration procedure in
which the product was dissolved in a minimum amount of diethyl ether and excess
hexane added followed by sonication until a precipitate formed. The resulting precipitate
was centrifuged, rinsed with more hexane, and dried under vacuum to afford 2 -11 (0.11
g, 72%) as a gray solid. 'H NMR after the first trituration showed some impurities and so
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product was triturated a second time to obtain 2 -1 1 (0.10 g, 66%) as a gray powder: R, =
0.62, 10% ethyl acetate in CH2CI2; !H NMK (500 MHz, CDCIj) 8 9.42 (d, J = 8.5 Hz.
1H, ArH), 8.11 (d, J = 7.7 Hz, 2H, Aril), 8.01-7.93 (m, 6H, Aril), 7.82-7.68 (m, 5H,
Aril), 7.57-7.33 (in, 9H, ArH), 7.04 (d, J = 9.6 Hz, 1H, H,), 6.82 (d, J = 8.0 Hz, 1H, 114),
5.56-5.53 (m, 1H, H3), 5.46-5.43 (in, 1H, H2); HR MS ealed for C, 8H27BOfl 590.1901,
found 590.1910.
Synthesis of l±)-3a.4l)-diacetoxv-lu.2ct-dih vdroxv-1,2.3.4letrahvdrobcnzofi'lphenanthrene (2 - 12 )
QH

The boronate derivative 2-10 (0.075 g, 0.16 mmol) was dissolved in a minimum
amount of a 1:2 mixture of EtOAc-acetone (13 mL).

A 50% aqueous solution of

hydrogen peroxide (0.15 mL, 5.2 mmol) was added, and the reaction was stirred at room
temperature for 10 hours. The reaction mixture was diluted with ethyl acetate, washed
sequentially with water, 10% aqueous ice-cold Na2S 0 3 and water. The organic layer was
dried over anhydrous Na2SC>4 and concentrated on a rotary evaporator.

The crude

product was passed through a plug of silica gel packed with CH2C12. The compound was
dissolved in 10% acetone in CH2C12 and passed through this silica plug. Additional 10%
acetone in CH2C12 was added until all of the compound was eluted. The resulting oil
obtained by evaporation of the solvent was dissolved in a minimum amount of ether and
precipitated in hexane. The precipitate was isolated by filtration and dried under vacuum
to afford 2-12 (0.027 g, 44%) as a colorless powder: Rr (10% acetone in CH 2CI2) = 0.34;
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*H NMR (500 MHz, CDCI3) 59.24 (d. J = 8.5 Hz, 1H, ArH), 7.97-7.45 (m, 7H, ArH).
6.45 (brs, 1H, OH). 5.89 (br s, 1H. OH), 5.32-5.29 (m, 1H, H,), 4.55-4.41 (m, 1H, H4),
4.20-4.18 (m, 1H, Hj), 3.73-3.71 (m, 1H, H2), 2.30 (s, 3H, OCOCHj), 2.13 (s, 3H,
OCOCH3); MS-ESI 403.1 [M + Na]+, 783.1 [2M + Na]*.
Synthesis of (±)-3a.4B-dihenzovloxv-la.2a-dihvdroxv-1.2.3.4telrahvdiobenzofclphenanthrenc (2-131

The boronate derivative 2-11 (0.10 g, 0.17 mmol) was dissolved in a minimum
amount of a 1:2 mixture of EtOAc-acctone (14 mL). To this solution was added a 50%
aqueous solution of hydrogen peroxide (0.15 mL, 5.2 mmol) in one portion, and the
reaction was stirred at room temperature for 5 hours. The mixture was then diluted with
ethyl acetate, washed sequentially with water, 10 % aqueous ice-cold NajSC^ and rinsed
with more water. The organic layer was dried over anhydrous NaiSOj and concentrated
on a rotary evaporator. The resulting yellowish-gray solid was dissolved in 5% ethyl
acetate in CH2CI2 and eluted through a plug of silica gel packed with CH 2CI2, using 5%
ethyl acetate in CH2CI2 as eluting solvent. The solution was concentrated on a rotary
evaporator and dried on vacuum line. The crude product was dissolved in a minimum
amount of ether and precipitated in hexane. The precipitate was isolated by filtration and
dried under vacuum to afford a colorless solid. The impure solid was purified by Si02
column chromatography eluting with 2% ethyl acetate in CH2CI2 to afford 2-13 (0.04 g,
58%) as a yellowish-white solid: R, (5% ethyl acetate in CH2CI2) = 0.38; m.p. 102-104
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°C; 'H NMK (500 MHz, CDC13) 5 9.29 (br d, J = 8.5 Hz, 2H, H 12 roaj(X
8.23-8.21, 8.10-7.92, 7.83-7.42 (m, 34H. ArH

minor™™). 7.09 (d, J = 4.7 Hz, 1H,

6.08~6.05 (m, 2H, IT4 major and minor
\
isomer). 5.84 (t, J —3.7 Hz, 1H, H2 In)nor isomer), 5.65 (t, J —3.2 Hz, 1H, H2
isomer), 4.74
Hi

minor isomer)*

6.76 (d, J = 2.6 Hz, 1H, H|

minor isomel),

major isomer)*

(br, 1H, H3mij„, isomer), 4.62 (br. 111, 1I3 minor isomer); MS-ESI 527.1 [M + Na]*, 1031.1 [2M
+ N af; HRMS ealed forC 32H240 6 504.1573, found 504.1578.
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CHAPTER 3
COMPUTATIONAL EVALUATION OF DIASTEREOSELECTIVITY IN THE
SYNTHESIS OF A KEY INTERMEDIATE LEADING TO NUCLEOSIDE ADDUCTS
OF BaP AND BePh

3.1 Introduction
As described in the introductory section, polycyclic aromatic hydrocarbons
(PAHs) are ubiquitous environmental contaminants, which exhibit cytotoxic, mutagenic
and carcinogenic activity through metabolic activation to diol epoxides.62 For more than
six decades, scientists have been trying to probe the structural factors responsible for
PAH carcinogenesis.121 Studies of a variety of diol epoxides have shown that factors
contributing to carcinogenicity include reactivity, conformation adopted by molecules
and absolute configuration in addition to the conformation.62 Metabolism and DNA
binding of any PAH results in 16 possible nucleoside adducts, in which each diol epoxide
reacts with dcoxyadenosinc or deoxyguanosine through cither a cis or trans oxirane bond
scission.25 The extent to which diol epoxide isomers of PAHs react with DNA varies,
and the reactivity of each diol is selective. Hence, for detailed structural and biological
studies, it is necessary to generate diastereoselective syntheses of each diol epoxidenucleoside lesion.

En route to a diastereomericaliy pure diol derived from the

dihydrodibenzoate of benzo[a]pyrene (BaP), an unexpected and interesting result was
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discovered.119 Catalytic OsCXi dihydroxylation of benzo[a]pyrcnc dihydrodibenzoate 3-1
proceeds with reasonably high facial selection producing tetraol dibenzoatc BaPI as the
major product (Scheme 1). A Narasaka dihydroxylalion using catalytic OsO,i and
phenylboronic acid, PhB(OHb, however, produced the tetraol dibenzoate boronate
BaPBl exclusively.11^ This boronate, upon oxidation, provides the diastereomerically
pure tetraol dibenzoate BaPI (Scheme 3.1).

(±)-3-1

(±)-BaPB1

(±)-BaPB2

OCOPh

OCOPh

(s)-BaP1

(±)-BaP2

Scheme 3.1 Synthesis of tetraol dibenzoate and tetraol dibenzoate boronate derivatives
of bcnzo[rr]pyrcne.
It is also of interest to apply the same set of reactions to the more sterically
congested benzo[c]phenanthrene (BcPh) derivatives (Scheme 3.2).

The question

therefore was to find out if the dihydroxylation reaction could equally be applicable to
BcPh. If the dihydroxylation reaction is applicable to BcPh, then by analogy to the Bal’
case the sequence outlined in Scheme 3.2 could occur.

As shown in Scheme 3.2,

subjecting (±)-/ran.v-3,4-dibenzoyloxy-3,4-dihydrobenzo[c]phcnanthrene 3-2 to Narasaka
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dihydroxylation could produce the isomers of the tetrahydrodiol dibenzoate boronate
derivatives BcPBl and BcPB2. The boronate could then be oxidized to the isomers of
3,4-bis(bcnzoy loxy)-1,2-dihydroxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene BcP 1 and
BcP2. An interesting question that arose during these studies was: Can computational
methods aid in understanding the diastereoselectivily of some of the reaction steps in the
syntheses of BaP (Scheme 3.1) and BcP (Scheme 3.2) intermediates'? Such intermediates
are then valuable precursors for the synthesis of nucleoside lesions.
B -0
...OCOPh
,

..

..

PhB(OH)2
'O C O P h------------------------0 s 0 4 (cal). NMO
CHj CI2

(±>-3-2

0 s0 4

OCOPh

(*)-BcPB1

H20 2
ElOAc
Acetone

NMO
THF-H20

OH
.

..OCOPh
OCOPh

(±)-BcP1

(±)-B cP2

Scheme 3.2 Synthesis of tetraol dibenzoate and tetraol dibenzoate boronate derivatives
of benzo[c]phenanthrene.
The computational techniques include drawing an initial structure of the
molecule, and then ap plying both molecular mechanics (MM) and quantum mechanics
(QM) methods; the computations can determine the physical properties of the molecules.
The incorporation of conformational searching methods, such as Monte Carlo (MC),
makes the treatment of large organic molecules with many degrees of freedom easier.
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MC conformational search using the MMFF94 force field determines the lowest-energy
conformation of each isomer.

Semi-empirical AMI quantum mechanical methods

determine the equilibrium geometry and heats of formation for the isomers. Boltzmann
weighting factors assess the relative probability or population of each isomer.
The flexible torsion angles for the MC and AMI geometries are measured and
compared.

Semi-empirical AMI calculations also provide thermodynamic quantities

such as standard enthalpies and entropies.

The solvation energies for the tetraol

dibenzoate isomers are also obtained using the SM5.4 model of Cramer and Truhlar.1 ”
Laali et al. have successfully carried out AMI scmi-cmpirical calculations to explain the
selectivity in the synthesis of stereoisomers of chrysene.12'1 Recently, a computational
investigation aimed at explaining the differences in stereochemical, structural, and
thermodynamic stability between stercoisomeric bcnzo[a]pyrcne diol epoxides has been
repotted.16 These workers investigated the origins of the stability of the stereoisomeric
benzo[a]pyrene deoxyadenosine adducts in a DNA mutational hot spot sequence using a
combination of molecular dynamics and molecular mechanics with Poisson-Boltzmann
surface area methods to compute the free energy differences. Similar computational
investigations have been repotted employing the (+)-lfl and (-)-l.V-fram «»ri-BcPh-/V’guanosinc adducts, void of the sugar residues, as prototypes.87 Computational methods
involved energy minimization aimed at investigating the benzylic ring conformation and
fjord region twist using high-resolution NMR solution structures.
The isomeric derivatives of bcnzo[«]pyrenc (Figure 3.1) arc represented by BaPl
and BaPBl for the anti isomers (major isomers) and BaP2 and BaPB2 for the syn isomers
(minor isomers).

The corresponding isomeric derivatives of benzofcjphenanthrene
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(Figure 3.2) are represented by BcPl and BePBl for anti isomers (major isomers) and
BcP2 and BcPB2 for the syn isomers.

Figure 3.1 Isomeric boronates of BaP and BcPh with torsion angles.

OCOPh
(±)-BaP1

Figure 3.2 Isomeric tetraol dibenzoates of BaP and BcPh with torsion angles.
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The torsion angles measured are also defined and shown in Figures 3.1 and 3.2.
Only the torsion angles at the point of difference in configuration of the isomers were to
be considered. The goal of this chapter then is to elucidate the fundamental structural
differences between the isomers that account for their difference in reactivity and to
relate the results to experimental observations.
3.2 Methods
Starting structures were first built in 2 dimensions (2D), then converted to 3
dimension (3D) in PC Spartan Pro (Wavefunction, Inc.).

The structures were then

refined by minimization with the Merck molecular mechanics force field (MMFF94).
The stereochemistry of the refined starting geometry was assigned by choosing configure
labels from the Model menu and checking chirality from the dialog that appeared. This
way the chiral centers were labeled using the R, S configuration. The refined molecular
structure was then subjected to a Monte Carlo (MC) conformational search to establish
the best conformer (low-energy conformer) for the molecule. In the Setup calculation
menu, conformer distribution and equilibrium geometry were chosen as the task to be
accomplished. Molecular mechanics using MMFF94 force field was chosen as the type
of calculation method. No constraints were applied and no frozen atoms were chosen.
After establishing the best energy conformation (global minimum) or a structure close to
it, AMI semi-empirical calculation was performed to establish the equilibrium geometry
of this conformer.

In setting up the quantum mechanical calculation, equilibrium

geometry was chosen as the task to be performed while scini-cmpirica! AMI was chosen
as the method. Again no constraints were applied and no frozen atoms chosen. In the
compute menu, solvation energy was chosen for the tetraol dibenzoate isomers, but not
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for the boronate dibcnzoate isomers, because the method has not been parameterized for
boron atom. Choosing the solvation energy in the compute menu enabled the calculation
of the aqueous solvation energy using the SM5.4 procedure of Cramer el al.m The
solvation energies calculated are usually added to the gas-phase total energies obtained
from AMI calculations. Because the SM5.4 procedure of Cramer el al. has not been
parameterized for the carbon-boron bond, solvation energy option was not chosen for the
boronate dibenzoate derivatives.

Frequency was also checked in the compute menu

ensuring the calculation of second derivatives of energy, which were used to calculate the
zero-point vibrational energies. Calculation of an electron density surface as well as the
electron density surface onto which the value of the electrostatic potential had been
mapped was performed.
The incorporation of MC conformational search method in PC SPARTAN Pro
was important particularly for the treatment of large and flexible organic molecules with
large numbers of degrees of freedom. First, an initial geometry was produced using the
Builder menu in PC Spartan Pro, and its structure was optimized by molecular mechanics
energy minimization using the MMFF94 forecfield to obtain initial strain energy, This
initial refined structure was then submitted to the MC conformational search that located
all readily accessible conformations with the goal of attaining the global minimum. The
resulting minimum energy conformcr was compared with previously found conformers to
test for the possibility of duplication. If the newly generated conformer was a previously
undiscovered conformer, then it was added to an accumulating list of unique conformers.
The cycle was then repeated, and a new starting geometry was obtained and energy
minimized. The search was terminated when new minima ceased to be found, and the
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lowest energy conformation was reported. Starting geometries were generated using
random or pseudorandom variations of molecular geometry. Because no bonds were
constrained the conformational search ran for a sufficiently long period of time covering
all regions of conformational space. The probability of finding new conforincrs at any
point in time depended upon the number of undiscovered conformers, in which case the
number of new conformers decreased as the search progressed. The search began at an
initial temperature of 5000 K, and this temperature was varied until the lowest energy
conformation was found at 300 K.
At the end of the conformational search, similar molecules and high energy
conformers were discarded, leaving only the best conformations (i.e., low energy
conformations). The best conformations, a maximum of 100 conformations, were
retained and displayed on a spreadsheet. By sorting these conformations, the spreadsheet
arranged them according to their potential energies in keal/mol beginning with the lowest
energy conformation. The lowest energy conformation was then saved in preparation for
a semi-empirical AMI calculation to determine the equilibrium geometry.
The semi-empirical AMI calculation was used to obtain the heat of formation of
the lowest energy conformer of one isomer relative to the other. In the AMI calculation,
the following menus were chosen in the Calculations dialog: Equilibrium Geometry,
Semi-empirical, AMI and MMFF conformer. The calculation was performed in the gas
phase with a total molecular charge of 0 and spin multiplicity of 1 .
The strain energies were obtained from the molecular mechanics (MM)
calculations, while the heats of formation were obtained from semi-empirical calculations
using a restricted Hartree-Fock AMI (RHF/AM1) model. The zero-point vibrational
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energies were obtained by checking the vibrational modes in the setup calculation menu.
Standard thermodynamic quantities obtained at 298.15 K and 1.00 atm included the
translational, rotational, and vibrational enthalpies and entropies. The conformational
enthalpies and entropies were calculated from the translational, rotational and vibrational
enthalpies and entropies. The conformational free energies and Boltzmann weighting
factors were determined using standard thermodynamic relationships.124
The Boltzmann weighting factor or fractional statistical weight,

, of each

isomer relative to the other was computed from the relationship
p _

iL _ ,

ar-u u»t

( 1)

N, "

Where AE12 is the relative energy of the isomers in keal/mol; R is the universal gas
constant in kcal mol'1 deg'1, and T is the temperature in kelvin. The free energy changes
(AG) were then computed from the relationship
AG = AH - TAS

(2)

The flexible torsion angles, at the point of difference, for each isomer were measured
using the Geometry model in PC Spartan Pro.
3.3 Results
The potential energies of the lowest energy conformations obtained after the MC
conformational

searches for the tetraol dibenzoate and boronate isomers of

benzo[a]pyrene and benzo[r)phenanthrene are shown in Table 3.1.

The calculated

Boltzmann weighting factors are also shown in Table 3.1. The flexible torsion angles for
the lowest energy conformations after the MC conformational searches are given for the
boronate isomers in Table 3.2 and for the tetraol dibenzoate isomers, in Table 3.3. Note
that there are five torsion angles for each of the boronate isomers and two torsion angles
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for each of the tetrao] dibenzoate isomers. Only those torsion angles at the point of
reaction and where the isomers differ in absolute configuration are considered. The heats
of formation by AMI semi-empirical method for the boronatc and tetraol dibenzoatc
isomers of benzo[«]pyrene and benzole]phenanthrene are shown in Table 3.4. Also
included are the energy differences between the isomers and the Boltzmann weighting
factors.

Table 3.1 Lowest Potential Energy Conformations Obtained by MC Conformational Searches at 298.15 K.
Compound

Polcntial (keal/mol)

BaPl

186.034

AE (keal/mol)

Boltzmann Factor N;/Ni
0.841

1.091
BaP2

187.125

BaPBl

125.548

0.159
0.987
2.566

BaPB2

128.114

BcPI

IS6.110

0.013
0 997
3.393

BeP2

189.503

BcPBl

176.450

0.003
0.993
2.944

BcPB2

179.394

0.007

Table 3.2 Measured Torsion Angles for the Boronate Isomers (degrees).
Angle

Atoms

BaPBl

Yl

C-C-B-O

-37.85

Y2

C-B-O-C

Yr

BaPB2

BcPBl

BcPB2

-24.70

-42.61

-34.44

-107.21

119.06

-102.07

-98.21

B-O-C-H

-145.82

137.20

77.44

-151.87

Y*

B-O-C-H

80.50

-75.94

-159.13

80.59

Ys

C-B-O-C

132.10

-144.58

129.65

125.85
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Table 3.3 Measured Torsion Angles for the Tctraol Dibenzoatc Isomers (degrees).
Angle

Atoms

BaPl

BaP2

BcPl

BcP2

Ya

H-O-C-H

-73.22

73.81

66.38

-71.47

r#

H-O-C-H

-71.09

96.76

68.46

-97.82

Table 3.4 Heals of Formation by AMI Semi-empirical Calirulations.
Compound

Hf (keal/mol)

BaPl

-125.206

AHf (keal/mol)

Boltzmann Factor N2/N|
0.951

1.788
BaP2

-123.418

BaPBl

-121.505

0.049
0.858
1.158

BaPB2

-120.347

BcPl

-129.653

0.142
0.925
1.532

BcP2

-128.121

BcPBl

-124.030

0.075
0.997
3.573

BePB2

-120.457

0.003

Tables 3.5 and 3.6 show the torsion angles measured for the AMI geometries of
the boronatc isomers of BaP and BcP and tctraol dibenzoatc isomers, respectively. As in
the case of the MC geometries, five torsion angles are reported for the boronatc isomers
and two torsion angles for the tetraol dibenzoate isomers. The four atoms defining the
torsion angles are also represented in the tables. For each isomer the same set of four
atoms were picked so a comparison between the isomers could be made without
ambiguity. The same symbol was used for the angles in both isomers. The torsion angles
for the boronatc isomers are read in a clockwise direction.
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Tabic 3.5 Measured Torsion Angies for the Boronate Isomers of AMI Geometry (degrees).
Angle

Atoms

yi

BaPBI

BaPB2

BcPBl

BcPB2

C-C-B-0

0.87

-5.62

-3.68

6.63

T!

C-B-O-C

-178.69

179.22

178.97

175.93

Y3

B-O-C-U

-118.94

121.00

116.67

-113.28

Y4

B-O-C-H

114.75

-112.43

-116.28

119.65

Ys

C-B-O-C

-178.61

176.36

179.12

-177.28

Table 3.6 Measured Torsion Angles for the Tetraol Dibenzoate Isomers of AM 1 Geometry (degrees).
Angle

Atoms

BaPl

BaP2

BePl

BcP2

Yu

H-O-C-H

-69.30

164.77

68.09

-170.03

Yp

H-O-C-H

-71.84

78.54

63.33

-59.95

The standard thermodynamic quantities computed at 298.15 K and 1.00 atm are
shown in Table 3.7.
The energy due to solvation for the tetraol dibenzoate isomers calculated using the
SM5.4 model of Cramer and Truhlar is shown in Table 3.8. The energy difference and
Boltzmann weighting factors calculated are also provided.
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Tabic 3.7 Thermodynamic Quantities at 298.15 K and 1.00 atm.
Compound

AG (kcal/mol)

G (kcal/mol)

11 (kcal/mol)

TS (kcal/mol)

284.904

344.260

59.356

284.977

344.275

59.298

322.049

396.141

67.092

330.261

396.279

66.018

277.153

334.969

57.816

277.127

335.234

58.107

320.926

386.836

65.910

321.695

386.836

65.141

BaPI
0.073
BaP2
BaPBt
1.211
BaPB2
BcPI
-0.026
BcP2
BcPBl
0.769
BcPB2

Tabic 3.8 Solvation Energies of Tclraol Dibenzoate Isomers.
Compound
BaPI

(kcal/mol)

AliVO|Vin,0i, (kcal/mol)

Boltzmann Factor
0.957

-13.389
1.868

BaP2

-11.521

BcPI

-10.350

0.043
0.710
0.734

BcP2

-9.616

0.290

3.4 Discussion
The major and minor isomers of the tetraol dibenzoates of benzojujpyrene BaPI
and BaP2 differ by 1.091kcal/mol with the minor isomer BaP2 having a greater energy
(Table 3.1). The Boltzmann factor of the minor isomer BaP2 relative to the major isomer
BaPI is 0.159, and assuming that only these isomers are formed, then the Boltzmann
factor for the major isomer is 0.841. Then the population would be 15.9% for the minor
isomer BaP2 and 84.1% for the major isomer BaPI. The same trend is seen for the
energies of the lowest energy conformations of the major and minor isomers of the
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boronatc derivatives of bcnzo[a]pyrene BaPBl and BaPB2 where the major and minor
isomers, BaPBl and BaPB2 respectively differ by 2,566 keal/mol with the minor isomer
BaPB2 having a greater energy. The Boltzmann factor results in populations of 98.7%
and 1.3% for the major isomer BaPBl and the minor isomer BaPB2 respectively. The
lowest potential energy conformations of the tetraol dibenzoatc isomers of
bcnzo[e]phenanthrenc BcPl and BcP2 differ by 3.393 keal/mol with the minor isomer
BcP2 having a greater energy. The Boltzmann distribution gives a 99.7% to 0.3% of the
major isomer BcPl relative to the minor isomer BcP2.

The boronate isomers of

bcnzo[c]phcnanthrcne, the major and minor isomers BcPBl and BcPB2 respectively,
differ by 2.944 keal/mol, and again the minor isomer BcPB2 has a greater energy with
Boltzmann ratio of 99.3% to 0.7%. From energy considerations, the higher the energy
the less stable the conformation and vice versa; thus, it is reasonable to expect the minor
isomer BcPB2 to have a higher energy.
Comparing the potential energies of conformations of BaP and BcP, the values for
BcP are slightly larger and the Boltzmann factor for the more stable isomers arc greater.
The trend is going from BaP to BcP, there is more major isomer than minor isomer. If
one considers the geometry of both BaP, which is planar, and the more sterically
congested BcP, which is non planar, one could infer that the slightly higher energies for
BcP may be reasonable by virtue of its geometry. Looking at the torsion angles for the
boronate isomers, Table 3.2, and comparing y'j and y’j for the major isomers (BaPBl and
BcPBl), the smaller torsion angles for BcPBl may be due to the proximity to the
congested fjord region of benzo[i']phenanthrcne. This tight geometry creates greater
strain energy. The torsion angles for the tetraol dibenzoatc isomers, Table 3.3, also show
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a similar trend. Therefore, the more congested the geometry of a conformer, the larger its
strain energy.
A more reliable evaluation of the stability of the isomeric compounds of BaP and
BcP can be accomplished by semi-empirical quantum mechanics. From AMI, the heats
of formation for the tetraol dibenzoate isomers of benzo[a]pyrene (BaPI and BaP2)
indicate stability assuming that the entropic contributions to the energy are negligible
(Table 3.4). The heats of formation of the major and minor isomers (BaPl and BaP2
respectively) differ by 1.788 keal/mol with the heat of formation of the minor isomer
(BaP2) being greater than that of the major isomer (BaPl). The Boltzmann factor gives a
ratio of 95.1% to 4.9% for the major isomer relative to the minor isomer (Table 3.4). The
heats of formation of the boronatc isomers of bcnzo|u]pyrcne (BaPBl and BaPB2) again
indicate that the minor isomer (BaPB2) is greater than the major isomer (BaPBl) by
1.158kcal/mol. The Boltzmann factor in this case gives a ratio of 85.8% to 14.2% for the
major isomer (BaPBl) relative to the minor isomer (BaPB2). In Table 3.4, the heat of
formation

of

the

minor

isomer

of

the

tetraol

dibenzoate

derivative

of

benzo[c]phenanthrene (BcP2) is greater than the major isomer (BcPl) by 1.532 keal/mol,
with the Boltzmann factor giving a ratio in percentage of 92.5% to 7.5% of the major
isomer relative to the minor isomer. A much larger difference in the heats of formation
in the boronate isomers of benzo[c]phenanthrcne, compared to the others, 3.573 keal/mol
is observed for the major and minor isomer with the minor isomer (BePB2) having a
greater energy than the major isomer (BcPBl). The major isomers all have lower heats
of formation and, therefore, are more stable. For the tetraol dibenzoate and boronatc
isomers, compared to the torsion angles of the MC geometries, the torsion angles of the
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AMI geometries are more symmetrical for the various isomers in which the angles are
almost the same in magnitude but differ in direction (Tables 3.5 and 3.6).
Considering thermodynamic quantities (Table 3.7), except in the case of tctraol
dibenzoate of bcnzo[e]phcnanthrenc (BcPI and BcP2), The results show that the
computed free energies favor the major isomer just as heats of formation (Table 3.4). For
the isomers BaPl and BaP2, the computed free energy favors the major isomer, BaPl, by
0.073 kcal/mol. For the isomers BaPBl and BaPB2, the computed free energy favors the
major isomer by 1.211 kcal/mol. For the BcPBl and BcPB2 isomers, the computed free
energy favors the major isomer by 0.769 kcal/mol. The computed free energy favors the
minor isomer in ease of the BcPI and BcP2 isomers by 0.026 kcal/mol. Computing free
energy differences due to solute entropy, however, shows that only in the case of the
BcPI and BcP2 isomers is the major isomer favored by 0.291 kcal/mol. The solvation
energies (Table 3.8) favor the major isomers in both BaP and BcP. The Boltzmann factor
of the isomers of BaPl and BaP2 show a ratio of 95.7% to 4.3% favoring the anti isomer
(BaPl). Boltzmann ratio of 71% to 29% in the case of BcPI and BcP2 favors the anti
isomer, BcPI, also. The heat of formation characterizes the stability of a molecule, with
the most stable molecule having the lower heat of formation. Within reasonable margin
of error, computational studies are in agreement with experimentally observed relative
stabilities.
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3.5 Summary
To determine the difference in energy between two isomers, it is necessary to
determine the lowest energy conformation or global minimum of each isomer. The
MMFF molecular model can be used for assigning the lowest-cnergy conformation, while
semi-empirical AMI quantum mechanical model can be used to obtain the bestoptimized geometry for the conformcrs and to determine the heats of formation, the
energies of solvation and other thermodynamic quantities.

Geometry optimizations

generally give structures of low energy. The use of MC conformational search facilitates
easy treatment of large organic molecules having many degrees of freedom.
Experimental results have shown the predominance of BaPl, BaPBi, and BcPBI
(major isomers) compared to BaP2, BaPB2, and BcPB2 (minor isomers). Experimental
results in the case of BcPl and BcP2 have shown a mixture of products one case in a ratio
of 60% to 40% and a second case in a ratio of 75% to 25%, but these were unoptimized
and the isomers were not isolated. Thus experimental results for BcPl and BcP2 are
inconclusive, and further experimentation is necessary.

On the other hand the

computational results in the BaP case arc a good match.
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CHAPTER 4

PALLADIUM-CATALYZED SYNTHESIS OF NUCLEOSIDE ADDUCTS
CORRESPONDING TO T! IOSE RESULTING FROM THE BINDING OF
BENZO[a]PYRENE RADICAL CATION TO 2 -DEOXYADENOSINE

4.1 Introduction
On the basis of the studies of polycyclic aromatic hydrocarbon (PAH) metabolism
coupled with the catalytic property of cytochrome P-450, it has been hypothesized that
PAHs arc mctabolically activated by single electron oxidation to form radical cations
which are also implicated in the DNA-adduct formation.2627 Single electron oxidation of
PAHs produces radical cations that then react with a variety of nucleophilic sites in
deoxyadenosine (dA) and deoxyguanosinc (dG) producing adducted nucleobascs and
nucleosides. A range of adducts can be produced from radical cations. Among these
adducts, /V7 adducts are labile and produce apurinic sites in DNA,26,27 Nl and /V5 adducts
are also known.26'27 Reaction of radical cations at the cxocyclic amino groups of dA and
dG can lead to stable lesions (Figure 4.1).26,27 Reactions of the radical cations with DNA
could, therefore, produce covalently modified DNA.

Errors in replication and

deficiencies in repair of such alkylated DNA could then be the underlying basis for tumor
production.

Due to our interest in chemical carcinogenesis, we wanted to develop

methods for the synthesis of nucleoside adducts of PAHs through both metabolic
pathways (explained in Chapter 1).

78
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Adducts. when incorporated into identical DNA sequences, would allow for a
detailed analysis of the structures and biological implications of each type of lesion.
Such studies may enable the determination of the significance of one metabolic pathway
over the other in the realm of chemical carcinogenesis induced by PAHs.

on
DB[a,/]P-10-N6 dA

Figure 4.1 Structures of nucleoside adducts from single electron oxidation of some PAHs.
Several approaches have been investigated to establish radical cations as key
intermediates in the metabolic activation of PAH. Electrochemical oxidation of some
PAHs in the presence of nucleosides has been used to generate PAH-nucleoside
adducts.3'’ ”

130 In some cases, adducts have been obtained in which covalent binding

to DNA is mediated by enzymes such as horseradish peroxidase or rat liver microsomal
cytochrome P-450.125,30133 An alternative approach for generating PAH radical cationnucleoside adducts involve the use of Ij as the oxidant.b4 PAHs are oxidized by I2 to
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form radical cations that react readily with a variety of nucleophiles. The generation of
PAH radical cation-nucleoside adducts involving the use of MnfOAch as oxidant has
also been reported.115 Whatever method is employed to generate radical cations, two
important features of these intermediates arc their low oxidation potentials making them
readily oxidizable, and their charge localization that allows for efficient and specific
reactivity towards nucleophiles.136
Because of the pioneering effort of the Lakshman group in the use of palladium
catalysis for nucleoside modification, we became interested in evaluating a rapid
synthesis of nucleoside adducts produced by single electron oxidation of benzo[a]pyrcnc
(BoP). Using various combinations of palladium catalyst, base and ligand, a library of
suitable reagent combination and solvent for the synthesis of nucleoside adducts has been
developed. In this chapter, evidence is presented that stable adducts at the exocyclic
amino groups of nucleosides produced by single electron oxidation of PAIIs can be
synthesized via a palladium-catalyzed carbon-nitrogen bond formation (Scheme 4.1).

TBDMSO

TBDMSO.

OTBDMS
X = NH2
X = Br

Pd catalyst
Ligand, Base
Solvent

Scheme 4.1 Palladium-catalyzed carbon-nitrogen bond formation.
Adduct structure determination was accomplished by using UV, NMR, and high
resolution mass spectrometry. This is the first evidence for the palladium-catalyzed
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synthesis of adducts corresponding to the binding of polycyclic aromatic hydrocarbon
radical cations to nucleosides. This method avoids the use of electrochemical apparatus
which is not readily available in most organic laboratories and is thus more convenient.
4.2 Synthesis
The last few years have seen a tremendous growth in palladium-catalyzed C-N
bond formation largely due to the efforts of Buchwald,| 17'n 9Hartwigl4<M42and Koie141.
Lakshman el al. have demonstrated that palladium catalysts is a powerful technique for
the introduction of aryl groups at the exocyclic amino group in dA .144 More recently, a
similar methodology was applied for dG modification.143 A retrosynthetic analysis of the
synthetic strategy for preparing single electron oxidation adducts is shown in Scheme 4.2.

6 -Amino-BaP

6 -Bromo-BaP

Scheme 4.2 Retrosynthetic analysis for the synthesis of single electron oxidation adducts.
As shown in the retrosynthetic analysis (Scheme 4.2), two possible alternatives exist for
the palladium-catalyzed arylation of dA and dG.144 These are: (a) Nucleoside is the amine
donor, which is reacted with a bromoaromatic compound, and (b) Aromatic amine is
reacted with a bromonuclcosidc.
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In their recent work on palladium catalysis, Lakshman el al.'u have demonstrated
that alternative (a) which involves reaction of a protected nucleoside with a
bromoaromatic was not viable with simple aromatic systems. Subsequently, Johnson and
coworkers demonstrated that option (a) is useful when the aromatic residue contains the
highly electron-withdrawing nitro group. 146 In the present study, particular interest was
geared towards ascertaining whether both options (a) and (b) arc usable when the aryl
residue is an extended aromatic system such as pyrene and ben/.o(«]pyrenc. It was also
important to evaluate which of the two combinations was superior for preparing 1
pyrenyl and 6-benzo[a]pyrenyl adducted dA.
Several factors needed investigation with each pair of coupling partners to
ascertain the viability of both approaches.
systems

1 -bromopyrene and

For initial experimentation, the simpler

l-aminopyrcne were chosen, both of which are

commercially available. The nucleosides can be easily synthesized following literature
procedure.144 The factors that could influence the reaction include palladium catalysts,
ligands, base and solvent, all of which are commercially available. Systematic studies
with palladium species, ligand, base and solvent as variables is important in designing a
protocol for palladium catalyzed synthesis of the nucleoside adducts. Identification of
optimal conditions with respect to the variables will then lead to the synthesis of the
nucleoside adducts.
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Table 4.1 Palladium Species. Bases and Solvents Used in the C-N Coupling.
Pd species

Pd2 (dba)3

Pd(OAc)2

Bases

CS2 CO3

K3 PO4

t-BuONa

Solvents

PhMe

DME

Dioxane

E

F

THF

G

H

Figure 4.2 Some commercially available ligands for Pd-catalyzed C-N reactions.
A: 2-(dicyclohexylphosphino)-2’-(ACV-dimethylamino)-1,1 ’-biphenyl.
B: (±)-2.2’-bis-(diphcnylphosphino)-1,1 ’-binaphthyl (BINAP).
C: 2-(dicyclohexylphosphino)-l,l'-biphcnyl.
I): 2 -(di-/ert-butylphosphino)-l, 1 ’-biphenyl.
E: 2 -(di-n’i7-butyIphosphino)-2 ’-(iV,/V-dimethylamino)-1,1 ’-biphenyl.
F: 2-(di-/<rf-butyIphosphino)-2’-mcthyl-l,l'-biphenyl.
G: 2-(dicyclohexylphosphino)-2‘-melhyl-l,i’-biphenyl.
H: 2-(dicyclohexylphosphino)-2’-isopropyl-1,1 '-biphenyl.
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The palladium species, bases and solvents that were employed in the synthesis arc
shown in Table 4.1 while some new ligands for palladium catalyzed C-N bond formation
are shown in Figure 4.2.

To determine adducts formed in biological systems, it is

important to efficiently synthesize and characterize adducts that can serve as reference
standards.
4.2.1 Synthesis of Pvrenvl Adduct of Deoxvadenosine (dA)
Both alternatives (a) and (b) shown in Scheme 4.2 were investigated in the
synthesis of the pyrcnyl adducts of dA. For alternative (a), the influence of various
palladium catalysts, ligands and bases on the course of the reaction between 3’,5’-bis-0(/er/-bulyldimethylsiiyl)-2’-dcoxyadcnosme (4-1) and 1-bromopyrene (4-2) was studied
(Scheme 4.3).

Scheme 4.3 Pd-catalyzed synthesis of an N6-pyrenyI adduct from 1-bromopyrene.
The amine (4-1) was coupled with 1-bromopyrene (4-2) in the presence of a
palladium catalyst, base, and ligand in an organic solvent resulting in the adduct 4-3
(Scheme 4.3). Among the commercially available ligands, A, B, C, and D (Figure 4.2)
were chosen based on the use of these ligands in palladium-catalyzed coupling reactions
as reported in the literature. Table 4.2 shows the results from the optimization studies.
Best results were obtained with Pd(OAc)2, BINAP and CS2CO3 (entry 3). As is amply
evident from Table 4.2 choice of the right combination of catalyst, ligand, and base is

with permission of the copyright owner. Further reproduction prohibited without permission.

85

critical. The reaction was cautiously carried out at a temperature not to exceed the
boiling point of the solvent. Reactions were monitored by TLC and purified by column
chromatography. The choice of solvent toluene was determined by both the solubility of
the reagents as well as its use in amination chemistry.
Table 4.2 Variables and Results for the Coupling of 4-1 and 4-2.
Entry

Pd species"

Ligand*

Base

Temp (°C)
Time (li)

Results'"

1

Pd2(dba)3

A

k 3p o 4

90, 20

41%, pyrene byproduct

2

Pd2(dba)3

A

t-BuONa

90, 20

24%, pyrene byproduct

3

Pd(OAc)2

B

Cs2C 03

90,4

90%

4

Pd(OAc)2

C

t-BuONa

90, 20

No product formation

5

Pd(OAc)2

C

k ,p o 4

90,21

No product formation

6

Pd(OAc)j

I)

t-BuONa

90,21

No product formation

7

PdfOAch

I)

k 3p o 4

90,21

No product formation

“ All palladium species were used in 10 mole %. "The following mole % of the ligands
were used A (30%), B (15%), C (20%), 1) (20%). 1 All reactions were carried out in
PhMe. Ligands: A: 2-(dicyclohexylphosphino)-2’-(A,,/V-dimethylamino)-l, 1'-biphenyl.
B: (±)-2,2’-bis-(diphenylphosphino)-l,l’-binaphthyl. C: 2-(dicyclohcxylphosphino)-l,l’biphcnyl. I): 2-(di-tm-butylphosphino)-l,r-biphenyl.
From Table 4.2, use of tris(dibenzylideneacetone)dipalladium [Pdafdba)^], in
combination

with

2-(dicyclohexylphosphino)-2’-(N,Ar-dimethylamino)-1,1'-biphenyl

ligand A, gave the desired product with either K3P04 (Entry 1) or sodium ferf-butoxide
(Entry 2).

In both cases, more catalyst was added after 18 hours, and the reaction

continued for two more hours. Low to modest yields, however, were obtained along with
the formation of pyrene as a byproduct.

Although the products were isolated
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chromatographically from the byproducts, ‘H NMR still showed inseparable and
uncharactcrizcd impurities. It is evident from Table 4.2 that the combination of ligand B.
Pd(OAc)j, and C sjCO j (Entry 3) was superior to all other combinations investigated both
in yield and reaction time, resulting in a 90% isolated yield of 4-3 with reaction complete
in 4 hours. To investigate the idea that no single variable will promote coupling but the
right combination of variables, the palladium catalyst Pd(OAc)i was used with different
ligands and bases. Interestingly, use of Pd(OAch in combination with other ligands and
bases resulted in little or no product formation (Entries 4-7, Table 4.2).

Reaction

mixtures in these cases were checked by TEC and were shown to contain substantial
amounts of 1 -bromopyrene.
To test option (b), 6-bromo-9[2-deoxy-3,5-bis-<9-(fe«-butyldimcthylsilyl)-P-Derythro-pcntofuranosyllpurinc144 (4-4) was reacted with 1-aminopyrcne (4-5) and the
influence of palladium species, ligand, and base on the outcome of the reaction
investigated (Scheme 4.4).

OTBDMS
4-4

NH2

OTBDMS

4-5

4-3

Scheme 4.4 Pd-catalyzed synthesis of pyrenyl adduct from l-aminopyrene.
In this case, ligands A and B that were shown to be superior to the other ligands
for alternative (a), were used. The choice of base was also limited to C.S2CO3 and K.3PO4.
The solvent used was 1,2-dimethoxyethanc (DME) because this solvent had previously
been used for similar aminoarylation chemistry on bromo dA with C-N bond formation at
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the C-6 position of dcoxynucleosides as reported by Lakshman et al.

Two different

reaction conditions (Entries 1 and 2, Table 4.3) were used. Compared to option (a), the
reaction times here were generally shorter.
Table 4.3 Variables and Results for the Coupling of 4-4 and 4-5.
Entry

Pd species"

Ligand*’

Base

1

Pd2(dba)3

A

2

Pd(OAc)2

B

Resullsr

K3PO4

Temp (°C)
Time (h)
80,2

52%, clean product

CSjCO^

80, 1

73%, somewhat impure

were used A (30%), B (30%). ' All reactions were carried out in DME.
Ligands: A: 2-(dicyelohexylphosphino)-2'-(/V./V-dimcthyUmino)-1,1'-biphenyl.
B: (±)-2,2’-bis-(diphcnylphosphino)-1,1 '-binaphthyl.
As in the previous case, the use of Pd(OAc)2 and BINAP with Cs2CC>3 gave a
better result but this was somewhat impure compared to the Pd2(dba)3, ligand A, and
K3PO4 combination. The product obtained from the Pd>(dba)3, ligand A, and K3PO4
combination was pure after column chromatography. However, the product in the case of
Pd(OAe)2, ligand B, and CS1CO3 combination contained some uncharacterized impurities
as evident by 'H NMR.

Efforts to vigorously purify the product by column

chromatography were unsuccessful.
4.2.2 Synthesis of Benzofalpvrenvl Adduct of Dco.wadenosine (dA)
Once the reaction was successfully established and worked well for the simpler
pyrene system, this methodology was extended to the biologically relevant hydrocarbon
benzofajpyrene. The requisite PAH precursors, 6-bromobenzo[a]pyrcnc (4-6) and 6aminobcnzo[a]pyrcnc (4-8) were prodided by our collaborators, but can be prepared by
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an NBS bromination and a nitration-reduction respectively.147 Both alternatives (a) and
(b) as shown in Scheme 4.2 were investigated.
For alternative (a), the influence of various palladium catalysts, ligands and bases
on the course of the reaction between 6-bromobenzo[a]pyrcne (4-6) and 3’,5’-bis-0-(/ertbutyldimethylsilyl)-2'-dcoxyadcnosinc (4-1) was investigated. Reaction of 4-6 with 4-1
in the presence of palladium catalyst, base and ligand results in the formation of 4-7
(Scheme 4.5).

Scheme 4.5 Pd-catalyzcd synthesis of benzo[«]pyrenyl adduct from 6-bromobenzo[a]pyrenc
Table 4.4 lists the experimental results. The solubility played a critical role in the
reactions, and unlike in the case of pyrenyl adducts, the reactions were not
straightforward.
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Tabic 4.4 Variables ami Results for the Coupling of 4-1 and 4-6.
Entry

Base

Solvent

1

CS2CO3

2

PhMe

Temp (°C)
Time (h)
100,24

Results"
Largely incomplete reaction

CS2CO3

DME

80.24

Largely incomplete reaction

3

CS2CO3

dioxane

100, 43

12 % isolated, incomplete

4

I-BuONa

dioxane

100,43

Largely incomplete reaction

5

CS2CO3

PhMe/THF 1:1

100, 72

Largely incomplete reaction

" The palladium species used was Pd(OAc)2 in 10 mole %, and ligand B was used in 15
mole %.
As seen on Table 4.4, option (a) of Scheme 4.2 was not successful in the synthesis
of N6-bcnzo[a]pyrcnyl adduct. Entry 1 (Table 4.4), Pd(OAc)2, ligand B, CS2CO3, and
PhMe combination was used, which is identical to the combination that had given the
best result in the case of pyrcnyl adduct (Entry 3, Table 4.2). In the present case the
reaction mixture was heated at 100 °C and after 24 hours, the reaction was monitored by
thin layer chromatography (TLC). TLC revealed that a substantial amount of starting
material was still present. In Entry 2, same catalyst, ligand and base were used but this
time the solvent was changed to a lower-boiling solvent 1 ,2 -dimcthoxycthanc (the solvent
used in C-N bond-forming reactions).144 However, this solvent change did not lead to
progress of the reaction to completion as TLC revealed a substantial amount of starting
material still present after 24 hours.
I11 Entry 3, PdfOAcE, ligand B, and CS1CO3 combination was used but with the
lower-boiling 1,2-dimcthoxyethanc (DME) replaced with a higher-boiling 1,4-dioxane.
In this case, some amount of product (12%) was isolated which was impure. Although
this reaction was allowed to run much longer, 43 hours, TLC still showed the presence of
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starting material, in Entry 4, Pd(OAe);, ligand 1$, and 1,4-dioxane combination was used
but this time the milder base CsiCCL was replaced with a much stronger base tertBuONa. The reaction mixture was heated at 100 °C and stirred continuously for 43
hours. The mixture was monitored by TLC and was shown to contain no product but a
substantial amount of starting material. In Entry 5, PdfOAcB, ligand B, and Cs^COj
combination was used with a 1:1 solvent mixture of PhMe/THF. The reaction mixture
was heated at 100 °C and stirred continuously for 72 hours. No product formation was
noticed upon monitoring by TLC but rather a substantial amount of starting material was
present.
To test option (b), 6-bromo-9|2-dcoxy-3,5-bis-0-(/er/-butyldimethylsilyl)-P-r>erythro-pcntofuranosylipurine (4-4) was reacted with 6-aminobenzo[a]pyrene (4-8) to
obtain 4-7 (Scheme 4.6).

4-4

4-8

4-7
| R = H. = Mono-Adduct
R = dA, m Bis-Adduct

Scheme

4.6

Pd-calalyzed

synthesis

of

benzo[«]pyrcnyl

adduct

aminobenzofajpyrene.
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Table 4.5 Variables and Results for the Coupling of 4-4 and 4-8.
Entry

Pd species"

Ligand"

Base

Solvent

Temp (°C)
Time (h)

Results

1

Pd(OAch

B

Cs2CO,

DME

80. 18

30%/22% mono-/bis-adduct

2

Pd.(dba),

A

K,PO<

DME

80, 18

39%/10% mono-Zbis-adducl

3

Pd(OAc) 2

B

CsjCO)

PhMe

80, 16

20%/26% mono-/bis-adduct

4

Pd(OAc);

B

C

dioxanc

100,5.5

51%/15% mono-/bis-adduct

5

Pd(OAc)2

B

CS2CO3

PhMc/THF

100,21

16%>/25% mono-/bis-adduct

sj

C O

j

1:1
7
™— i r ^ r
“ All palladium species were used in 10 mole
%. l' The ligands were used in 30 mole %.

Ligands: A: 2-(dicyclohexylphosphino)-2'-(iV,/V-dimethylamino)-1,1’-biphenyl.
B: (±)-2,2’-bis-(diphcnylphosphino)-1,1 ’-binaphthyl.
The influence of palladium species, ligand, and base on the outcome of the
reaction was investigated (Table 4.5).
Two points worth mentioning from the table (Table 4.5) arc the fact that solubility
plays a critical role, and the reaction is not straightforward because two products were
isolated. Based on 'H NMR and high resolution mass spectrometry, the two products
were identified as the desired adduct (mono-adduct) and a bis-adduct. As can be seen on
Table 4.5, there seem to be a correlation between solvent effect and the ratio of the
products. It is worthy of note that in all the entries, product formation was observed.
In Entry 1, PdtOAch, ligand B, and Cs>CO;i combination was used with 1.2dimethoxyethanc (DME) as solvent. The reaction mixture was stirred at 80 °C for 18
hours leading to product formation as determined by TLC. Two products were isolated
by column chromatography, and based on 'H NMR and high resolution mass
spectrometry, these were identified as the mono-adduct and bis-adduct (structures are
shown in the experimental section). The products were obtained in a ratio of 30% to 22%
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of the mono- to bis-adduct. Because the desired product could be isolated by column
chromatography, the next step was to investigate what experimental variables lead to
more of the desired product in a reasonable yield. Following earlier work,144 it had been
shown that Pdj(dba)j, ligand A, K3PO4, and 1,2-dimcthoxyethanc (DME) combination
was highly effective for C-N bond formation at the C-6 position in deoxynucleosidcs.
The difference between this combination and the combination in Entry 1 is the nature of
the palladium catalyst and the base. As shown in Entry 2, this combination was applied
to synthesize the bcnzo[a]pyrenyl adduct. The reaction mixture was heated and stirred
continuously at 80 °C for 18 hours leading to product formation. Interestingly enough,
more of the mono-adduct was formed as the two products isolated were in a ratio of 39%
to 10% of mono- to bis-adduct. Although the desired adduct was obtained in only a
modest 39% yield, it was encouraging to investigate other variables of the reaction. The
effect of solvent on the product ratio was then investigated.
In Entry 3, Pd(OAc)2, ligand B, CS2CO3, and PhMe combination was used. The
reaction mixture was heated at 80 °C for 16 hours leading to product formation as
determined by TLC. Two products were isolated in a ratio of 20% to 26% of mono- to
bis-adduct. Only an overall yield of 46% was obtained, with more of the undesired
product (bis-adduct) being formed. The best result was obtained in Entry 4 (Table 4.5)
both in terms of reaction time and yield of the desired product. The system Pd(OAc)i,
ligand B, CS2CO3, and dioxane was quite effective, with a relatively short reaction time,
and an overall product yield of 66% with the ratio of mono- to bis-adduct being 51% to
15%. Next, a solvent mixture was used. In Entry 5, Pd(OAc)2, ligand B, and CS2CO3
combination was used as in entry 1 but instead a 1:1 mixture of PhMe and THF was
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employed as the solvent system.

The reaction mixture was heated and stirred

continuously at 100 °C lor 21 hours leading to the formation of two products. The two
products isolated were in a ratio of 16% to 25% of mono- to bis-adduct. The use of
solvent mixture in this case was not successful in biasing the reaction towards formation
of more of the desired product (mono-adduct).
4.3 Summary
The applicability of palladium-catalyzed cross coupling methodology in the
synthesis of nucleoside adducts arising from single electron oxidation of PAHs has been
demonstrated for the first time.

The synthesis of nucleoside adducts have been

accomplished in both the case of a simpler aromatic system pyrene and a more extended
aromatic system benzo(a]pyrene. A case by case analysis of suitable coupling partners
has been performed. Unlike in the case of pyrenyl adduct where only one product was
isolated, reaction in the case of bcnzo[u]pyrcnyI adduct was not straightforward as two
products were typically isolated. Also, solubility played a critical role in the reaction.
For the benzo[u]pyrenyl adduct there seemed to be a solvent dependence of the ratio of
the mono- and bis-adduct. Both bromo-aromatic and arylamines seem potentially useable
but these reactions need case by case evaluation and no generalizations can be made.
Evidence for the structure of the adducts was obtained by NMR, high resolution mass
spectrometry and UV. The synthesized adducts can be incorporated into DNA to produce
oligomers containing single electron oxidation adducts for biological, biochemical and
physical studies as well as for comparisons with the diol epoxide adducts.
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4.4 Experimental
Palladium(ll)acetate [Pd(OAc)2j, tris(dibenzylideneacetonc)dipalladium
[Pd2(dba).i], l-bromopyrcne 4-2, l-aminopyrcne 4-5, ligands A-D, CS2CO3, K3 PO4 , tertBuONa, toluene, and 1,2-dinicthoxycthane (1,2-DME) were purchased from commercial
sources and were used without further purification. The catalysts and ligands were stored
under a nitrogen atmosphere in a dessicator at 0 °C and the bases were stored in a
dessicator at room temperature. THE was distilled from LiAHj, and 1,4-dioxane was
distilled from NaBH4. The benzo[a]pyrcnc derivatives, 6-bromobenzo[ajpyrenc 4-6 and
6-aminoben/.o|«|pyrene 4-8 were provided by our collaborators. The bromonucleoside

4-4 was synthesized as described.144
Reactions were monitored by TLC on glass-backed Whatman TLC plates
prccoatcd with silica gel 60 (250pm layer thickness).

Column chromatography was

performed using 200-300 mesh silica gel. Proton nuclear magnetic resonance ('ll NMR)
and homonuclear two-dimensional chemical shift correlation spectroscopy (COSY)
spectra were recorded in deuterated solvents on a Bruker AVANCE-500 (500 MHz)
spectrometer. Chemical shifts (8) are reported in parts per million (ppm).

'H NMR

splitting patterns are designated as singlet (s), doublet (d), triplet (t), quartet (q), or
quintet (quint). All first order splitting patterns are assigned based on the appearance of
the multiple!. Splitting patterns that are not easily visualized arc designated as multiple!
(m). Coupling constants (7) arc reported in Hertz (Hz). High resolution mass spectra
(HRMS) were determined on an AX505 spectrometer.

UV absorbance spectra were

recorded on a Beckman DU-640 spectrophotometer in methanol (Figures 19A-21A,
Appendix A).
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Synthesis of Pvrcnvl Adduct of Dcoxvadenosine (4-3)

4-3

In an oven-dried, screw-cap vial containing a stirring bar were placed Pd(OAc)2
(1.5 mg, 6.68 pmol), (±)-2,2’-bis-(diphenylphosphino)-1,1 ’-binaphthyl (6.3 mg, 10.1
pmol), and anhydrous toluene (0.68 mL). The mixture was then flushed with nitrogen
and stirred at room temperature for 5 minutes.

This was necessary to preform the

palladium-ligand complex. To the resulting solution was added the amine 3’,5’-bis-0(tert-butyldimethylsilyl)-2’-deoxyadenosine 4-1 (49 mg, 0.102 mmol), 1-bromopyrene 42 (19.1 mg, 0.068 mmol), and CS2CO3 (31 mg, 0.095 mmol). The vial was Hushed with
nitrogen, sealed with a Teflon-lined cap, and placed in a sand bath that was maintained at
90 °C. The reaction was monitored by TLC and was complete after 4 hours. The
reaction mixture was cooled to room temperature, diluted with ethyl acetate and extracted
twice with water.

The organic layers were dried over anhydrous Na2SOj and

concentrated on a rotary evaporator.

The crude product was purified by column

chromatography using CH2CI2, followed by 5% acetone in CH2CI2 to obtain 90% of 4-3
as a pale yellow solid: Rr (5% acetone in CH2CI2) = 0.37: UV. X„,a,(nm) 238, 275, 341
(methanol); *11 N\1R (500 MHz, CDCI3) 5 8.62 (d, J = 8.3 Hz, 1H. ArH), 8.50 (s, 1H.
Il8), 8.30-8.00 (m, 10H, 8ArH, NH & 1H2), 6.54 (t, J = 6 5 Hz, 1H, H, ), 4.67 (m, 1H,
H30, 4.07 (app q,

= 3.1 Hz, 1H, H4 ), 3.93 (dd, J = 11.2, 4.1 Hz, 1H, H5 ), 3.82 (dd, J
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= 1 1 . 1 ,3.0 Ilz, 111 , Hj.), 2.73 (appquint, J,„ = 6.6 Hz, 111 , Hr). 2.50 (Odd, / = 13.0, 6. 1 ,
4.1

Hz, 1H, H2), 0.96, 0.94 (2s. I8H, ten-Bu), 0.14 (s. 12H, SiCH,); HRMS ni/z, [M +

1]* CMH,gN}0 3Si2 call'd 680.3452, found 680.3454.

12

OTBDMS
4-7

In an oven-dried, screw-cap vial containing a stirring bar were placed Pd(OAc);
(2.065 mg, 9.20 pmol), (±)-2,2’-bis-(diphenylphosphino)-l,r-binaphthyl (17.18 mg,
27.6 pmol), and 1,4-dioxanc (1 mL). The mixture was stirred at room temperature for 5
minutes after flushing with nitrogen. This was necessary to preform the palladium-ligand
complex. To the resulting solution was added 6-aminobenzo[a]pyrene 4-8 (49.2 mg,
0.184

mmol),

6-bromo-9-[2 -dcoxy-3 ,5 -bis-0 -(/<.'/7-butyldimcthylsilyI)-|)-D-erythro-

pentofuranosyljpunne 4-4 (0.05 g. 0.092 mmol), CsjCO.i (44.95 mg, 0.138 mmol), and
additional 1,4-dioxanc (0.84 mL). The vial was flushed with nitrogen, sealed with a
Teflon-lined cap, and placed in a sand bath that was maintained at 100 °C. The reaction
was monitored by TLC and was complete after 5.5 hours. The reaction mixture was
cooled to room temperature, diluted with ethyl acetate and extracted twice with water.
The organic layers were dried over anhydrous NaiSCL and concentrated on a rotary
evaporator. The crude product was purified by column chromatography using CH2CI2,
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followed by 2% acetone in CHjCli. Two fractions were collected in 51% and 24% and
were identified as the mono- and bis-adduct respectively.
Mono-Adduct: This was obtained in 51% yield as a yellow solid: Rf (2% acetone
in CH2CI2) = 0.51; L'V. Ainal(nm) 256, 265, 287, 299, 372, 392 (methanol); 'll NMR (500
MHz, CDCIj) 6 9.10 (d, J = 8.4 Hz, 1H, ArH), 9.07 (d, J = 9.6 Hz, 111, ArH), 8.45 (d, J =
8.2 Hz, HI, ArH), 8.36 (d superimposed on broad singlet, J = 9.1 Hz, 2H, ArH), 8.23 (d,
J = 7.8 Hz, 1H, ArH), 8.22 (br s, 1H), 8.14 (d, J = 9.0 Hz, IH, Aril), 8.06 (d, J = 7.2 Hz,
IH. ArH), 7.96 (m, 2H, ArH), 7.88 (d, J = 9.0Hz, 1H, ArH), 7.83 (t, J = 7.2 Hz, 1H,
ArH), 7.72 (t, J = 7.2 Hz. IH, ArH), 6.53 (br, HI. Hr). 4.69 (br, IH, Hv), 4.07 (br, IH,
Hr), 3.95 (br, IH, Hs ), 3.84 (br d, J = 9.0 Hz, IH, Hy), 2.79 (m, IH, Hr ), 2.50 (m, HI.
Hr), 0.94 (br s, 18H, rerr-Bu), 0.14 (br s, 12H. SiCHj): HRMS m/z, [M + H+
C^HsiNsOjSij ealed 730.3609, found 730.3607.
Bis-Adduct: This was obtained in 24% yield as a pale yellow solid: R( (2%
acetone in CH2CI2) = 0.30; UV, U n m ) 255, 265, 288, 300, 377, 398 (methanol); Ml
NMR (500 MHz, CDCb) 6 9.14-9.11 (m, 2H, ArH), 8.50 (s, IH, Aril), 8.49 (s, IH,
ArH), 8.46 (d, J = 9.0 Hz, IH, ArH), 8.34 (d, J = 9.0 Hz. IH, ArH), 8.22 (d, J = 7.8 Hz,
HI, ArH), 8.19 (d, J = 9.6 Hz, IH, ArH), 8.00 (d, 7 = 6.6 Hz, IH, ArH12), 7.93 (t,7 = 7.2
Hz, IH, ArH), 7.87 (s, 2H, ArH). 7.78 (d, J = 9.0 Hz, IH, ArH), 7.75 (t, J = 7.8 Hz, HI,
ArH), 7.59 (t, J = 7.2 Hz, IH, ArH), 6.45 (2t, J = 6.6 and 6.6 Hz, 2H, Hr), 4.59 (m, 211,
Hy), 4.00 (m, 2H, Hr), 3.78 (dd, J = 10.9, 5.0 Hz, 2H, H5 ), 3.72 (dd, J = 11.2, 3.7 Hz,
2H, Hv), 2.69 (m, 2H, H2 ), 2.40-2.36 (m, 2H, Hr), 0.91,0.81 (2s, 36H, rert-Bu), 0.10,
-0.031, -0.038, -0.070, -0.076 (5s, 24H, SiCHj); HRMS m/z, [M + 1]+ C„4HwN<)0 ,,Si4
ealed 1192.6091, found 1192.6066.
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CHAPTER 5
SYNTHESIS OF UNUSUAL NUCLEOSIDE ANALOGS

5.1 Introduction
Nucleosides are organic compounds consisting of a nitrogen-containing
heterocyclic base linked to a sugar. The sugar unit can either be ribosc or deoxyribosc
while the base can be derived from two heterocyclic ring systems referred to as punne
and pyrimidine (Figure 5.1 ).148 In each nucleoside, a glycosidic bond is formed between
C-l of the sugar and cither N-l of pyrimidine or N-9 of purine.

Figure 5.1 The sugar unit and base structure of nucleosides.
Nucleotides are compounds that contain a phosphate group in addition to the
nucleoside components.

Considerable interest has been drawn to the chemistry of

nucleosides and nucleotides because these compounds form the building blocks of
nucleic acids, DNA and RNA, which are at the center of life processes. They also
function as activated intermediates for biosynthesis, energy stores, components of
cocnzymes, and metabolic regulators.149

98
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Analogs of nucleosides and nucleotides arc widespread in nature, and a variety of
synthetic derivatives have been made that exhibit varying degrees of biological activity.
Synthetic analogs have been critical in the understanding of DNA, RNA, protein
synthesis, and the regulation of biosynthesis of nucleic acid precursors.150 Natural
analogs of purine and pyrimidine nucleosides have proven to be efficient as antibacterial,
antiviral, and anticancer or antitumor agents, as a result of their functions as enzyme
inhibitors and antagonists.151 Antibiotic effect is exhibited primarily through inhibition
of the synthesis of nucleic acid precursors or by interfering with peptide-chain elongation
in the ribosome. As a result of the biological activity of nucleosides and their modified
analogs, interest has been geared towards the synthesis of modified nucleosides for more
than four decades.152 The structures of natural nucleosides are shown in Figure 5.2.

OH OH

OH OH

OH OH

OH OH

Adenosine

Guanosine

Cytidine

Uridine

OH

OH

OH
Deoxyadenosine

OH
Deoxyguanoslne

Deoxycytidino

Deoxythymidlno

Figure 5.2 Structures of natural nucleosides.
In recent times, the finding that nucleoside derivatives such as 2’,3’dideoxycytidine, 2',3'-didcoxyinosine, and 3’-azido-3’-deoxythymidine (AZT) are
potentially effective therapeutic agents for the treatment of diseases such as acquired
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immune deficiency syndrome (AIDS) has triggered explosive new developments in the
synthetic chemistry of nucleosides.153 Purine nucleosides containing aryl substituents at
the C-2 and C -6 positions could have potential pharmacological activity and could be
used to probe the effect of such substituents on DNA structure and stability.154

O6-

Substituted derivatives of 2'-deoxyguanosine (dG) have interesting biological activity.'55
For example 0° alkylation of dG has been proposed to reduce the number of hydrogen
bonding sites in the guanine moiety.156 As a result, the formation of (/'-alkyl guanine
derivatives has been established as a potent mutagenic and carcinogenic modification.157
In particular, ( / ’-methyl dG has been shown to produce mutations and misinformation
during replication.155
Several methods have been reported in the literature for the synthesis of
nucleoside derivatives with the hope of obtaining therapeutically useful agents. Among
these methods, we have reported facile synthesis of ( / ’-alkyl-, ( / ’-aryl-, and
diaminopurinc nucleosides from 2’-deoxyguanosinc.158 The application of SuzukiMiyaura cross-coupling has also been reported for the synthesis of nucleoside
derivatives.154 The methods for the synthesis of nucleoside derivatives, reported by our
group, are simple and convenient and offer advantages over other methods. The research
idea was accomplished through team effort of the Lakshman group, with contributions
from the author to this effort. In this chapter therefore, the synthesis of certain nucleoside
derivatives based upon new methods is presented.
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5.2 Synthesis
The synthesis of nucleoside derivatives necessitates the use of reagents and
reaction conditions that will be tolerant to the hydroxyl protecting group on the sugar
moiety and will not destabilize the glycosidic linkage.

The synthesis of unusual

nucleosides from natural nucleosides has been studied extensively.150 Modification of
naturally occurring nucleosides is quite attractive because the starting materials, the
natural nucleosides, can be obtained commercially and when the analogs are not
commercially available such as the halonuclcosidcs, their synthesis can readily be
accomplished in an efficient manner. The synthetic approach we have explored involves
modification of the purine base while keeping the sugar structure constant. The hydroxyl
groups of the sugar moiety are conveniently protected.

Analogs of two naturally

occurring nucleosides, dcoxyadenosine (dA) and dcoxyguanosine (dG), have been used
for the synthesis of nucleoside derivatives. For the synthesis of the dG derivatives, the
goal was to obtain modified nucleosides in which the N1 of the purine base remains
unprotected.
5.2.1 Synthesis of f/-Alkvl Nucleosides
Reaction at the Ob position of dG is well known.

Jones,157 Reese159160 and

Plata161'162 have reported the synthesis of 0 6-sulfonyl derivatives of dG.

Jones and

Gaffney have reported the displacement of the sulfonate group at the Ob position of dG in
the presence of trimethylamine leading to 0 6-alkyl ethers.157 An intermediate quaternary
ammonium salt is formed which is then trapped with alcohol to give the desired ether.
The method of Jones and Gaffney, however, involved protection of the sugar hydroxyls
and N 2 of the purine base by acylation. Noyori el al. have reported the synthesis of Ob-
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allyl

3 ', 5 ’-bis-(?-/f77-butyldimethylsilyl-2 '-deoxyguanosine

from

an

(/-sulfonate

precursor using allyl alcohol as solvent.164 Although the (/-sulfonate is not protected at
the N2 position, the use of alcohols as solvents could be problematic.158 A common
feature among these synthetic methods is the use of highly volatile nitrogen nucleophiles
such as trimethylamine (bp 3 °C) for displacement of the sulfonate.

Such volatile

nucleophiles on a large scale may not be convenient to handle due to toxicity and their
unpleasant odor.165
An effective route for the synthesis of 6-substituted dG derivatives using
trifluoroacctic anhydride/pyridinc has been reported/''’ This method, although efficient in
synthetic application, has a shortcoming in that the use of sodium alkoxidcs as base could
be incompatible with silyl protecting groups. The synthesis of (/-alkyl dG derivatives,
in which the purine N2 is unprotected, by the Milsunobu reaction condition has been
reported.167168 The reaction conditions arc compatible with silyl protecting groups but
product separation is tedious from residual reactants and byproducts.

The case of

displacements at the C-6 position of purines by the use of l,4-diazabicyclo[2.2.2)octane
(DABCO) as leaving group has been reported.165,169 The displacement of chloride from
the C-6 position of purines has also been reported.169 However, because chlorination of
deoxyguanosinc (dG) proceeds in low yields,155 chlorinated dG was not considered a
good starting point for our synthesis. Based on the disadvantages of other synthetic
approaches in the literature, it would be useful to develop a convenient and simple
procedure for the synthesis of purine nucleoside derivatives from 2 ’-deoxyguanosine.
Goals included the synthesis of 3’,5'-0-disilyl nucleoside derivatives in which the purine
N2 is unprotected, the use of highly volatile trimethylamine is avoided, and the
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development of a procedure in which a variety of compounds can be synthesized from a
single precursor.158
The synthesis of Of,-a!kyl derivatives was accomplished as a one-pot, two-step
reaction stalling from 3’,5'-bis-0-TBDMS (/-mcsitylenesulfonate of dG 5-1 (Scheme
5.1).

1 1,2-DME, DABCO, DBU
2. R-OH, rt

R = CH3 = 5-2
R » (CH3)2CH = 5-3

Scheme 5.1 Synthesis of 0 6-alkyl 2'-dcoxyguanosine 5-2 and 5-3.
When

treated

with

l,4-diazabicyclo[2.2.2]octane

(DABCO),

and

1,8-

diazabicyclo-[5.4.0]unde-7-ene (DBU) in 1,2-DME, 5-1 undergoes facile displacement in
the presence of a primary or secondary alcohol to afford 5-2 or 5-3. With both primary
and secondary alcohols, product formation was observed, but the reaction with secondary
alcohol gave low yield. Table 5.1 below summarizes the yield and reaction time while
details of the synthesis arc given in the experimental section.
Table 5.1 Yields and Reaction Times for the Synthesis of (/-Alkyl 2’-dG Derivatives.
ROH

Reaction time/h

Product

Yield (%)

CH3OH

24

5-2

80

(CHj)2CHOH

72

5-3

15
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The rationale for the mechanism of the formation of ( / ’-alkyl 2'-dG derivatives is
shown in Scheme 5.2.

The reaction may proceed through the intermediary of the

expected ammonium salt which is not isolated 5-la. This intermediate ammonium salt is
then displaced by the various alcohols in the presence of DBU to afford the desired
products. Evidence of this mechanism has been reported.158

5-1*

Scheme 5.2 Mechanism for the synthesis of 0 6-alkyl 2 ’-deoxyguanosinc analogs.
5.2.2

Synthesis of A^-Substiluted Diaminopurinc Nucleosides

Based on the success of the synthetic methodology for the synthesis of 0°-alkyl
nucleoside derivatives, we thought a simple route to the A^-substiluted diaminopurinc
nucleosides might involve a direct SNAr displacement of the sulfonate 5-1 by amines. In
the case of the amines, however, higher temperature was required for the reactions to
proceed to yield the desired products.158 Both primary and secondary amines were used
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and in all cases, the yields were generally good to excellent.

Unlike reactions with

alcohols, reactions with amines did not require an additional tertiary amine or base such
as DABCO and DBU respectively.
Reaction of benzylaminc with 3',5’-bis-0-TBDMS O^-mcsitylenesulfonatc of dG
5-1 in 1,2-DME and tricthylamine afforded 5-4 in 80% yield (Scheme 5.3).

/
HN

<1 X

TBDMSO

OTBDMS

Ph

OTBDMS
5-4

5-1

Scheme 5.3 Synthesis of ,V’-bcnzyl-2,6-diaminopurinc nucleoside analog 5-4.
Reaction of allylaminc with 3’,5’-bis-0-TBDMS f / ’-mesitylenesulfonate of dG 51 in 1,2-DME and triethylamine afforded 5-5 in 77% yield (Scheme 5.4).

cr%
<? J

X NH2

N

TBDMSO^

HN

CH2=CHCH2 NH2, Et3N
1,2-DME, 50 “C

*

77%

OTBDMS
5-1

Scheme 5.4 Synthesis of Ar-allyl-2-aminopurine nucleoside analog 5-5.
The reaction with secondary amines was efficient and products were obtained in
good to excellent yields.

This contrasts with the reactions of the alcohols where

secondary alcohols gave poor yields.
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Reaction of a solution of A'.A'-dimethylamine in tetrahydrofuran (THF) with 3',5’bis-O-TBDMS 0 6-mesitylenesulfonate of dG 5-1 in 1,2-DME and triethylaminc afforded
5-6 in 86% yield (Scheme 5.5).

Scheme 5.5 Synthesis of A^uV'-dimethylamino^-aminopurine nucleoside analog 5-6.
Reaction of morpholine with 3’,5’-bis-0-TBDMS O^mesitylenesulfonate of dG
5-1 in 1,2-DME and triethylaminc afforded 5-7 in 94% yield (Scheme 5.6).

Scheme 5.6 Synthesis of 6-morpholino-2-aminopurine nucleoside analog 5-7.
The products were purified by column chromatography and characterized by 'H
NMR and high resolution mass spectrometry. Details of the synthetic procedure and
results from characterization are given in the experimental section.
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5.2.3

Synthesis of Hydrophobic C-6 Arvl 2'-Dcoxvnucleosidc

Prompted by interest in palladium catalyzed nucleoside modification, the utility of
Suzuki-Miyaura cross-coupling170 was explored for the synthesis of C -6 aryl 2’dcoxynucleosides.154 A detailed comparison of the utility of C -6 chloro- and C -6
bromopurine nucleosides in Suzuki-Miyaura cross-coupling reactions has also been
reported.154 The coupling of 6-bromo-9[2-dcoxy-3,5-bis-0-(/erv-butyldimcthylsilyl)-[l-Derylhro-pentofurunosyl]purine 5-8 with 3-methoxyphcnylboronic acid 5-9 in the presence
of Pd(OAc):, 2-(dicyclohexylphosphino)biphenyl (L-l), and KiP0 4 in anhydrous 1,4dioxanc

afforded

6-(3-mcthoxyphcnyl)-3’,5’ bis-0-(rerf-butyldimcthyl-silyl)-2’-

deoxynebularine 5-10 in 73% yield (Scheme 5.7).
och3

5-9

B(OH)j
Pd(OAc)2, L-1, K3 PO4
1,4-dloxane, 100”C, 1h
73%
5-10

Scheme 5.7 Synthesis of 5,10.
The compound was purified by column chromatography and characterized by 'H
NMR and high resolution mass spectrometry.

Details of the synthesis and

characterization arc given in the experimental section.
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5.3 Summary
A convenient and concise strategy for the synthesis of ( / ’-alkyl and / / ’-substituted
diuminopurinc nucleosides from 2’-dcoxyguanosinc has been demonstrated. In reactions
with a primary and secondary alcohol, good yield was obtained using the primary alcohol
while the secondary alcohol gave a poor yield. In contrast, reactions proceeded smoothly
with both primary and secondary amines giving diamino nucleosides in very good to
excellent yields.

While reactions with the alcohols proceeded at room temperature,

reactions with the amines were carried out at 50 °C. The reactions were generally
complete within 24 hours for primary alcohols as well as for primary and secondary
amines. Because a wide variety of compounds can be obtained from a single precursor,
this chemistry can be applicable in combinatorial technology or automated parallel
synthesis.
The utility of Suzuki-Miyaura cross-coupling for deoxynucleoside modification
has also been reported for the first time. The result presented in this chapter on the use of
palladium catalysis in nucleoside modification is part of a larger project. The Lakshman
group has carried out a detailed and systematic study on the applicability of SuzukiMiyaura cross-coupling for deoxynucleoside modification. In particular, studies geared
towards understanding the catalytic systems and the generality of the approach have been
earned out. This methodology permits the synthesis of unusual nucleosides that are not
readily synthesized by other methods.
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5.4 Experimental
The arylborome acid, palladium(ll)acetate [PdfOAch], 1,2-DME, DABCO, DBU,
2-(dicyclohcxylphosphino)-biphcnyl (L-l), K3 PO4 , alcohols and amines were purchased
from commercial sources and were used without further purification. The catalyst and
ligand were stored under N2 in a desiccator at 0 °C and the base was stored in a desiccator
at room temperature. For the cross-coupling reaction, 1,4-dioxanc was distilled from
NaBHj just before starting the reaction.

Compound 5-1 was synthesized as

dcscribed.l7land compound 5-8 was synthesized as described.144
Thin-layer chromatography (TLC) was performed on glass-backed Analtcch TLC
plates precoatcd with silica gel (250 pm layer thickness).

Column chromatographic

purifications were performed on Nalland 200-300 mesh silica gel.

’H NMR were

recorded at 500 MHz in deacidificd CDCI3 (for (/-alkyl and /V6-substituted
diaminopurinc nucleoside products), and regular CDCI3 for the C -6 aryl 2’dcoxynucleosidc product.

Deacidification was performed by percolating the solvent

through a bed of solid NaHCC>3 and basic alumina. Chemical shifts (8) are reported in
parts per million (ppm).

All first order splitting patterns are assigned based on the

appearance of the multiple!.

Splitting patterns that are not easily visualized arc

designated as multiple! (m). Coupling constants (J) are reported in Hertz (Hz). High
resolution mass spectra (11RMS) were determined on an AX505 spectrometer, at the
University of Oklahoma.
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Synthesis of Oll-Mcthvl-3'.5'-bis-<’,>-rt'n-bulvldimclhvlsilvl-2’-dcoxvguanosine (5-2)
OCH3

OTBDMS
5-2

To a solution of 3’,5'-bis-0-TBDMS 0 6-mesitylcncsulfonate of <JG 5-1 (100 mg.
0.147 mmol) in 1,2-DME (1.47 ml.) were added DABCO (33.1 mg, 0.295 mmol). 4 A
molecular sieves, and methanol (30 jiL, 0.741 pmol). After allowing the mixture to stir
at room temperature for 30 minutes DBU (33 nL, 0.221 /xmol) was added. The mixture
was stirred at room temperature for 24 hours. Completion of the reaction was monitored
by TLC. The mixture was diluted with ethyl acetate and subjected to aqueous extraction.
The organic layer was dried in anhydrous NaiSO-r, concentrated on a rotary evaporator
and dried further under vacuum.

The crude product was purified by column

chromatography using CH2CI2 to load compound and 2% methanol in CH 2CI2 to elute the
product. Concentration of fractions afforded 60 mg of 5-2 (80% yield) as a white solid:
Rr (silica/CH2Cl2) = 0.38; ‘H NMR (500 MHz, deacidified CDCI3) 8 7.92 (s, 1H. H„),
6.33 (t, J = 6.5 Hz, 1H, H, ). 4.84 (s, 2H, NH2). 4.60 (m, 1H, Hr), 4.07 (s. 3H, OCHj),
3.98 (app q, Jm = 3.9 Hz, 1H, Re), 3.82 (dd, 7= 11.1, 4.3 Hz. 1H, Hr). 3.76 (dd, J =
11.1, 3.2 Hz, IH, H5 ), 2.58 (app quint, 7app = 6.8 Hz, IH, Hr), 2.36 (ddd, J = 13.0, 6.1,
3.8 Hz, IH. Hr). 0.92 (s, 18H, tert-Bu), 0.11, 0.09. 0.08 (3s. 12H, SiCllj); HRMS m/z,
[M + 1]+ C23H44N504Si2 ealed 510.2932, found 510.2946.

ced with permission of the copyright owner. Further reproduction prohibited without permission

I ll
Synthesis of ('/-lsopropvl-3’.5’-bis-Q-/m-butvldimcthvlsilvl-2’-deoxvguanosine (5-3)

OTBDMS
5-3

To a solution of 3’,5’-bis-0-TBDMS 0 6-mesitylencsulfonatc of dG 5-1 (50 mg,
0.074 mmol) in 1,2-DME (0.75 mL) were added DABCO (16.5 mg, 0.147 mmol), 4

A

molecular sieves, and isopropanol (28.2 /tL, 0.368 /imol). After allowing the mixture to
stir at room temperature for 30 minutes DBU (16.5 /tL, 0.11 /imol) was added. The
mixture was stirred at room temperature for 48 hours.
observed as judged by TLC

No product formation was

Another 5 equivalents of isopropanol were added and the

reaction mixture stirred at room temperature for another 24 hours. After a total of 72
hours, product formation was observed but the reaction was incomplete. With the hope
of driving the reaction to completion, the mixture was stirred at 50 °C for 2 hours, but
TLC still showed some starting material present. The mixture was diluted with ethyl
acetate and subjected to aqueous extraction. The organic layer was dried in anhydrous
NajSOj, concentrated on a rotary evaporator and dried further under vacuum. The crude
product was purified by column chromatography using CII2CI2 to load the compound and
2% methanol in CH2CI2 to elute the product. Concentration of fractions afforded 6 mg of
5-3 (15% yield) as colorless oil: Rf (silica/CH2Cl2) = 0.75; ‘H NMR (500 MHz,
dcacidificd CDCIj) 5 7.80 (s, IH. H„), 6.23 (t, J = 6.4 Hz, III, II,-). 5.46 (sept, J = 6.2 Hz,
1H, OCH), 4.71 (s, 211, NH2), 4.51 (m, IH, Hj ), 3.87 (app q, Jm = 3.3 Hz, IH, H4), 3.74
(dd,y= 11.1, 4.3 Hz, IH, Hy), 3.65 (dd,7= 11.1,3.2 Hz, IH, Hs ), 2.46 (app quint, Jm =
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6.1 Hz, 1H, H2 ), 2.24 (ddd, J = 13.1, 6.0, 3.6 Hz, 111, Hr). 1.32 (d, J = 6.2 Hz, 6H, CH3),
0.82, 0.81 (2s, 18H, ten-Bu), 0.04-0.01 (3s, 12H, SiCll3); HRMS m/z, [M + 1]*
CjjHagNjOgSij calcd 538.3245, found 538.3242.
Synthesis of 2-Amino-6-(henzvlamino)-9-l2-deoxv-3.5-bis-0-(ffr/-butvldimethvlsilvl)-BD-pm/iro-pentofuranosvIlpurinc (5-4)
,/^ P h

HN'

OTBDMS
5-4

To a solution of 3’,5’-bis-0-TBDMS 0 6-mesitylenesulfonatc of dO 5-1 (100 mg,
0.147 mmol) in 1,2-DME (1.50 mL) were added EtjN (103 gL, 0.739 gmol), 4

A

molecular sieves, and bcnzylamine (80.1 pL, 0.733 pmol). The mixture was stirred at 50
°C for 24 hours. Completion of the reaction was monitored by TLC. The mixture was
diluted with ethyl acetate and filtered. This was followed by sequential extractions with
10% aqueous citric acid and saturated NaHC03.

The organic layer was dried in

anhydrous Na2SO.», concentrated on a rotary evaporator and dried further under vacuum.
The crude product was purified by column chromatography using CHjCIj to load the
compound and 2% methanol in C lfC I 2 to elute the product. Concentration of fractions
afforded 69 mg of 5-4 (80% yield) as a white powder: R( (silica/3% MeOH in CH2CI2) =
0.49; *H NMR (500 MHz, deacidificd CDCI3) 6 7.76 (s, 1H. Hg), 7.33 (m, 511, ArH),
6.31 (l. J = 6.6 Hz, 1H, Hr). 5.83 (s, 1H, NH), 4.79 (s, 2H, NH-), 4.70 (s, 2H, NCH2),
4.59 (m, 1H, Hr), 3.98 (app q. 7lpp = 4.1 Hz, 1H, H, ), 3.82 (dd, J = 11.1, 4.5 Hz, 1H,

ced with permission of the copyright owner. Further reproduction prohibited without permission.

113
Hs ), 3.76 (dd, J = 11.1.3.4 Hz, IH. Hs ), 2.59 (app quinl, 7a(>p = 6.1 Hz, 1H, Hr). 2.35
(ddd. J = 13.0, 6.0. 3.7 Hz, 1H, Hr). 0.92 (2s. 1811, tm-Bu), 0.11, 0.08, 0.08 (3s, 12H,
SiCHj); HRMS ni/z, [M + N af C..9H44N(,Na0 3SiJ calcd 607.3224, found 607.3233.
Synthesis of 2-Amino-6-(allvlaminot-9-l2-dco\v-3.5 bis-CM/err-bulvldimcthvIsilvD-B-Dent/iro-oentofuranosvIlpurine (5-51
HN

OTBDMS
5-5
To a solution of 3’,5’-bis-0-TBDMS (Amesitylenesulfonalc of dG 5-1 (100 mg,
0.147 mmol) in 1,2-DME (1.50 mL) were added EtjN (103 pL, 0.739 pmol), 4

A

molecular sieves, and allylaminc (0.042 mg, 0.737 pmol). The mixture was stirred at 50
°C for 24 hours. Completion of the reaction was monitored by TLC. The mixture was
diluted with ethyl acetate, filtered, and subjected to aqueous extraction. The organic
layer was dried in anhydrous Na2SO.i, concentrated on a rotary evaporator and dried
further under vacuum. The crude product was purified by column chromatography using
CH2CI2 to load the compound and 2% methanol in CH2CI2 to elute the product.
Concentration of column fractions afforded 61 mg of 5-5 (77% yield) as light yellowish
powder: R, (silica/3% McOH in CH2CI2) = 0.24; ' l l NMR (500 MHz, dcacidificd
CDCI3) 6 7.77 (s, 1H, H8), 6.30 (t, J = 6.8 Hz, 1H, Hr ), 5.87 (tdd, J = 17.0, 10.3, 6.0 Hz,
1H,=CH), 5.58 (brs.NH), 5.28 (dd,7= 17.0, 1.2 Hz, IH, =CHua„s), 5.16 (d. J = 10.3, 1.2
Hz., IH, =CH,,S), 4.67 (br s, 2H. NCH2), 4.59 (m. 111, H3 ). 4.23 (br s, 2H, NH2), 3.97
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(appq, Jw = 3.5 Hz, lH .H a), 3.82 (dd,7 = 11.0, 4.5 Hz, 111, H5 ), 3.76 (dd,7 = 11.0, 3.3
Hz, 1H, H5), 2.60 (app quint, yapp = 7.0 Hz, 1H, Hr ), 2.34 (ddd, J = 12.9, 5.9, 3.5 Hz,
1H, H; ), 0.92 (2s, 18H, tert-Bu). 0.11,0.09,0.OS (3s, 12H, SiCHj); HRMS ni/z, [M + l]"
C25H47N60 3Si2 cak'd 535.3248, found 535.3262.
Synthesis of 2-Amino-6-fdimethvlamino)-9-l2-deoxv-3.5-bis-0-trerr-buivldimethvlsilvl)B D (’n ’t/iro-Dcntofuianosyllpurine (5-61
H3 C ,ch 3
N

OTBDMS
5-6

To a solution of 3’,5’-bis-0-TBDMS 0 6-nicsitylcnesulfonate of dG 5-1 (100 mg,
0.147 mmol) in 1,2-DME (1.13 mL) were added IitjN (103 11L, 0.739 /tmol), 4

A

molecular sieves, and dimethylaminc (2 M solution in THF, 0.37 mL, 0.7 mmol). The
mixture was stirred at 50 °C for 24 hours. Completion of the reaction was monitored by
TLC. The mixture was diluted with ethyl acetate, filtered, and subjected to aqueous
extraction. The organic layer was dried in anhydrous Na^SO*. concentrated on a rotary
evaporator and dried further under vacuum. The crude product was purified by column
chromatography using CH2CI2 to load the compound and 2% methanol in CH 2CI2 to elute
the product. Concentration of column fractions afforded 66 mg of 5-6 ( 86% yield) as a
white powder: Rr (silica/3% McOH in CH2CI2) = 0.47; *11 NMR (500 MHz, dcacidified
CDCIj) 8 7.71 (s, 1H, H„), 6.33 (t, 7 = 6.1 Hz, 1H, Hr ), 4.58 (s, 2H, NH2), 4.58 (m, 1H,
Hy), 3.98 (app q, 7jpp = 4.0 Hz, 1H, Ha ), 3.78 (dd, 7=11.1, 4.6 Hz, III, Hs ), 3.75 (dd, J
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= 11.1, 3.8 Hz. 1H. Hs ), 3.45 (s, 6H. NCH3), 2.57 (app quint, Jm = 6.6 Hz, 1H, Hr).
2.34 (ddd, J = 13.1,6.0, 3.4 Hz, IH, Hr). 0.92, 0.91 (2s, 18H, tert-Bu). 0.11, 0.08, 0.07
(3s, 12H, SiCHj); IIRMS m/z. [M + 11* C:4H.7N0O,Sh calcd 523.3248, found 523.3224.
Synthesis of 2-Amino-6-mofpholino-9-f 2-deox v-3.5-bis-6>-trprt-butvldimethvlsilvl)-B-D(’rvr/uvr-pcmofuranosvl ipurine (5-7)

TBDMSO

OTBDMS
5-7

To a solution of 3',5’-bis-0-TBDMS (/-mesitylenesulfonate of dG 5-1 (100 mg,
0.147 mmol) in 1,2 DMH (1.50 mL) were added Et3N (103 pL, 0.739 pmol), 4 A
molecular sieves, and morpholine (64.3 pL, 0.737 pmol). The mixture was stirred at 50
°C for 24 hours. Completion of the reaction was monitored by TLC. The mixture was
diluted with ethyl acetate, filtered, and subjected to aqueous extraction. The organic
layer was dried in anhydrous Na2SOr, concentrated on a rotary evaporator and dried
further under vacuum. The crude product was purified by column chromatography using
CH2C12 to load the compound and 2% methanol in CH2C12 to elute the product.
Concentration of column fractions afforded 78 mg of 5-7 (94 % yield) as a while powder:
Rr (silica/3% McOH in CH2C12) = 0.27; *11 NMR (500 MHz. dcacidifted CDCIj) 8 7.73
(s. IH, H»), 6.33 (t, 7 = 6.7 Hz, 1H. Hr ).4.61 (s, 2H, NH2),4.58 (m, IH, Hr), 4.23 (br s,
411, NCH2), 3.97 (app q, 7W = 4.1 Hz, IH, Hr), 3.80 (t, J = 4.9 Hz, 4H, OCH2), 3.78 (dd,
J= 11.1,4.6 Hz, IH, H5 ), 3.75 (dd,7= 11.1, 3.6 Hz, IH, Hs-). 2.56 (app quint, Jlpp = 6.5
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Hz, 1H, Hr ), 2.34 (ddd, J = 13.0, 6.0, 3.4 Hz, IH, H2). 0.92, 0.91 (2s, 18H, /ert-Bu),
0.10, 0.08, 0.07 (3s, 12H, S1CH3); HR MS

h i/ ; ,

[M + I f CssHwNsC^Sij ealcd 565.3354,

found 565.3377.
Svmhcsis of 6-(3-Mcthoxvphcnvl)-3’.5’-bis-(7-fit’>/-butvldimethvlsilvn-2'dcoxvnebularine 15-10)

OTBDMS
5-10

In an oven-dried, screw-cap vial containing a stilting bar were placed Pd(OAc):
(2.00 mg, 8.91 jtmol), 2-(dicyclohexylphosphino)biphcnyl (4.80 mg, 0.014 mmol), 3mcthoxyphcnylboronic acid (21 mg, 0.138 mmol), and KjPOj (39 mg, 0.184 mmol).
Finally, the bromonucleosidc 5-8 (50 mg, 0.092 mmol) was added followed by freshly
distilled, dried 1,4-dioxane (0.6 mL). The vial was flushed with nitrogen, scaled with a
Teflon-lined cap, and placed in a sand bath that was maintained at 100 °C. The reaction
was monitored by TLC and was complete after 1 hour. The reaction mixture was cooled
to room temperature and filtered through Celite. The residue was washed with CHiCb
and the filtrate evaporated to dryness.

The crude product was purified by column

chromatography eluting with CII2CI2. Fractions containing the product were combined,
evaporated and dried under vacuum to afford 38 mg of 5-10 (73% yield) as a yellow oil:
Rr (CH2CI2) = 0.38; 'll NMR (500 MHz, CDCIj) 5 9.01 (s, IH, purine-H), 8.44 (s, 1H,
purine-H) overlaps with (br d, IH, Ar-H, J - 7.0 Hz), 8.36 (br s, IH, Ar-H), 7.49 (t, J =
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8.0 Hz. 1H, Ar-H). 7.09 fdd, J = 8.2, 2.7 Hz, 1H, Ar-H), 6.59 (t, J = 6.5 Hz, 1H. Hr ),
4.67 (m, IH, Hr ), 4.07 (app q, 7lpp = 3.5 Hz, 1H, H< ), 3.95 (s, 3H, OCHj), 3.90 (dd, J =
11.2,4.1 Hz, 1H, H5 ), 3.81 (dd,/ = 11.2, 3.2 Hz, 1H, H5 ), 2.72 (app quint, Jm = 6.3 Hz,
1H. H2-). 2.51 (ddd, J = 13.0, 5.9. 3.8 Hz, 111, H: ). 0.94. 0.91 (2s, 18H, lert-Bu), 0.13,
0.10, (2s. 12H, SiCHj); HRMS m/z. (M + Naj* C 2vH4,,N404Si:Na calcd 593.2955. found
593.2957.
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CHAPTER 1
OVERVIEW

1.1 Brief Summary of Research Goal
The functions of numerous biological systems depend on peptides and proteins.
The conformation adopted by peptides and proteins therefore is extremely important in
light of their functions in biological systems. Most natural peptides are oligomers of aamino acids (a-peptides) and arc conformationally flexible which makes them unsuitable
for design purposes.

Oligomers of P-amino acids (P-pcptides), however, provide a

greater opportunity for conformational rigidity making them much more suitable for
design purposes. Naturally occurring a-amino acids have been shown to adopt defined
stable conformations, giving rise to regular secondary structure in natural (a-) peptides.
Synthetic oligomers of p-amino acids (p-pcptidcs) can also fold into compact, stable and
well-defined secondary structures, but compatibility between a- and P-peptide secondary
structures remains largely uninvcstigalcd.
Heterogeneous backbone oligomers are oligomers containing both u- and p-amino
acid residues in an alternating sequence.

No information is available in the current

literature concerning the structure of such heterogeneous backbone oligomers. The goal
herein is the synthesis of heterogeneous backbone oligomers and the investigation of
folding propensity. Also of interest is the investigation of whether a potentially folded
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structure complies with (3-pcptidc folding rules, and how the overall folding is perturbed
by varying the a-amino acid. The determination of what structural role is played by each
kind of residue in the conformation adopted by the oligomers is of equal importance. In
the field of foldamers, the focus is on the search for non-natural oligomer backbones with
an increased tendency to adopt compact, stable, and specific conformations in solution.1
1.2 Foldamers
Foldamers are unnatural oligomers that fold into specific, compact and welldefined conformations in solution,1,2

The complex

activities of biological

macromolecules, such as proteins and RNA, are due to stably folded structures resulting
from non-covalent interactions.3 Two main classes of foldamers are known based on if
folding is accompanied by association.1 One of these classes of foldamers that only fold
arc single-stranded foldamers such as peptidomimetics and their non-biological
analogues. Another class of foldamers is the multiple-stranded foldamers which both
fold and associate and examples of which are nucleotidomimetics and their nonbiological analogues. In the development of foldamers, three distinct goals have been
identified.2 These goals include the design of novel oligomers with the propensity to fold
in a predictable manner, an efficient synthesis of monomers and oligomers, and the
search for potential chemical applications. The principles underlying these goals arc
elaborated in the subsequent paragraphs.
A variety of low-resolution and high-resolution spectroscopic techniques can be
used for the identification of novel folded conformations of non-natural oligomer
backbones.

Examples of low resolution spectroscopic techniques include one-

dimensional nuclear magnetic resonance, amide proton-deuterium exchange, circular
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dichroism, and infrared spectroscopy. High-resolution spectroscopic techniques such as
two-dimensional nuclear magnetic resonance (2-D NMR) can provide information on the
specific backbone orientation of foldamers in solution.

X-ray crystallography can

provide information on the specific orientation or spatial arrangement of the folded
structure in the solid state.
The design of efficient methods for the synthesis of monomers in
stcrcochcmically pure form is extremely important in the development of foldamers. An
efficient monomer synthesis and optimization of oligomer synthesis will allow a quick
evaluation of foldamers for potential biological applications.
The most important goal in foldamcr development is the search for interesting
biological applications. The design of efficient synthesis must therefore take into account
particular properties of the foldamers that confer important chemical functions.
In recent years, several research groups have reported various types of foldamers
that mimic the major secondary structures found in nature such as helices, sheets, and
turns. For most oligomers, backbone conformation is specified by hydrogen bonding
while others do not rely on hydrogen bonding to stabilize secondary structures. Figure
1.1 shows examples of hydrogen-bonded and non-hydrogen-bonded foldamer backbones.
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The most thoroughly studied foldamers arc oligomers of P-amino acids (P-pcptidcs). The
major secondary structures in proteins have also been reported to be found in P-peptidcs.
Before discussing p-peptides, it will be important to briefly review the main secondary
structures in oligomers and proteins.
1.3 Review of Protein Structure
Peptides and proteins are comprised of amino acid units (residues) joined by
amide bonds between the carboxyl group of one amino acid and the amino group of the
other. The function of a particular protein depends on its three-dimensional structure.
There arc generally four levels of protein structure.4 The sequence of amino acids,
stabilized by peptide bonds, is known as the “primary structure.”

The “secondary

structure” is defined in terms of the way in which the amide backbone (dihedral torsion
angles) folds locally. The classification of “secondary structure” includes descriptions
such as helices, sheets, and reverse turns. The spatial relationship between the various
components of secondary structure gives rise to the “tertiary structure." The last level of
protein structure is the quaternary structure which arises from the association of protein
subunits stabilized by non-covalcnt interactions such as hydrophobic forces, hydrogen
bonds, and salt bridges. This review will focus on secondary structure because among
synthetic oligomers reported in the literature, the prominence of secondary-type
structures has been confirmed experimentally.
There are three main classes of secondary structure conformations based on either
local or non-local (non-covalcnt) interactions between residues in sequence. Among the
regular secondary structures arising from non-local interactions arc u-helices and ()sheets. Local interactions on the other hand are due to torsional preference of the peptide
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backbone and examples of secondary structures in this category are reverse turns.
Peptide segments in a protein that are not characterized by any regular or repeating
conformation are referred to as "random-coil'' regions.
The a-helix is the most common form of secondary structure in proteins, in which
the polypeptide chain is coiled into a helix. The helical structure is held in place by weak
hydrogen bonds between the i1* and (i+4)'h residues of the helix. An a-hclix takes a
cylindrical form in which the hydrogen-bonds all point in the same direction and are
approximately parallel to the helical axis. The hydrogen-bond directionality confers a net
dipole with a partial positive charge at the N terminus and a partial negative charge at the
C-terminus. The side chains of the amino acid residues form the surface of the helix.
The helix is right-handed in nature and contains 3.6 residues per tum of the helix with a
translation along the helix axis of 1.5 A per residue/
In P-sheets, adjacent strands of extended polypeptide chains are arranged in either
a parallel or antiparallel orientation. Compared to helices, a typical p-sheet involves non
local interactions between amino acid residues that arc sequentially distant
(intramolecular) or that are from different molecules (intcnnolecular).

The p-sheet

structure resembles a twisted plane, unlike the rod-like cylinder of the a-helix. The twist
of the P-shect is generally right-handed in orientation, regardless of whether the strands
of the sheet are oriented parallel or antiparallcl to one another.4

In the sheet

conformation, a network of hydrogen bonds forms in the plane of the sheet. The side
chains of the amino acids are oriented above and below the plane of the sheet.
Sometimes a P-shcct occurs on the surface of a protein with the side chains directed away
from the protein being predominantly hydrophilic, and the side chains directed towards
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the protein being predominantly hydrophobic. This alternation between hydrophilic and
hydrophobic nature of the side chains between the two faces of a jJ-sheet, results in an
amphiphilic character for the sheet. In a parallel p-sheet the adjacent P-strands have
identical N- to C-terminus orientation, while the N- to C-terminus directionality of
adjacent strands alternates in an antiparallel p-sheet (Figure 1.2).5
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Figure 1.2 Two-dimensional projections of parallel and antiparallel P-strands. The arrows
indicate the directionality (from N- to C-terminus) of the p-strands. Hydrogen bonds are
indicated with dashed lines.
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Reverse turns, also known as loops, arc strictly local in nature.'1The turns reverse
the directionality of the peptide backbone spatially. Different types of reverse turns exist
depending on the number of residues considered to define the turns.4 The most eommon
turn is a P-tum which consists of lour residues at positions i to i + J (Figure 1.3).
Another type of reverse turn structure, the y-tum,6a consists of three residues at positions i
to i + 2. Generally each type of reverse turn is defined in terms of the <> and v torsion
angles of the central residues, a y-tum contains one central residue and a p-tum contains
two central residues. Typically, a hydrogen bond is formed between the carbonyl oxygen
of the first residue in the turn and the amide proton of the third residue (y-tum) or fourth
residue (P-tum).

The presence of hydrogen bond, although observed in most reverse

turns, is not a necessary requirement for the classification of p-tum.'’1’ Reverse turns have
also been implicated in the development of small p-sheet models such as p-hairpins.
Most of the classic y-tums are known to occur at the ends of P-hairpins.
R i*3

O

Figure 1.3 Example of a p-tum peptide structure. Residues R j,i and R,,: form the loop.
Classification based on 0 and q/ of loop residues. Dashed line indicates potential H-bond.
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P-Hairpins are anliparallcl hydrogen-bonded strands of p-shcet that arc adjacent in
sequence.6'1 The loop of a reverse turn refers to the residues not involved in hydrogen
bonding.
1.4 P-Peptides
Like natural peptides and proteins, p-peptides can adopt folded conformations
including common secondary structures such as helices,7 10 turns,11'12 and sheets.1’
Compared to natural peptides, P-peptides have the advantage of increased conformational
stability in an aqueous environment.114 The p-peptide backbone compared to natural
peptides is resistant to protease degradation and has the potential for a great variety of
substitution patterns.15 In addition P-peptides form more stable helices in solution
compared to a-peptides.16 P-Peptides can form stable secondary structures with as few as
four to six residues in solution,10 compared to over 20 residues needed for stability of the
natural analogs. P-Peptidcs can also readily form cyclic compounds that stack into tube
structures.17 This stability, important for biological activity, makes p-peptides good
candidates for useful drugs.12 P-Peptides have thus been reported with a variety of
biological activities.18'22 As a result of the importance of P-peptides, the paragraphs that
follow will review some early studies on p-amino acids and their conformations.
1.4.1 Early Studies on 11-Amino Acids
Early attempts at realizing ordered peptide structures with P-amino acids date
from the end of the 1960s and were continued in the 1970s.2125 In 1994, Dado and
Gcllman studied the intramolecular hydrogen bonding properties of p- and y-amino acid
derivatives.26 They hypothesized that the formation of secondary structures by oligomers
of ct-amino acids is due in part because formation of short range hydrogen bonds, such as
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intramolecular 5- or 7-membcred hydrogen bonded rings, is energetically unfavorable
among a-amino acid oligomers (Figure 1.4).

Based on their hypothesis. Dado and

Gcllman reasoned that other oligomers in which formation of short range hydrogen bonds
is unfavorable might also be predisposed to form secondary structures. To test this
hypothesis further. Dado synthesized various derivatives of P-alaninc as well as yisobutyric acid and using IR spectroscopy, examined the intramolecular hydrogen
bonding of these molecules. The results demonstrated that while short range hydrogen
bonds (7- and 9-membered rings) were common among the diamides of y-aminobutyric
acid, the same was not true for diamides of P-amino acids (Figure 1.4). Therefore, based
on these studies, Dado and Gellman concluded that oligomers of p-amino acids (Ppeptides) could potentially form stable secondary structures. The studies carried out by
Dado and Gellman did not take into account substitution on a-, P-, or y-carbons which
could potentially have some constraining effects.
5-membered ring

8-membered ring

7-membered ring

7-membered ring

6*membered ring

9-mombered ring

Figure 1.4 Favorable and non-favorable intramolecular hydrogen bonding in a-, p-, and yamino acid peptides.
Although predicted that P-pcptides are capable of forming stable and compact
secondary structures, investigations of the NV1R solution structures of poly-P-alaninc
indicated that the polymer had no folded conformation.25 In contrast, IR data in the solid
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stale indicated the formation of sheets.” Various research groups have studied polymers
of a-isobutyl-L-aspartatc by X-ray diffraction, CD, and IR spectroscopy. In 1978, Yuki
et al. reported that the polymer of a-isobutyl-L-aspartatc formed extended sheets with
hydrogen bonding between the strands.*3 In the mid 1980s, Femandez-Santln and co
workers reported that in the solid state, the polymer of a-isobulyl-L-aspartate formed two
helical conformations characterized by intramolecular 16- and 20-mcmbered hydrogen
bonded rings.2<>1" In 1995, Ldpez-Carrasquero et al. contrasted initial reports by
Fcmandez-Santin and co-workers and instead proposed that the helical conformations
formed by the polymer of a-isobutyl-L-aspartatc was characterized by 14- and 18membered hydrogen bonded rings.11
The biggest breakthrough in the synthesis (J-pcptides of defined sequence that
allowed crystallographic and high-resolution NMR data to be obtained was achieved by
the research groups of Gellman7 '0'138'14 and Secbach.12'16 1712 Gellman and co-workers
have synthesized and characterized oligomers of /ra/i,v-2-aminocyclopcntanecarboxylic
acid (ACPC),8 mj/w-2-aminocyclohcxanecarboxylic acid (ACHC),9 and trans-3aminopyrrolidinc-4-carboxylic acid (AGP).14 Gellman et al. showed that while ACHC
adopted a 14-helical conformation in organic solvent, ACPC adopted a 12-helical
conformation. Oligomers containing both ACPC and ACP residues were also shown to
form 12-hclical conformations in aqueous solution.14 Sccbach and co-workers showed
dial p-peplides composed of acyclic residues with side chains derived from a-amino acids
also formed 14-helical conformations in organic solvent.'6
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1.4.2 Helix Nomenclature
Helical conformations have been described using several different conventions in
the literature. However, the best convention is that which describes the helix based on
the number of atoms involved in the hydrogen bonded ring formed. This convention is
capable of describing all helices reported in the literature this far.
1.4.2.1 14-Helix
A 14-hclical conformation consist of a 14-mcmbcred hydrogen-bonded ring
between a carbonyl oxygen in the i,,' position and an amide proton in the (i + 2 )r position
towards the N-terminus.9 The helix dipole is thus negatively charged at the N-tcrminus
and positively charged at the C-tcrminus. This orientation is opposite to what is observed
in naturally occurring a-helices. The 14-helix is more stable compared to the u-helix.
1.4.2.2 12 Helix
A 12-helical conformation consist of a 12-membered hydrogen-bonded ring
between a carbonyl oxygen in the f ' position and an amide proton in the (i + 3)"1position
towards the C-terminus.8 The helical dipole points in the same direction as the a-helix,
but in opposite direction compared to the 14 helix.
1.4.2.3 Other Helices
Other helices include the 10-helix and the 10/12 helix.

The 10-helical

conformation consist of a 10-mcmbcrcd hydrogen-bonded ring between the amide proton
of the i"' residue and the carbonyl oxygen of the (i + i f residue. The 10/12 helical
conformation on the other hand is characterized by 10- and 12-membcrcd hydrogenbonded rings.'1 The directionality of the 10-mcmbcrcd hydrogen-bonded ring is almost
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perpendicular lo the helical axis, while the 12-membered hydrogen-bonded ring is
parallel to the helical axis.
1.4.3 6-Amino Acid Conformation
In polypeptides of a-amino acids, the backbone conformations are defined by
three sets of torsion angles Q, xp, and to (Figure 1.5).33 Generally in peptides and proteins,
the torsion angle about the peptide bond is restricted to a Irons geometry (to = 180).
Backbone conformation of ()-amino acid residues in peptides is determined by four main
chain torsional variables b, 0, \|/, and to, using the convention of Balaram (Figure 1.5).33

H

H

Figure 1.5 Backbone conformation of P-amino acid.
By this convention, the backbone conformation is read sequentially from the N- to
the C-terminus with the torsional variables defined as 0 (N- Ce), 0 (C^-C0), v ( C“-C'),
and u) (C'-N) (Figure 1.5). In p-amino acids, the torsion angle about the C-C bond (0)
can lie close to the gauche (0 = ± 60°) and irons (0 = 180°) conformations.33 A
predominance of gauche conformations can easily lead to the formation of folded
structures.
1.5 Factors Affecting Oligomer Structure
In the design of non-natural secondary structures, a number of factors must be
taking into consideration. These factors affect the overall conformation and the nature of
folding of oligomers. The conformation of a folded oligomer is defined by noncovalent
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interactions between non-adjacent monomer units.

The folding of oligomers is

considered in solution, which means solvent is critical in folding.
1.5.1 Intramolecular Interactions
The creation of a defined oligomer secondary structure necessitates restricting the
oligomer to adopt only specific conformations.

Intramolecular interactions play an

important role in directing the formation of secondary structure.

Attempts at using

donor-acceptor interactions of aromatic rings to control the conformation of aedamers
(aromatic oligomers with stacking propensities) has been reported.34 The formation of
intramolecular donor-acceptor complexes in aedamers was ascertained by nuclear
magnetic resonance (NMR), and ultraviolet (UV) spectroscopy.
1.5.2

Conformational ControI and Hydrogen Bonding

Oligomer secondary structures can also be obtained by limiting the accessible
oligomer backbone conformations. The formation of oligomer secondary structure often
incorporates intramolecular hydrogen bonds, which are weak attractive forces.

A

common approach in the design of oligomer structure is to favor hydrogen bonding
formation, while eonformationully restricting the monomers. Evidence for the formation
of intramolecular hydrogen bonds in vinylogous peptides have been reported by Hagihara
ct al:'s Gcnnari and co-workers have reported the importance of carbon-carbon double
bonds, sulfonamides, and hydrogen bonding in the structures adopted by vinylogous
sulfonamidopeptide.s.'’<’■'’, An extended conformation was maintained by the double bond,
while the sulfonamides imposed a turn in the oligomeric backbone. Based on TR data, an
intramolecular 14-mcmbered hydrogen bonded ring was proposed, while crystal structure
instead indicated an intramolecular 12-membered hydrogen bonded ring.

ced with permission of the copyright owner. Further reproduction prohibited without permission.

132
The contribution of aromatic ring substitution pattern and intramolecular
hydrogen bonds to the conformation of oligoanthranilamidcs has been reported. ’8 It was
found that while ortho substitution favored a linear extended conformation, meta
substitution favored a helical conformation. The incorporation of chiral centers into side
chains have been reported to favor helical conformations in peptoids.3l)
1.5,3 Solvent Effects
The interactions between oligomers and solvent can affect the conformations
adopted by oligomers. The ability for an oligomer to fold can be favored or disfavored
by such solvent properties as dielectric constant, solubility, and hydrogen bonding
capability. Solvent effects on the conformations of phcnylaectylene oligomers have been
reported by Nelson and co-workers.'10 Based on NMR and UV spectroscopic studies, they
concluded that a well-ordered conformation was observed in deuterated acetonitrile, but
not in deuterated chloroform. The difference in behavior of the oligomer in the different
solvents could be a result of difference in solubility. The oligomer was found to be
completely soluble in chloroform irrespective of the number of residues and had many
conformations. In acetonitrile, however, the oligomer became less soluble as the chain
length increased resulting in a single, well-defined conformation.
1.6

Methods for Conformational Analysis

Several different analytical techniques exist to probe the secondary structure of
peptides in different solvents. Among the techniques applicable for the research in this
thesis are one- and two-dimensional NMR, molecular modeling, and circular dichroism
(CD).
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1.6.1 One- and Two-Dimensional NMR
There exist a number of one-dimensional and two-dimensional NMR techniques
to probe peptides for solution conformations.
Some useful information can be derived from one-dimensional 'H NMR
techniques.

For example, the occurrence of aggregation can be investigated by

concentration dependent one-dimensional NMR.

Monomeric peptides are usually

characterized by sharp, and well-resolved resonances.

When peptides associate

intermolecularly with increasing concentration, broaden lines with decreased intensity are
formed. Another technique is the exchange between the amide-protons of peptides or
proteins and the solvent protons which occurs in dynamic equilibrium. If the pseudo
first-order exchange rate is delayed, then some kind of steric or chemical hindrance, such
as hydrogen bonds is implicated.
In two-dimensional NMR spectroscopy, proton resonances or chemical shifts arc
assigned to the respective protons by experiments that can be divided into two general
classes: experiments that measure through-bond interactions, and experiments that
measure through-space interactions. Through-bond interactions arise through nuclei that
are coupled, or covalently connected through one or more bonds to each other. Throughspace interactions result from dipolar relaxation mechanisms between nuclei that are not
necessarily close in a covalent sense, but arc close to one another in space.41

Two-

dimensional experiments effectively spread out the resonances making it easier to assign
protons and observe interactions, that would otherwise be difficult to observe by onedimensional experiments due to resonance overlap. A general outline of the information
that can be obtained from the various experiments is presented below.
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1.6.1.1 COSY and TOCSY
Both COSY and TOCSY experiments examine the through-bond (J-couplcd)
interactions between nuclei that are directly connected through covalent bonds. The
homonuclear 'H NMR COSY (correlated spectroscopy) experiment generates cross peaks
for protons connected to each other and separated by two or three bonds (2J or 3J).43
TOCSY (total correlated spectroscopy) experiment generates cross peaks between a
nucleus and all other nuclei in its spin system.42 A spin system refers to all the protons
that are either directly coupled to one another, or coupled through intervening protons.
This magnetization, however, docs not pass through quaternary carbons, such as the
carbonyl carbon of the peptide backbone. The TOCSY experiment is very useful for
peptides, since each amino acid residue forms a spin system, separated from the spin
systems of other residues by the carbonyl carbon of the amide bond. A model system to
illustrate the interaction between cross peaks is shown in Figure 1.6. A standard COSY
spectrum would show cross peaks between the following proton pairs: H|-Hp, and
(Figure 1.6). In a TOCSY spectrum, Hi would show cross peaks to Hp and H„, but not to
Hj, which is isolated from the spin system of H|-Ha by the intervening quaternary
carbonyl carbon (Figure 1.6).

Figure 1.6 Model to illustrate 'H NMR J-couplcd and dipolar relaxation interactions.

ced with permission of the copyright owner. Further reproduction prohibited without permission.

135
1.6.1.2 NOESY and ROESY
Both techniques are based on through-space dipolar interactions.

Dipolar

interactions between two nuclei can generate a Nuclear Overhauscr Enhancement
(NOE).45 The magnitude of the dipolar interaction and NOE is modulated by a l/r°
dependence on distance. This means an observable NOE is generated only between
protons that are relatively close to one another, typically within 5 A of each other. NOE
experiments are generally used to determine the three-dimensional structure of peptides
in solution. Both short-range and long-range NOEs are used to characterize the solution
conformation of peptides and proteins. The definition of short-range refers to nuclei that
are close in a through-bond sense (Hi and Hp in Figure 1.6), while long-range refers to
nuclei separated by many bonds (Hi and fy. Figure 1.6). Generally, information from
NOESY (Nuclear Overhauscr Effect Spectroscopy)44 and ROESY (Rotational
Overhauscr Effect Spectroscopy)45 experiments arc used together to generate NOEs that
reflect the real extent of through-space interactions between protons. While the NOESY
experiment is based on the NOE signal, the ROESY experiment is based on the ROE
(Rotational Overhauscr Effect) signal. Both NOE and ROE intensities have 1/ / ’ distance
dependence.
1.6.2 Computational Methods
Molecular modeling can be used in conjunction with NMR data to determine
three-dimensional solution structure of peptides. Experimental information from NMR
such as NOE and coupling constant data can be incorporated into a computational
method for accurate prediction of solution conformations.

The general strategy for

computational modeling of peptides that has been reported in the literature involves
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building and modeling dipeptidc units. Peptides have been studied by both ab initio and
molecular mechanics methods.46 Molecular dynamics methods have been applied to
predict the folding patterns of P-pcptidcs.47"w'l3b Molecular mechanics force fields were
used in the simulations, and promising results have been obtained.

Appclla el al.

predicted the 14-helical conformation of (5-peptides made of trans-ACHC by
computational methods,47 and this was consequently confirmed by experiment.50 YunDong and De-Ping have carried out ab initio quantum mechanics studies on P-pcptidc
models.40,51 Their theoretical studies was based on locating low-energy conformations
and conformations associated with (he formation of secondary structures using dipeptidc
models.

Their theoretical calculations gave results in agreement with experimental

observations.
1.6.3 Circular Dichroism
Circular dichroism (CD) is a spectroscopic method that measures the differential
absorbance of left- and righl-circularly polarized light by a compound in solution. The
differential absorbance is expressed as molar ellipticity, and arises as a result of the
intrinsic chirality of the chromophore or when the chromophorc is placed in a chiral
environment.4 In the case of peptides, the amide chromophore absorbs strong signals due
to the backbone peptide conformation in the far UV region (240-180 nm) of the CD
spectrum.

The CD spectrum in the near UV region (320-260 nm) reflects the

environments of the aromatic amino acid side chains. The peptide CD spectrum is
sensitive to the solution conformation of the peptide as a result of the difference in
absorbance.4 CD has been widely used to detect regular secondary structural features in
peptides and proteins, such as u-hclix and |)-shcet.52
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The CD signals for a-helix, p-sheet and random coil structures of peptides and
proteins arc well characterized. The CD spectra of a-helices are characterized by minima
around 208 nm and 222 nm, and a maximum around 192 nm. In comparison, p-shects
are characterized by CD spectra consisting of a minimum around 218 nm and a maximum
between 195-200 nm. The CD spectra of random coils consist of a strongly negative
signal near 200 nm and a weak maximum close to 220 nm.
Different characteristic CD signals are observed for each type of turn in p~
turns,53'5'1 making it considerably more difficult to predict a general characteristic of such
CD signals. The CD spectra of P-hairpins are difficult to analyze, since p-hairpins arc a
combination of p-strand and P-tum, and only the contribution of p-tum to CD is
characterized.

The CD signals of antiparallel P-hairpins, however, have been

qualitatively observed to resemble that of p-sheets.52
As mentioned earlier, compatibility between a- and P-peptide secondary
structures remains largely uninvestigated. It will be interesting to synthesize oligomers
containing a- and P-amino acids in an alternating sequence and then check for the ability
of such oligomers to fold.

The synthesis and characterization of heterogeneous

oligomers, the main focus of this part (Part II), is described in chapter two. Chapter three
provides all the experimental details from chapter two.

In chapter four, attempts at

modeling heterogeneous oligomers to predict experimental results are presented. Finally
in chapter five, computational simulations of linkers between u- and P-peptide helices are
presented.
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CHAPTER 2
SYNTHESIS AND CHARACTERIZATION OF HETEROGENEOUS OLIGOMERS

2.1 Inlroduction
Heterogeneous oligomers of alternating frwi.v-2-aminocyclohexanecarboxylic
acid (ACHC) with various a-amino acids were designed and synthesized to study their
conformational properties. Heterogeneous oligomers arc synthesized by both solution
phase and solid phase methods. Standard coupling reagents are used with the coupling
proceeding from the C-tcrminus towards the N-terminus. For efficient coupling to be
effected, it is desirable to obtain the monomer in a pure form. It is also important to use
protective groups that are tolerant to reaction conditions. For solution phase synthesis,
tcrt-butyloxycarbony! (Boc) group is used for N“ protection while the benzyl group is
used for protection of the C-terminus. The a-amino acids are obtained commercially and
are used without further purification.

The desired a-amino acids for solution phase

synthesis arc those protected with the Boc group at the N-tcrminus with a free carboxylic
terminus. For solid phase synthesis, the desired a-amino acids are those protected with 9fluorenylmethyloxycarbonyl (Fmoc) at the N-terminus. The side chains of those a-amino
acids containing reactive groups were also protected to prevent side or unwanted
reactions.
carboxylic

The p-amino acids required for coupling, tran.v-2-aminocyclohcxancacid

(ACHC),

and

Fmoc-piperidine

carboxylic
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synthesized and purified. The optical rotation is checked to make sure the monomer is
pure enough for coupling.
The advantage of efficient monomer and oligomer syntheses is that rapid analysis
for structural characterization is ensured. Oligomer synthesis consists of three main
steps: (1) activation of a-carboxyl group. (2) coupling with an amino component, and (3)
deprotection.55 In the synthesis of peptides, it is extremely important to maintain the
chirality of the constituted amino acids to avoid racemization.56 An efficient oligomer
synthesis necessitates, solubility of the constituent amino acid monomers in organic
solvents, complete exclusion of racemization at every step of the synthesis, and a
quantitative yield of product at every coupling step.55
Protecting groups are selected that can be easily removed, leaving the peptide
bond and the various side chain functions unaffected and generating only relatively
harmless by-products. The major difference between solid phase synthesis and solution
phase synthesis is protection of the C-terminus. In solid phase synthesis, the insoluble
polymeric support may be considered to be the C-terminus protecting group, while in
solution phase synthesis, more conventional protecting groups are used.56 Most
commonly, the C-terminus is protected as an alkyl or aryl ester.

Both sequential

elongation and segment condensation strategics may be employed in solution phase
synthesis of oligomers.

Sequential elongation is effective for the synthesis of small

peptides and preparation of peptide segments in the construction of larger peptides and
proteins.56 The use of carbodiimidc derivatives for the activation of the carboxyl group in
the synthesis of peptides was first reported by Sheehan and Hess.57 Carbodiimide
derivatives are now the most widely used coupling reagents for both solid phase and
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solution phase synthesis of peptides.5'’58 It is now common to use the carbodiimide
coupling reagents in the presence of additives, to suppress racemization and accelerate
aminolysis.59'60,61 The synthesis of p-amino acid monomers for oligomer coupling are
presented in the paragraphs that follow.
2.2 Synthesis of A,-(9-Fluorenylmethyloxy)-/ran.s-ACHC by Enzymatic Resolution
The

synthesis

of

iV-(9f!uoicnylmethyloxyearbonyl)-/ra/i.v-ACHC

was

accomplished stalling from the commercially available anhydride, compound 2 - 1 , which
was quantitatively converted to the diester 2-2 by refluxing in methanol and thionyl
chloride. The symmetric dicster was subsequently converted to the monoester 2-3 by
enzymatic desymmetrization through selective ester hydrolysis using pig liver esterase
(Scheme 2.1).
o

-JC O O M #

1. MeOH, Reflux

2. SOCI2
2-1

O

99%

U

s

pig liver oslerase
pH 8 , HjO, Acetone

'COOMa

3. PhH, Reflux
4. BnOH, Reflux

cc

'COOMo

91%

2-2

1. EtOCOCI, NEtg
2. NaN3
__

,COOH

2-3

NHCbz
BnOH
'C O O M e
2-4

82%

Scheme 2.1 Synthesis of Carbamate Ester 2-4.
Precedence for this enzymatic reaction was first reported by Ohno and co
workers,62 and subsequently adapted by Gellman group 63 Ohno and co-workers reported
that the enzyme pig liver esterase selectively hydrolyzes one of the two methyl ester
groups of 2-2 to afford 2-3 in high enantiomeric excess.62 No diacid formation was
observed as had been reported and the enantioselective hydrolysis of the diester by pig
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liver esterase generally terminated at the monoestcr stage.62 An explanation to this is
probably because the initially formed monoester exists as a carboxylate anion in weakly
alkaline buffer-media, and may be too polar to be incoiporated into the hydrophobic
binding site of the enzyme.62 This implies that the enzymatic reaction can continue until
all the diester is consumed.

In addition, Olino and co-workers62 also developed

conditions for obtaining 2-4 from 2-3 by a Curtius rearrangement (Scheme 2.1). Thus the
monoestcr 2-3 was reacted with ethyl chloroformate and triethylamine in acetone and
then sodium azide in water was added to the reaction mixture. The resulting acyl azide
solution was subjected to thermal rearrangement in benzene and treated with benzyl
alcohol to afford the p-aminocstcr derivative 2-4 (Scheme 2.1). An excess of benzyl
alcohol is needed in this reaction for the efficient trapping of the resulting isocyanate to
form a Cbz-protectcd amino group.

Appclla el al., of the Gcllman group, have

reproduced these results but in their case, 2-4 could not be purified from benzyl alcohol.03
Similar to the work of Appclla et al., the above procedures were reproduced and yet the
carbamate 2-4, could not be separated from benzyl alcohol. The mixture was however
carried on in subsequent synthetic steps.
Reduction of the alkcne and removal of the Cbz protecting group in 2-4 was
accomplished by catalytic hydrogenation (Scheme 2.2). Thus the protected (3-aminocster
2-4 was subjected to hydrogenation of the carbon-carbon double bond and
hydrogenolysis of the benzyloxycarbonylamino group by treatment with catalytic Pd/C
under a hydrogen atmosphere.

After reduction and deprotection of 2-4, the benzyl

alcohol was easily separated from the amine product by acid-base extraction.

The

resulting |i-aminocstcr, free from benzyl alcohol, was then reacted with di-/ert-butyl
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dicarbonate (B0C2O) and potassium carbonate to afford 2-5 (Scheme 2.2). An alternative
route to 2-5 involved a one pot reaction in which hydrogenation, hydrogenolysis, and
Boc-proteclion were carried out in one step.

a,

NHCbz

1.

H2, Pd-C. MeOH

♦ BnOH

’COOMo

2. Boc20 , K 2C 03
80%

a,

.NHBOC

NaOMe. MeOH

'C O O M e

2*5

R ef|ux
62%

a:

.NHBoc

LiOH.
LiUn. H2O
M2U2j

Aq MeOH

'CO O M e

97%

Scheme 2.2 Synthesis of Boc-ACHC-OBn 2-8.
Epimerization of the protected [1-aminoester 2-5 with NaOMe in refluxing MeOH
yielded the trails isomer 2 -6, which was contaminated with a small amount of the cis
isomer 2-5. Rccrystallization in 11-heptane provided pure 2-6 (Scheme 2.2). The methyl
ester was hydrolyzed to provide Boc-ACHC 2-7, whose optical rotation was comparable
to the same compound synthesized and reported by Appclla el a /."'1 The C-tcrminus of the
Boc-prolected free acid was protected with a benzyl group to afford 2-8 (Scheme 2.2),
that was used as an intermediate for solution phase synthesis of oligomers.
To obtain the required monomer for solid phase synthesis, Fmoc-protection was
necessary since it has been demonstrated that in the solid phase synthesis of oligomers,
Fmoc-bascd protection strategy is most facile.58 The desired monomer for solid phase
synthesis 2-9, was obtained from the corresponding Boc-protected free acid 2-7 by
deprotection of the amino group followed by rcprotection with the Fmoc group as shown
in Scheme 2.3. Two different synthetic methods were used to synthesize 2-9 from the
corresponding Boc-protected free acid. The first method involved the use of an organic

;ed with permission of the copyright owner. Further reproduction prohibited without permission.

143

base DIEA in acetonitrile while the second method involved the use of weak inorganic
base sodium bicarbonate in acetone/watcr. Both methods yielded the desired Fmocprotected acid in moderate to good yields.

a

NHBoc

1. 4NHCI/Dioxane

COOH
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a

NHFmoc
COOH

0°C------ r t
76%

Scheme 2.3 Synthesis of (K,K)-Fmoc-ACHC 2-9.
The synthetic routes that have been described above (based on enzymatic
hydrolysis) enabled the synthesis of benzyl (IK. 2K)-At-/er/-butyloxycarbonyl-/ru«v-2aminocyclohexanecarboxylate 2-8, for solution phase synthesis, and (lK,2K)-FmocACHC 2-9 for solid phase synthesis.

Although the monomers, 2-8 and 2-9, were

obtained in quantitative yield, the major drawback was that the synthetic routes only
provided access to one enantiomer (R,R). The method does not allow the synthesis of
(S,S)-Fmoc-ACHC, which will be required for the synthesis of oligomers incorporating
natural a-amino acids (L-configuration). Also several column chromatographic steps
were involved, which is generally not convenient when dealing with large amount of
material. The search for an alternative and more efficient synthetic route to the (1-amino
acid monomers should be based on overcoming the shortcomings of the use of pig liver
esterase. An efficient synthetic route to the monomers, therefore, should be one that can
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give access to both enantiomers, ami can afford quantitative amount of the pure
monomers with little or no column chromatography involved. Towards this end. the
synthesis of the P-amino acid monomers by reductive animation presented in the next two
sections is an efficient synthesis that precludes the use of column chromatography and
enables both enantiomers to be synthesized.

This chemistry was developed by the

Gcllman group64 and successfully implemented.
2.3

Synthesis of P-Amino Acid Monomers by Reductive Animation

Reductive amination methodology for the synthesis of cither enantiomer of trans3-aminopyrrolidinc-4-carboxylic acid (APC), and fra/r.s-2-amino cyclopcntanecarboxylic
acid (ACPC) respectively had been previously reported by the Gellman group.65'66 Both
synthetic routes were inspired by the chemistry developed by Bartoli and co-workers.67
Bartoli and co-workers demonstrated that sodium inetal reduction of cyclic p-enamino
ester 2 -10 will result in the formation of the trans y-amino alcohol in high
diastereoselectivity and excellent yield (Scheme 2.4).

2%
2-12

Scheme 2.4 Diastereosclective reduction of p-amino ester by Bartoli and co-workers.07
Based on this chemistry, the Gellman group66 hypothesized that replacement of
the benzylamine with an optically pure cc-methyl benzyl amine would allow reduction to
produce predominantly the most stable diastcrcomeric alcohol, which could be separated
and after purification carried on to give optically pure Fmoc-ACPC.

ed with permission of the copyright owner. Further reproduction prohibited without permission

145

The synthesis to either enantiomer of ACPC was successfully accomplished.66
The synthetic route, however, suffered from low yields at the reduction stage, and overall
low yields were obtained when the reaction was carried out on a larger scale. A different
approach was taken that led to the successful reductive amination of P-ketoestcr 2-13 to
p-aminocster 2-14 in the synthesis of APC derivatives (Scheme 2.5).65

Scheme 2.5 Diastercoselective reduction reported by the Gellman group.65
Inspired by their success in APC synthesis,65 the Gellman group modified their
synthetic route to Fmoc-ACPC. 66 P-Ketoester 2-15 was subjected to reductive amination
conditions followed by saponification, dcprotcction and protection to afford Fmoc-ACPC
2-17 (Scheme 2.6).
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Scheme 2.6 Synthesis of 2-17 by reductive amination, reported by the Gellman group.6
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The synthetic routes developed,05'66 although efficient, reproducibility became a
problem in the Gellman group. Purification of the final product by recrystallization
seemed almost impossible, and an inseparable impurity (observed by HPLC) of mass unit
corresponding to a product due to incomplete hydrogenolysis of the chiral auxiliary was
observed in oligomers containing the Fmoc-ACPC monomer.08 Investigation into the
difficulty in reproducibility revealed that the impurity that could not be separated from
the monomer upon recrystallization was due to the presence of dibenzylfulvenyl alcohol,
a decomposition product from the use of Fmoc-OSu in excess at the final protection
step.08 The impurity observed in the oligomers containing Fmoc-ACPC monomers could
be due to contamination of the monomer by a tertiary carbamate that could be
incorporated into a part of the oligomer.68
These problems were addressed by a modification of the initial synthetic route.66
Complete removal of the chiral amine was ensured by carrying out transfer
hydrogenation instead of simple hydrogenation, and the number of equivalents of FmocOSu was reduced making it the limiting reagent.08 The results of the modification were
the reproducibility of the synthetic methodology, and the formation of pure enantiomers
in very good yields. This methodology has been adapted for the synthesis of monomers
of ACHC,64 and has been implemented for the synthesis of Fmoc-ACHC, and 4-/V-(9Fluorcnylmcthyloxycarbonyl)-l-fert-butyloxyearbonyl-!raiu-pipcridine carboxylic acid
which are presented in the proceeding sections.
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2.3.1

Synthesis of nfl,2fl)-2-(9//-Fluorei)-9-vlmeilivloxvcarbonvlamino)Cvclohcxanecarhoxvlic Acid hv Reductive Aminalion

The results of the synthetic route leading to the synthesis of Fmoc-(/f,/f) ACHC
arc summarized in Scheme 2.7. The key step involves the reductive animation of the (3ketoester 2-18 with chiral (R)-(+)-a-methy!benzylaminc.

0
6 '
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NaHCO^^^
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jCOjEt

2-21

89%

2-9

Scheme 2.7 Route to Ftnoc-(R.R) ACHC 2-9 based on reductive amination.
The synthetic route (Scheme 2.7) was inspired by earlier work in the Gellman
group,65'66 and the asymmetric synthesis of eis-2 -aminocyclohexanccarboxylic acid
reported by Xu el al.w

The (3-kctoester 2-18 is allowed to react with (R)-a-

methylbcnzylamine in refluxing benzene with catalytic tolucncsulfonic acid and
continuous removal of water using a Dean-Stark trap. The resulting cnamine 2-19 is
isolated as a pale yellow oil by distillation at reduced pressure. Xu et al.1'9 had reported
that NaBHj/acid reduction of the enamine 2-19 resulted in four diastereomeric (iaminocstcrs. The diastcrcoselectivity and cis/trans selectivity were found to depend on
the carboxylic acid, co-solvent, ratio of aeid/substratc, and the reaction temperature.
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Assignment of the diastcreomers was based on their respective 'H NMR spectra.60
When the enamine 2-19 dissolved in toluene was added to a mixture of sodium
borohydridc and isobutyric acid at 0 °C, the enamine was reduced only to two
diastcreomers (both cis, no traits) with a 94% diastcrcomeric excess. The diastereomeric
product was then subjected to epimerization using sodium in absolute ethanol. Following
cpimcrization, the crude product was purified by a two-step crystallization protocol that
allows isolation of the hydrochloride salt 2-20 in diastereomcrically pure form. Thus, the
crude product from epimerization reaction was dissolved in ethyl acetate and converted to
a mixture of hydrochloride salts by treatment with 4N HC1 in dioxane. Rccrystallizalion
from acetonitrile yielded pure 2-20 (>99% tie) in 51% overall yield from 2-19. The 'H
NMR spectrum of the purified P-aminoester 2-21 was identical to the spectrum for the
same diastereomcr that was reported by Xu et til 69 Thus the diastereoselectivity was
determined by proton NMR.
The synthetic route was completed by alkaline ester hydrolysis, reductive removal
of the chiral auxiliary (a-mcthylbcnzylaminc), and Fmoc protection of the resulting
amino group using Fmoc-OSu and sodium bicarbonate in aqueous acetone. The crude
product was purified by recrystallization in n-hexane/chloroform to afford 2-9 in 76%
overall yield. The optical rotation was determined and compound 2-9 was found to have
the same optical rotation as the reference compound synthesized by enzymatic resolution.
This synthetic route is efficient and leads to the formation of either enantiomer of FmocACHC with no chromatography involved.
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2.3.2

Synthesis of(3A‘.4ff i- 1 -(/V-tcit-BulvloxN carbon vl)-3-hvdrox vcarbonvl-4-

l9//-fluorcn-9-vl-mcthvloxvcarbonvlamino)-Pipcndine by Reductive Amination
Reductive amination methodology was also applied for the large scale synthesis
of the enantiomeric derivatives of piperidine (Scheme 2.8).
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Scheme 2.8 Synthesis of 2-26.
The benzyl group was removed from the piperidine carboxylate salt 2-22 by
transfer hydrogenation followed by protection with a ferf-butyloxycarbonyl (Boc) group.
The Boc-protected P-ketoester was then subjected to reductive amination using (fl)-amcthylbenzylaminc in refluxing benzene with catalytic tolucnesulfonic acid and removal
of water by a Dean-Stark trap to afford 72% of the enamine 2-23 after silica gel flash
column chromatography.
The resulting enamine 2-23 was reduced in situ with sodium borohydride and
isobutyric acid. This reduction produced a mixture of two diastereomeric Boc-prolcctcd
P-aminoeslcrs, all cis and no trans isomers. The cis diastercomcrs were obtained in a 7:1
(major to minor isomer) ratio based on proton NMR, after column chromatography.
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Epimcrization of the cis isomeric mixture in sodium and absolute ethanol afforded the
crude trans mixture. The crude P-aminoestcr mixture was dissolved in ethyl acetate and
converted to a mixture of hydrochloride salts by treatment with 4N IICI in dioxane. A
single trans isomer crystallized in relatively pure form (>95% cle), with some
contamination from the other trans isomer. After recrystallization from acetonitrile, the
pure product 2-24 was obtained in 22% overall yield from 2-23. A small amount of 2-24
was subjected to a base wash to obtain 2-25. of which the diastereomeric excess upon
proton NMR was shown to be >99%. Hydrolysis of the ester group, followed by removal
of the chiral auxiliary from 2-24 and protection of the resulting amino group afforded the
crude product. The crude product was purified by crystallization from n-hexane and
chloroform to afford 53% of 2-26.
2.4

Solution Phase Synthesis of Heterogeneous Oligomers

Oligomers were synthesized in solution by conventional peptide coupling
methods with A',/V-dimethylaminopropyl-3-ethylcarbodiimide hydrochloride salt (HDC1)
as the coupling reagent, and 1-hydroxybcnzotriazolc hydrate (HOBt) as additive to
suppress raccmization and accelerate aminolysis. Coupling was designed to proceed
from the C- towards the N-terminus. Protecting groups were needed for the amino and
carboxy groups.

A tm-butyloxycarbonyl (Boc) protecting group, which is easily

removed under acidic conditions, was chosen for the amino group, and a benzyl group
(Bn), which is removed by hydrogenolysis, was chosen to protect the carboxy group. A
retrosynthetic analysis for solution phase coupling is shown in Scheme 2.9. A sequential
coupling strategy was employed starting with the synthesis of the dimeric backbone.
The synthesized P-amino acid monomers had the R.K configuration and for compatibility
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in the synthesis, it was desirable to use unnatural a-amino acids having the Dconfiguration. Several different reaction conditions were tried to synthesize the dimeric
backbone and the best condition was obtained with EDCl/HOBt as coupling reagents,
diisopropylcthylamine (DLEA) as base, and N,/V-dimcthylformamidc (DMF) as solvent.
The same combination of reagents was subsequently applied for the synthesis of trimers,
tctramcrs and higher oligomers.

Scheme 2.9 Rclrosynthetic analysis for solution phase oligomer synthesis. R is the amino
acid side chain.

2.4.1 Synthesis of Dimers
The synthesis of dimers was accomplished starting with the Boc-protected free aamino acid as the electrophile. The (l-amino acid protected by a Boc group at the Nterminus and a benzyl group at the C-tcrminus was first dcprotected at the N-terminus to
form a free amine that would serve as the nucleophile. Standard dcprolcelion methods
involving the use of 4N HCI in dioxane to deprotecl the Boc group was earned out as
shown in Scheme 2.10. Once the Boc group was deprotcctcd, the free amine was then
coupled to the free acid using standard coupling reagents (Scheme 2.10).
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,COOBn

1 . 4N

HCI/dloxane
BocHN

o
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2. HOBt, EDCI, DIEA, DMF

0
BocHN ^ J L

oh

h
Scheme 2.10 Dimerization of ACIIC with a-amino acids.
Dimer couplings generally went lor an average of 4S hours and the yields were
usually very good to excellent even after column chromatography. The dimers were
characterized by 'H NMR and MS-ESI. The structures of the various dimers that were
synthesized and their yields are shown Figure 2.1. Synthetic details are given in chapter
3.

Boc-D-Pha-ACHC-OBn (2-28)
94%

H,C CH 3
Boc-O-Val-ACHC-OBn (2-29)
80%

Figure 2.1 Structures and yields of heterogeneous dimers (In all cases, stereochemistry of
the a-am ino acid is O while the p-amino acid is /?,/?).
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2.4.1

Synthesis of Trimcrs. Tctramers, and Higher Oligomers

A sequential or stepwise coupling from the dimer was employed to synthesize
oligomers with three or more residues. A general synthetic route leading to oligomers
beyond the dimer is shown in Scheme 2.11.
Boc-AA-ACHC-OBn or Boc-ACHC-OBn
Pd/C, H-., MeOH

4N HCI in dioxane

©

Boc-AA-ACHC-OH
or
Boc-ACHC-OH

H,N-AA-ACHC-OBn

EDC1, HOBt, D1EA,
DMF
Boc-AA-ACHC-AA-ACHC-OBn
or
Boc-ACHC-AA-ACHC-OBn
Scheme 2.11 Synthetic route to oligomers with more than two residues; AA = a-amino
acid.
Synthesis was successful to the level of the tctramers but beyond the tctramers,
solubility became a problem. An attempt was made to synthesize the hexamer containing
Ala which unfortunately did not yield any good results. Poor solubility of the compounds
in organic solvents was a major issue and the reaction was messy. Observation of the
spectra obtained by MALD1 and electrospray ionization mass spectrometry indicated the
mass of the desired product, but other uncharacterized impurities were more abundant.
Although the original idea was to make oligomers of u- and [3-amirio acids in alternating
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sequence, another design was tried in which some oligomers were synthesized having aamino acids but with [i-amino acids at the N- and C-termini. The idea was to investigate
the effect of terminal P-amino acids on the conformation of a chain of a-amino acids.
The trimers and letramers were purified by column chromatography, and when it was not
possible to carry out chromatography due to low solubility, repeated precipitation was
used to purify the oligomers. The oligomers were characterized by MS-ES1 and low
resolution 'll NMR. Conformational and structural analysis was not carried out with
these solution phase oligomers because a more purified form of the oligomers is needed
for such studies. Purified samples for conformational analysis by CD and NMR could
only be obtained from HPLC, and because of solubility problems HPLC grade samples
could not be obtained. The structures of the various oligomers synthesized and their
yields are shown in Figures 2.2 and 2.3.

Trimer and tetramer refer to oligomers

containing three and four residues respectively. Synthetic details arc given in chapter 3.
The yields reported are based on recovered product upon column chromatography
or repeated precipitation.

The mass spectra were usually clean after column

chromatography and repeated precipitation with the peak corresponding to the molecular
mass of the oligomers being the most significant peak. Purity check by HPLC, however,
was not performed to make sure the oligomers were clean enough for analysis due to the
oligomers being insoluble in HPLC solvent systems.
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Boc ACHC-D-Phe ACHC OBn (2-31)
52%

Boc-OVal-0-Phe-ACHCOBn (2-30)
85%

Boc-ACHC-0-Val-ACHC-OBn (2-32)
62%

ch2
CHj
ch2
ch2
NH

C

Cl
Boc-OLys(2-CI-Z)-0-Val-ACHC-OBn(2-33)
84%

Figure 2.2 Structures and yields of heterogeneous trimcrs (In all cases, stereochemistry of
the a-amino acid is D while the |3-amino acid is R.R).
The heterogeneous dimer (dipeptide) 2-28 was /V-dcprotected with 4N HCI in
dioxanc, and coupled with the Boc-a-amino acid (Boc-Val-OH) to give the
heterogeneous trimer (tnpeptidc) 2-30 in 85% yield. The heterogeneous dimer 2-28 was
iV-dcprotectcd with 4N HCI in dioxane, and coupled with the Boc-P-amino acid (BocACHC-OIi) to afford the heterogeneous trimer 2-31 in 52% yield. The heterogeneous
dimer 2-29 was /V-dcprotectcd with 4N HCI in dioxanc, and coupled with the Boc-Pamino acid (Boc-ACHC-OH) to give the heterogeneous trimer 2-32 in 62% yield. The
heterogeneous dimer 2-29 was A'-deprotectcd with 4N HCI in dioxane, and coupled with
the Boc-a-amino acid (Boc-Lys-OH) to obtain the heterogeneous trimer 2-33 in 84%
yield.
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Boc-D-Phe-ACHC-D-Phe-ACHC-OBn (2-35)
72%

Boc-D-Val-ACHC-0-Val-ACHC-OBn (2-36)
80%
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Boc-D-Lys (2-CI-Z)-ACHC-D-Val-ACHC-OBn (2-38)
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c \'
Boc-ACHC*£>Lys (2-CI-Z)-D-Val-ACHC-OBn (2-39) 75%

Figure 2.3 Structures and yields of heterogeneous tetramers (In all cases, stereochemistry
of the ct-amino acid is l) while the p-amino acid is R,R)-
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The heterogeneous letramer 2-34 was synthesized from two heterogeneous dimers
of 2-27. Thus, the heterogeneous dimer 2-27 was deprotected on the C-terminus by
hydrogenolysis (H2, Pd/C) and then coupled with the corresponding iV-dcprotcctcd (using
4N HCI in dioxane) heterogeneous ditner 2-27 to give the heterogeneous letramer
(tetrapeptide) 2-34 in 75% yield. In a similar manner, the heterogeneous letramer 2-35
was synthesized from two heterogeneous dimers of 2-28 The heterogeneous dimer 2-28
was deprotected on the C-tcrminus by hydrogenolysis (H2, Pd/C) and then coupled with
the corresponding /V-deprotectcd heterogeneous dimer 2-28 to give the heterogeneous
letramer (tetrapeptide) 2-35 in 72% yield. The heterogeneous tetramer 2-36 was also
synthesized from two heterogeneous dimers of 2-29. Therefore, the heterogeneous dimer
2-29 was deprotected on the C-terminus by hydrogenolysis and then coupled with the
corresponding /V-dcprotccled heterogeneous dimer 2-29 to afford the heterogeneous
tetramer (tetrapeptide) 2-36 in 80% yield (Figure 2.3).
The heterogeneous tetramers 2-37, 2-38, and 2-39 were synthesized by coupling a
tripeptidc with an a- or p-amino acid. For the preparation of the heterogeneous tetramer
2-37, the tripeptidc 2-30 was /V-deprotccted, using 4N HCI in dioxane, and coupled with
the Boc-a-amino acid (Boc-Lys-OH) to obtain 2-37 in 60% yield. The heterogeneous
tetramer 2-38 was prepared by deprotection of the trimer 2-32 at the N-terminus, using
4N HCI in dioxane, and coupling with the Boc-u-amino acid (Boc-Lys-OH) to yield 90%
of 2-38.

Finally, the heterogeneous tetramer 2-39 was synthesized from the

heterogeneous trimer 2-33, that was /V-deprotectcd, and the corresponding Boc-P-amino
acid (Boc-ACHC-OH). By coupling /V-deprotcctcd 2-33 with Boc-ACHC-OH, 2-39 was
obtained in 75% yield. Full experimental details are given in chapter 3.
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2.5

Solid Phase Synthesis of Heterogeneous Oligomers

Oligomers were synthesized following the general protocol for solid phase
synthesis from the C- towards the N-terminus.70 The general protocol involves
deprotection, activation, and coupling (Scheme 2.12).

Acid Labile
Linker

o

Fmoc-Alpha Amino Acid
-N H 2

HBTU, DIEA, H03t, DMF

O

Acid Labile
Linker

1. 20% Piperidine in DMF

—N

NHFmoc

H

NHFmoc

Elongation

2. Fmoc-ACHC. HBTU
DIEA. HOBT. DMF

/^ v

O

Acid Labile
Linker
l_____________

Acid Labile
Linker

—

1. 20% P'pendine in DMF

Heterogeneous
Peptide

Heterogeneous
Peptide

2. Ac?0 , Et3N, CH2CI2. 2 h

-NHAc

95% TFA, 2.5% Ethanedithiol
2.5% H20

Heterogeneous 1
peptide

Scheme 2.12 Generalized route for solid phase synthesis.
Extended deprotection, extended coupling and extended flushes were employed to
ensure that synthesis was complete. The columns in the synthesizer were loaded with
three-fold excess of amino acid that is sufficient for coupling, iV, /V-Dimcthylformamidc
was used as solvent while HBTU and DIEA reagents served as the activators. The
purpose of the activators was to convert the carboxyl group to an active ester which then
reacts with the deproteeted a-amino acid. The use of llOBt as an additive was necessary
to suppress any possible racemization and accelerate aminolysis. Piperidine and DMF
served to deprotcct the Fmoc-protected a-amino group on the peptide resin in preparation
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for coupling. THF was used as the secondary solvent to clean the column of primary
solvent after synthesis.

At the end of the synthesis, the oligomers (peptides) were

acctylatcd and rinsed. The peptides were then cleaved from the resin by a protocol
involving the use of 95:2.5:2.5 TFA:ethancdithiol:H20 and stirring for about 5 hours.
The peptides (Figures 2.4 & 2.5) were precipitated by evaporation of the deprotection
solution, followed by addition of methanol to solubilize the peptides, and addition of
excess cold anhydrous diethyl ether.

0

A

o
NH

NH,

.OH

NH,

0
,k% - k - N H

0

A

Ac-ACHC-D-tys-ACHC-D-Tyr-ACHC-D-Lys-NHj (2-40)

Ac-ACHC-L-Lys-ACHC-t.-Tyr-ACHC-L-Lys-NH2 (2-41)

Figure 2.4 Heterogeneous hexamers synthesized by solid phase method.
The crude peptides were obtained in good yields (calculation based on the initial
loading of the resin) and high purity as determined by analytical HPLC. The peptides
were further purified by reverse phase HPLC, characterized by MALDI-TOF mass
spectrometry, and the correct structure verified by high resolution 'H NMR spectroscopy.
The purified peptides were used for structural characterization (conformational analysis)
by CD and NMR spectroscopy.

with permission of the copyright owner Further reproduction prohibited without permission.

160

Ac-ACHC-D-Lys-ACHC-D-Tyr-ACHC-D-Lys-ACHC-D-Tyr-NH2 (2-42)
OH

Ac-ACHC-L-Lys-ACHC-L-Tyr-ACHC-Mys-ACHC-6-Tyr-NH2 (2-43)

Figure 2.5 Heterogeneous octamers synthesized by solid phase method.

2.6 Characterization of Oligomers
The characterization of oligomers reported in this section is based on
conformational

analysis.

Several

conformational analysis of peptides.

spectroscopic

techniques

arc

available

for

Two of these techniques, CD and NMR

spectroscopy were used for conformational analysis of the heterogeneous oligomers 2-40,
2-41, 2-42, and 2-43.
2.6.1

One- and Two-Dimensional Nuclear Magnetic Resonance

One- and two-dimensional NMR spectroscopic measurements were carried out by
Margaret Schmitt (Gcllman group. University of Wisconsin-Madison). High-resolution
ID data were collected on all heterogeneous oligomers 2-40, 2-41, 2-42, and 2-43, in
order to determine the proper temperature for 2D experiments. The proper temperature
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was determined based on the dispersion of significant protons at various temperatures.
Proton chemical shifts vary slightly depending on temperature, and adjustments in
temperature may result in better dispersion for more complete 2D assignment and
analysis. Resonance assignments were made based upon COSY and TOCSY data, as
well as sequential ROES from ROESY data. Data were collected at either 4, 14 or 24 °C.
as necessary for the best resolution of spectra overlap. Unfortunately, a complete 2D
assignment could not be made (no observed long-range NOEs or ROEs) for the
heterogeneous oligomers 2-40, 2-41, 2-42, and 2-43, due to significant spectral or
resonance overlap.
2.6.2 Circular Diehroism
Circular diehroism (CD) has been extensively used to obtain information on the
secondary structure of peptides and proteins in solution. The CD patterns for a-peptides
and proteins have been characterized for common secondary structures such as a-helix
and P-shect. However, for p-peptides, the correlation between CD patterns and types of
secondary structure is an ongoing research. No CD information is available for structural
characterization of heterogeneous oligomers. For proper estimation of the secondary
structure content of a peptide or protein from CD it is essential to accurately know the
concentration of the sample.5*’ The concentrations of the oligomers were determined by
measurements of rijvo calibrated by reference to tyrosine. Because the physical details of
absorption of circularly polarized light are not well understood, CD prediction of a new
type of secondary structure is often difficult and must be used in conjunction with other
methods of characterization. CD as a structural technique, however, plays an important
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role in complementing higher resolution structural approaches of X-ray crystallography
and NMR.5' The CD spectra of an oligomer can provide insight into its conformation.
The CD spectra of the hcxamcr 2-41. and octamer 2-42 arc presented in Figure 2.6. The
CD spectra were recorded in Tris buffer.

Figure 2.6 CD of hexamer 2-41 (less intense) and octamer 2-42 (more intense) in Tris
buffer.
Both hexamer 2-41 and octamer 2-42 are composed of (/f,tf)-ACHC, but while
hexamer 2-41 is composed of (X)-a-amino acids, octamer 2-42 is composed of {R)-aamino acids. Thus the CD spectrum of the hexamer is inverted relative to the CD
spectrum of the octamer since the a-amino acids have an enantiomeric relationship. The
CD spectrum of the octamer 2-42 shows a positive band at about 216 nm. and negative
bands at 199 nm and 229 nm (Figure 2.6). This spectrum may indicate some form of
secondary structure. The hexamer 2-41 is characterized by maxima at 212 and 230 nm.
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and a minimum at 220 nm. The CD bands of the hexamcr arc less intense than the longer
octamcr. A qualitative interpretation for the increase in intensity of the CD bands for the
octamer 2-42 compared to the hexamcr 2-41, could be that a more organized structure is
formed with increase in number of residues.
2.7 Summary
An enzymatic approach has been applied to synthesize optically active trans-2aminocyclohcxanccarboxylic acid (ACHC). This methodology is advantageous in that
the reaction can be carried out on multihundred gram scale to afford enantiomerically
pure ACHC from readily available starting materials. This method, however, only offers
one enantiomer of Fmoc-ACHC. The method does not allow the synthesis of (S,S)Fmoc-ACHC, which is required for the synthesis of oligomers incorporating a-amino
acids with the (S) stereochemistry. The synthetic route was adapted from published
procedures.61
An alternative synthetic approach, based on reductive amination, has been
successfully applied for the synthesis of Fmoc-ACHC and Fmoc-piperidinc carboxylic
acid. This synthetic route is advantageous in that it is simple, practical, scalable, and
allows the preparation of multi-gram quantities of the monomers without the need for
chromatography, especially in the case of Fmoc-ACHC.

The reductive amination

methodology is applicable for the synthesis of cither enantiomer of Fmoc-ACHC and
Fnioc-piperidine carboxylic acid from a (3-ketoester, which makes the method more
advantageous compared to the enzymatic approach.

The key step that makes this

methodology more practical is the diastcrcomeric enrichment through HCI salt
crystallization. This new methodology was adapted by Schinnerl el ul.M of the Gellman
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group and have been successfully implemented to synthesize the (3-amino acid monomers
for oligomer synthesis.
Heterogeneous oligomers, containing a- and p-amino acids in an alternating
sequence, have been synthesized for the first time. A systematic approach was employed
to select the right combination of coupling reagents, base, and solvent. Strategies in
protection and deprotection were also successfully applied in the synthesis as this is
critical in coupling reactions. Both solution phase and solid phase methodologies were
applied in the synthesis of oligomers.

All oligomers were characterized by mass

spectrometry and nuclear magnetic resonance (’H NMR).

The characterization of

oligomers based on conformational analysis using high resolution one- and twodimensional NMR, and CD was attempted. The correct structure of the oligomers was
verified by one-dimensional ‘H NMR, but complete two-dimensional structural
information could not be obtained due to extensive resonance or spectra overlap. From a
qualitative interpretation of the CD spectra, it could be concluded that oligomers form
some kind of ordered conformation in solution.

with p e rm is s io n o f the c o p y rig h t o w n er. F u rth e r rep ro d u ctio n p ro h ib ited w itho u t p e rm is s io n .

CHAPTER 3
EXPERIMENTAL

3.1 Solution Phase Oligomer Synthesis
The following general procedures were carried for solution phase oligomer
synthesis. Melting points (m.p.) were obtained on a Thomas Hoover Capillary Melting
Point Apparatus and arc uncorrectcd. Optical rotations were measured on a Perkin-Elmer
241 digital polarimeler using sodium light (D line, 589.3 nm) and are reported in degrees;
concentrations (c) are reported in g/100 mL. Proton nuclear magnetic resonance (*H
NMR) was recorded in deuterated solvents on a Brukcr AC-300 (300 MHz) spectrometer.
Chemical shifts are reported in parts per million (ppm, 8) relative to tetramethysilane (8
0.00).

In the absence of tetramcthylsilanc in the deuterated solvent, the standard

chemical shift of the solvent is referenced
solutions of CDCL and

C D 3 O D , C D C I3

( C D C Ii,

8 7.26; GDjOD, 8 3.30). For mixed

is referenced. ‘H NMR splitting patterns arc

designated as singlet (s), doublet (d), triplet (t), quartet (q), or quintet (quint). All first
order splitting patterns are assigned based on the appearance of the multiples For those
,

splitting patterns that could not be easily visualized or interpreted, a designation of
multiplet (m) or broad (br) was used. Coupling constants arc reported in Hertz (Hz).
Carbon nuclear magnetic resonance (l3C NMR) spectra were recorded on a Brukcr AC300 spectrometer. Chemical shifts are reported in ppm (8) relative to the central line of
the C D C I 3 triplet (8 77.0), or the CD3OD septet (8 49.0).

165
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Carbon NMR data were assigned using distortionless enhancement by
polarization transfer (DEPT) spectra obtained with a phase angle of 135°:

(C) not

observed; (CH) positive; (ClI>) negative; (Cl [ 3 ) positive. Electrospray ionization (ESI)
mass spectra were determined on a Kratos MS-80 mass spectrometer. Dry ethanol was
prepared by distillation from diethyl phthalatc and sodium. Dry methanol was prepared
by distillation from Mg(OMc)2 (Mg turnings (5 g), 12 (0.5 g), methanol (100 mL)).
Benzene was freshly distilled from Na/bcnzophenone kctyl and stored under N2.
Methylene chloride was distilled from CaHj.

Hexane was distilled at atmospheric

pressure. Diisopropylcthylamine (DIEA) was distilled from Call;.

Unless otherwise

noted, all other commercially available reagents and solvents were used without further
purification. All commercially available reagents and solvents, unless stated otherwise,
were purchased from Aldrich, except for 4 N MCI in dioxanc, which was purchased from
Pierce. Analytical thin-layer chromatography (TLC) was curried out on Whatman TLC
plates precoated with silica gel 60 (250 pm layer thickness).

Visualization was

accomplished using cither a UV lamp, potassium permanganate stain (2 g of KMnOj,
13.3 g of K2COj , 3.3 mL of 5% (w/w) NaOH, 200 mL of HjO), ninhydrin slain (0.5 g of
ninhydrin, 150 mL of n-butanol, 5 mL of glacial acetic acid), or phosphomolybdic acid in
ethanol. Column chromatography was performed on EM Science silica gel 60 (230-400
mesh). Solvent mixtures used for TLC and column chromatography are reported in v/v
ratios. All glassware were dried in an oven at 120°C.
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3.2 Solid Phase Oligomer Synthesis
In solid phase methodology, the oligomer is synthesized and then purified by
HPLC. The general procedures for solid phase synthesis and purification arc presented in
the sections that follow.
3.2.1 Oligomer Synthesis
Solid phase oligomer synthesis was earned out using the automated peptide
synthesizers Synergy or Pioneer, Applied Biosystems Model 432A (Foster City, CA). N9-Fluorenylmcthyloxycarbonyl amino acids and 2,4-dimethoxybenzhydrylamine resin
(Rink Amide) cartridges were obtained from E.I. du Pont de Nemours & Co., Inc.
(Boston, MA) or Novabiochem (San Diego, CA) and advanced Chcmtech (Louisville,
KY).

Peptide synthesis reagents such as DMF, piperidine, TFA, 1,2-cthanedithiol,

thioanisolc,

l-hydroxy-7-azabenzotriazole

(HOAT),

0-(7-azabenzotriazol-l-yl)-

N,N,N’,N’-trimcthyluronium hexafluorophosphate (HATU), were all purchased from
Aldrich Chemical Company (Milwaukee, Wl) and were used without further purification.
HBTU, HOBt, DIEA were purchased from Applied Biosystems (Foster City, CA).
Standard solid phase techniques with N“-Fmoc-protected amino acids70 using
2,4-dimethoxybenzhydrylaminc resin (Rink Amide AM) cartridges on a 25 pmole scale
were applied. The resins were either preloaded with the C-tcrminal amino acid or acidlabile amine. Synthesis proceeded from the C-terminal to N-terminal direction. Each
coupling reaction was carried out at room temperature in DMF with three equivalents of
amino acid. Coupling reactions were monitored by the conductivity of the solution.
Reaction times were doubled to ensure that coupling was complete.

The coupling

reagents used were I1BTU and DIEA as activators with HOBt as the additive. In each
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step of the coupling, the chemicals were delivered at a scale of 75 pmoles which is three
fold excess relative to the estimated resin capacity. For amino acids with reactive groups
on their side chains, protection of the reactive groups was ensured to prevent unwanted
side reactions. Notably the tyrosine and lysine side chains were protected with the icrtbutyl and Boc-protected groups respectively.
At the end of each coupling reaction, the N-tcrminul Fmoc-protectcd amine was
dcprotccted by applying 20% piperidine in DMF at room temperature for about 60
minutes. Fmoc deprotection reactions were also monitored by the solution conductivity.
Upon addition of the last residue, the resin, still in the peptide synthesis column, was
rinsed with methanol or methylene chloride and dried under a stream of nitrogen. The
dried resin was transferred into a 10 mL round-bottom flask for the cleavage reaction.
To cleave the peptides from the resin, a solution consisting of 2.5% Milliporc
water and 2.5% ethanedithiol in TFA was used. The solution and resin were stirred at
room temperature for approximately 5 to 6 hours. The resin beads were filtered off using
a plug of glass wool and rinsed two to three times with additional TFA. TFA was blown
off under a gentle stream of nitrogen. The peptides were isolated via precipitation. A
minimal amount of MeOH was added to dissolve the peptides, and diethyl ether (10 mL)
was added to form a while precipitate. The mixture was cooled in an acctonc/dry ice bath
for 5 minutes, and centrifuged at 3000-4000 rpm until the precipitate formed a pellet at
the bottom of the centrifuge tube.

The ether was decanted, and the pellet was

resuspended in cold ether (10 mL) and centrifuged again; the process was repeated three
times. During the final wash 10 mL of Millipore water was added to 10 mL of cold ether
and the mixture was centrifuged again. The ether was decanted and the aqueous layer,
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containing the crude peptide was transferred to a round bottom flask for lyophilization.
Crude yields for peptide synthesis were usually around 90%.
3.2.2 Oligomer Purification
1IPLC purification was performed on an Hewlett Packard-1050 HPLC using a
semi-preparative Cis column (Vydac) with a flow rate of 3 ml-/minute. Analytical HPLC
was carried out using a Cis column (Vydac) with a flow rate of 1 mL/minute. Gradient
elution was used with the following solvent systems: solvent A = 0.1% TFA in water,
solvent B = 80:20 CfLCN / 0.1% TFA in water. Peptides were purified by reverse phase
semipreparative HPLC with a Cl 8-silica column (5 pm, 10 x 250 mm; Vydac, Hesperia,
CA). Purity of peptides was monitored by reverse phase analytical HPLC with a C 18silica column (5 pm, 4 x 250 mm; Vydac, Hesperia, CA). Peptide chromatograms were
monitored at 220 nm, which corresponds to the absorption of the amide chromophorc.
Crude peptides were dissolved in Milliporc water at a concentration of 0.2 mg/mL and
passed through a 0.45 pm polyvinylidene difluoride syringe filter to remove particulate
material. Each injection typically contained a ca. 1.5 mg of peptide. The shape of the
chromatograph was analyzed to ensure good resolution and peak shape. The injection
volume was typically decreased if poor resolution or separation was noticed. Gradient
conditions were adjusted to about 0.5% of Cl LCN/HiO/TFA (80:20:0.01) per minute.
Peptide homogeneity was assured by analytical HPLC using a C18-silica
analytical column (5 pm, 4 x 250 mm; Vydac, Hesperia, CA) and CH3CN/H2O/TFA
eluents at a flow rate of 1 mL/min. The peptides were generally >95% pure, based on
analytical HPLC.

Peptide identity was initially confirmed by matrix-assisted laser
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desorption time-of-flight mass spectroscopy (MALD1-TOF-MS), and subsequently by
high resolution 'H NMR analysis.
3.3 Analytical Methods
Analytical methods such as nuclear magnetic resonance (NMR) spectroscopy,
circular dichroism (CD) spectroscopy, and MALD1-TOF mass spectrometry were used to
characterize the oligomers. Both one- and two-dimensional NMR techniques were used
for characterization.

Sample preparation for low resolution one-dimensional NMR

follows the same general protocol for all solution phase synthesis, which is conventional
and so will not be considered in this section. Sample preparation for high resolution oncand two-dimensional NMR, however, is not straightforward as the concentration of the
sample is important, and this is reported in the paragraph that follows.
3.3.1 NMR Spectroscopy
Samples were prepared by dissolving the peptide in deuterated methanol
(CDjOH) to a concentration of approximately 3 mM. A trace amount of 2,2-dimethyl-2silapentanc-5-sulfonatc (DSS) was added for referencing. Samples were syringe-filtered
into 5 mM NMR tubes and sonicated to ensure homogeneity. Data were collected on a
VARIAN lnova-600 spectrometer in the chemistry information center (Department of
Chemistry University of Wisconsin-Madison, supported by N1H and NSF).

High-

resolution one-dimensional NMR data were gathered on all samples to determine proper
temperature for two-dimensional NMR experiments, based on the dispersion of
significant protons at various temperatures. Resonance assignments were made based
upon COSY andTOCSY data, as well as sequential ROEs from ROESY data. Data were
cither collected at 4, 14 or 24 °C, as necessary for best resolution of spectral overlap.
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3.3.2 CD Spectroscopy
A 2 mg/mL slock solution of each peptide in Millipore water (concentration
determined by muss of freshly lyophtlizcd peptide) was mixed with aqueous Trisbuf'fcrcd saline to give aqueous solutions of 0.2 mg/mL peptide in 10 mM Tris, 150 mM
NaCI, pH 7.2. The final concentration of the peptides in each aqueous Tris-buffcred
saline solution was calculated from the UV absorbance of the 2 mg/mL stock solution.
The extinction coefficient of each peptide was assumed to be 1420 cm '1 M '1 at 275 nm,
the wavelength of a-tyrosinc.71 All CD spectra were obtained on an AVIV 62A-DS CD
spcctropolarimcter using 1 nm bandwidth, 1 nm resolution, 10 seconds averaging time, 1
scan per second, 0 second delay, and a path length of 0.1 cm or 1 mm. The temperature
of the sample was maintained at 25 °C, unless otherwise stated. Data were obtained in
both methanol and Tris buffer. Data were obtained at high concentration (typically 1-2
mM) and low concentration 0.1 mM. Scans usually ranged from 260 nm to 190 nm but
with a high peptide concentration, the increased in dynode voltage prevented the
detection of signal below 200 nm. Baseline spectra were subtracted from the raw data to
obtain the real CD spectra. Data were converted to cllipticity, [0] in deg cm 2 dm ol1,
according to the equation:
[01 = \|/*Mr / 100*f*c
where t|/ is the CD signal in degrees, Mr is the molecular weight divided by the number of
chromophores. / is the pathlcngth in dm, and c is the concentration in g/mL.
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3.3.3 MALD1-TOF Muss Spectrometry
Mass spectra of all peptides were obtained using Bruker Reflex II MALDI-TOF
Mass Spectrometer with a 337 nm laser. Spectra were resolved to the mass unit of the
peptides.

MALDI-TOF data were obtained for all HPLC purified samples of the

peptides. For MALDI experiments, a matrix of a-cyano-4-hydroxycinnamic acid was
used. The instrument was calibrated to a standard mixture of leu5-cnkcphalin (M+H* =
556.28), angiotensin I (M+FT = 1296.7) and neurotensin (M+H* = 1672.9). The mass of
the pure peptides matched the theoretical mass of the peptide within a very narrow
margin of error.
Abbreviations

Used:

EDCEHCI

=

/V,A-dimethylaminopropyl-3-

ethylcarbodiimidc hydrochloride salt, DMF = ALV-dimcthylformamide, TFA =
trifluoroacctic

acid,

DlEA

=

diisopropylethylaminc,

MOAT

=

l-hydroxy-7-

azabcnzotriazolc, HOBt = 1-hydroxybenzotriazole hydrate, IIBTU = O-bcnzotriazolyl-1yl-AjV.A’^ ’-tctramethyluronium hexafluorophosphate, 1IATU = 0-(7-azabenzotriazoll-yl)-AUV,,ty\/V’-trimethyIuronium hexafluorophosphate, TFE = trifluorocthanol, Boc;0 =
di-rert-butyl dicarbonatc, Z = bcnzyloxycarbonyl group.
3.4 Synthetic Details
Details of the synthesis of |)-amino acid monomers and heterogeneous oligomers
that were reported in chapter 2 arc presented in the sections that follow. The molecular
structures are also presented. The p-amino acid monomer Fmoe-ACHC and derivatives
were synthesized by enzymatic resolution and reductive animation methodology. The
Fmoc-piperidine monomer was synthesized by reductive amination methodology. The
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heterogeneous oligomers were synthesized by both solution phase and solid phase
methods.
Synthesis of (l/?.6.V)-Mcthvl 6 methosvcarbonvl-3-cvclohcxcnecarboxvlate (2-2)

.COOMe
XOOMs
2-2

The compound 2-2 was prepared from the phthalic anhydride 2-1 following
procedure developed by the Gellman group.'1' To the anhydride (35.0 g, 230 mmol) was
added methanol (200 mL) and the mixture was refluxed for 4.5 hours. The mixture was
subsequently cooled to room temperature and then 0 °C in an ice bath followed by drop
wise addition of thionyl chloride during a 30 minute period. The mixture was stirred
allowing temperature to rise gradually from 0 X to room temperature for 8 hours. The
reaction mixture was concentrated on a rotary evaporator and dried further under vacuum
to obtain 45.1 g (99%) of 2-2 as a pale yellow oil: Ky = 0.67. 1:1 hexane/ethyl acetate; 'll
NMR (300 MHz. CDCI,): 6 5.66 (m, 1H, HOC'H), 3.68 (s. 3H. OCH3). 3.04 (m, 1H.
CHCOOCH,),

2.60-2.49

(m,

IH,

CTTCHCOOCH,),

2.39-2.29

(m,

1H,

CHjCHCOOCHj ); UC NMR (75 MHz, CDCI,): 8 177.4 (C), 122.3 (CH), 50.7 (CH,).
39.0 (CH), 24.6 (CH2); MS-ESI m/z 199.2 [M + H f, 221.2 (M + Na]+, 419.4 [2M +
Na]+.
Synthesis of UK. 65')-6-Mcthoxvcarboi)vl-3-cvelohcxene-l-carboxylic acid (2-3)
COOH

i

X

^^C O O M e

2-3

Compound 2-3 was prepared following the procedure of Ohno and co-workers,62
that had been successfully applied by the Gellman group.63 Precaution was taken to make
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sure all glassware was clean. All glassware was washed in acid bath and rinsed twice
with Millipore water. To Millipore water (2.6 L) was added KH1 PO4 (61.79 g, 454
mmol) and the pH of the resulting solution adjusted to 8 by adding a prepared solution of
2.5 M NaOH and using a pH meter calibrated at pH 4 and pH 10. The diester 2-2 (45 g,
227 mmol) was dissolved in reagent grade acetone (131 mL) and this solution added to
the aqueous KH1PO4 solution. Pig liver esterase (10.5 mL. 48189 units) was added, and
the resulting solution was stirred for 24 hours. The reaction was monitored by TLC (1:1
hexane:ethyl acetate, R, (2-2) = 0.67, Rf (2-3) = 0.24). After ascertaining that reaction
was complete, the enzyme was filtered off through cclite in a fritted glass funnel. The
resulting solution was then acidified with 1M 11C1 to a pH about 2 and then extracted
three times with ethyl acetate (1200 mL total). The organic extracts were dried over
MgS04, concentrated, and dried under vacuum overnight to afford 38 g (91 %) of 2-3 as
a thick yellow oil: 'll NMR (300 MHz, CDClj): 5 11.24 (br s, 111, OH), 5.68 (in, 211,
HC=CH), 3.70 (s, 3H, OCHO, 3.07 (m. 2H, CHCOOCH, and CHCOOH), 2.62 - 2.54
(m, 2H, CH;CHCOOCH3 or CJTCHCOOH), 2.41 - 2.32 (m. 2H. CHjCHCOOCHj or
CHiCHCOOH); ,JC NMR (75 MHz, CDCI3): 8 179.6 (C), 173.5 (C), 125.0 (CH), 124.8
(CH), 51.7 (CHj), 39.4 (CH), 39.2 (CH), 25.5 (CHi), 25.3 (Cli2); MS-ESI m/z 207,1 [M
+ Na]*.
Synthesis of Methyl (1,5. 6/0-6-Bcnz.vloxvcarbonylaminocvclohcx-3-cnccai'bo.\vlatc (241
NHCbz

f

T

+ BnOH

^X O O M a
2-4
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Compound 2-4 was prepared according to the procedure of Ohno and coworkers,62 that was successfully adapted by Appclla el al.63 of the Gellman group. The
monoestcr 2-3 (7.08 g, 38.4 mmol) was dissolved in acetone (125 mL) and the resulting
solution cooled to 0 °C. To this solution was added litiN (7.0 mL. 50.2 mmol), followed
by slow addition of ethyl chloroformate (4.77 mL. 49.9 mmol). Mixture was stirred at 0
°C for 15 minutes. In a separate flask, NaN, (4.01 g, 61.7 mmol) was dissolved in
Millipore water (35 mL), and this solution added to the reaction flask. The temperature
was gradually raised to room temperature and stirring continued for 3 hours.

The

reaction mixture was diluted with water (123 mL) and the resulting solution extracted
three times with diethyl ether (900 mL total). The organic extracts were dried over
MgSOi, concentrated without heating, and put under vacuum for a few minutes to afford
yellow oil. To this oil was added anhydrous benzene (97 mL), and the resulting solution
refluxed under a nitrogen atmosphere for 3 hours. The solution was cooled to room
temperature followed by the addition of benzyl alcohol (13.9 mL, 133.8 mmol). The
resulting solution was refluxed under an atmosphere of nitrogen for 22 hours. A yellow
solution containing droplets of another liquid on the bottom of the flask was formed. The
solution was cooled to room temperature, and the solvent was then removed on a rotary
evaporator to afford 22.1 g (82% yield of 2-4 based on 'l l NMR) of yellow liquid being a
mixture of 2-4 and benzyl alcohol: 'll NMR (300 MHz, CDCIj): 5 7.39-7.22 (m, ArH of
2-4 and BnOH), 5.67 (m, 2H. HC=CH), 5.45 (br d, J = 9 Hz, 1H, NH), 5.06 (s, 2H,

ArCHj) 4.64 (s, ArCH> of BnOH), 4.23 (m, 111, CHNHCbz), 3.66 (s, 3H, OCH,), 2.80
(m, 1H, CHCOOCHj), 2.57 - 2.43 (m, 1H), 2.42 - 2.25 (m, 2H), 2.23 - 2.10 (m. 111).
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Synthesis of Mclhvl (JS. 67?)-b-/e/'/-buttloxvcarbonvlaminocvclohcxancearboxvlate (2-5)
^.N H B oc

^•'"'X O O M e
2-5

Compound 2-5 was prepared by two methods.
Method I
Methanol (25 mL) was added to a mixture of 2-4 and benzyl alcohol (3.81 g),
followed by 10% Pd-C (0.10 g) under nitrogen. The solution was shaken on a Parr
apparatus underHj (50 psi) for 46 hours. The solution was then filtered through a plug of
glass wool, concentrated, and dried under vacuum to obtain a yellow liquid. Water (5
inL) was added to the liquid, and then 2 M HCI was added to the solution until a pH of 2
was obtained. The resulting solution was extracted with diethyl ether three times (75 mL
total) to remove benzyl alcohol. To the resulting aqueous solution was added 10%
K;COj portion wise until a pH of 9 was obtained. Dioxune (10 mL) was added, followed
by BociO (1.76 g, 8.1 mmol). The resulting solution was stirred for 33 hours. The
solution was then transferred to a separatory funnel, water (10 mL) was added, and the
solution extracted three times with ethyl acetate (150 mL total). The combined organic
extracts w’erc dried over MgSOi, concentrated, and dried under vacuum overnight to
obtain a viscous yellow liquid. The crude product was purified by Si02 flash column
chromatography, eluting with 6:1 hcxane:ethyl acetate (Rr = 0.26) to afford 2-5 us a
colorless oil (2.37 g, 70%).
Method 2
A mixture of 2-4 and benzyl alcohol (4.95 g) was dissolved in methanol (25 mL)
and transferred to a hydrogenation flask. This was followed by the addition of 10% Pd-C
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(0.85 g) and Boc;0 (4.5 g, 20.5 mmol) under Ni. The solution was shaken on a Panapparatus under H2 (50 psi) for 24 hours. The solution was then passed through a plug of
silica gel and cclite, concentrated, and dried further under vacuum overnight to obtain
pale yellow oil. The crude product was purified through a slurry-packed SiC>2 column
eluting with 4:1 hexane:ethyl acetate (Rr = 0.41). The product eluted in fractions 8-21
(15 mL fractions collected) to afford 3.5 g (80% yield) of 2-5 as a colorless oil: 'll NMR
(300 MHz. CDCI3): 8 5.32 (br, HI. Nil), 3.85 (m. 111, CHNHBoc). 3.69 (s, 3H, OCH,).
2.79 (br q, J = 4.5 Hz, 1H, CHCOOClh). 2.07-1.94 (m, 1H), 1.84-1.55 (m, 4H), 1.511.25 (m. 12H; includes large singlet at 1.43): l3C NMR (75 MHz, CDCI3): 5 174.2 (C),
155.3 (C). 79.0 (C), 51.5 (CH3), 49.0 (CH), 44.9 (CH3). 29.7 (CH2), 28.2 (CH3), 26.8
(CH2), 23.7 (CH2), 22.5 (CHj); MS-ESI m/z 280.1 [M + N a)\ 537.2 [2M + Nap.
Synthesis of Methyl UR. 2AfVN-rm-butvloxvcarbonvl-fra;i.t-2aniiiiocvciohexanccarboxvlate (2 -6 )
NHBoc
''COOMo
2-6

Compound 2-6 was prepared by epimerization of the ci.r-isorner 2-5. Sodium
(0.10 g, 4.34 mmol) was weighed out under hexane, and placed into a flame dried
schlcnk flask outfitted with a condenser. The flask was placed under vacuum and N2
repeatedly, three times, to remove hexane. The flask was then cooled to 0 °C, and
anhydrous methanol (4 mL) was added. The mixture was kept under N2 and vented to
remove evolved gases until all the sodium dissolved.

In another flame-dried flask

containing 2-5 (0.71 g, 2.76 mmol), that had been dried under vacuum overnight, was
added anhydrous methanol (8 mL) and the flask was swirled to dissolve the ester. The

ced with permission of the copyright owner Further reproduction prohibited without permission.

178

ester solution 2-5 was then transferred via cannula to the Schlenk tlask containing
NaOMc solution. The resulting solution was then refluxed for 5 hours. The solution was
cooled to room temperature and then 0.5 M NKiCl (16 mL) was added. The mixture was
stored under N- overnight and colorless needle-like crystals formed during this time. The
solvent was mostly removed on a rotary evaporator, and the precipitate collected by
suction filtration to obtain white solid after drying under vacuum.

The solid was

recrystallized from n-heptane to afford 0.44 g (62% yield) of 2-6 as colorless crystals:
m.p. 90-91 °C; ‘H NMR (300 MHz. CDCIj): 5 4.50 |br. 1H, NH), 3.67 (s and m, 4H.
OCHj and CHNIIBoc), 2.23 (dt, J = 11.4, 4.2 Hz. 1H, CHCOOCH,). 2.08-2.00 (m, III),
1.95-1.86 (m. 111), 1.81-1.53 (m, 2H), 1.51-1.29 (m, 11H; includes large singlet at 1.42),
1.26-1.11 (m, 2H); ,JC NMR (75 MHz, CrX-lj): 6 174.3 (C), 154.7 (C). 79.0 (C). 51.5
(CHj), 51.0 (CH), 50.0 (CH). 32.8 (CH;), 28.3 (CH2), 28.1 (CH,), 24.5 (CHS), 24.2
(CIIj); MS-ESI m/z 280.1 [M + NaJ*. 537.2 (2M + Na]L
Synthesis of 1R. 2/()-N-rerr-butvloxvcarbonvl-rrnn,v-2-aminocvclohcxanecarbox_y)ic acid
(2-7)
^^^N H B oc

2-7

Compound 2-7 was prepared from the corresponding ester by hydrolysis.
Methanol (80 ntL) and water (26 mL) were added to 2-6 (1.35 g, 5.25 mmol), followed
by LiOH.H20 (2.64 g, 62.9 mmol) and 30% aqueous H?Oj (3.72 mL.. 29 mmol). The
mixture was stirred at room temperature for 50 hours. A solution of NajSCH (8.78 g, 69.7
mmol) in water (52 mL) was then added at 0 °C, and the mixture stirred for 25 minutes.
The methanol was removed on a rotary evaporator leaving a colorless solution. The
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solution was cooled to 0 °C again followed by addition of 2M HCI until white precipitate
formed which did not dissolve on swirling. The mixture was treated with ethyl acetate
which caused the white precipitate to dissolve. The aqueous layer was isolated and the
pH measured (pH = 1). The aqueous layer was extracted with the original ethyl acetate
layer once and then four times with fresh portions of ethyl acetate.

The combined

organic extracts were dried over MgSOj, concentrated on a rotary evaporator and dried
further under vacuum to obtain 1.23 g (97% yield) of 2-7 as a shiny white solid that
looked pure by NMR.

A sample of this white solid was recrystallized in ethyl

acetate/hcxanc but there wasn’t any marked improvement in purity: m.p. 154-155 °C; 'H
NMR (300 MHz, CDClj): 6 11.64 (br, 111. COOH), 4.65 (br. Ill, Nil), 3.65 (br m, 1H).
2.25 (td, J = 11.4, 3.6 Hz, HOOCCH), 2.08-1.95 (m, 2H). 1.75-1.14 (m, 6 H), 1.43 (s, 9H,
CH,); ,3C NMR (75 MHz, CDCl,): 6 179.0 (C), 154.9 (C), 79.2 (C), 50.9 (CH), 49.5
(CH). 32.6 (CH: ), 28.4 (CH2), 28.1 (CH,). 24.4 (CH.), 24.2 (CH2); MS-ESI m/z 266.1
[M + N a]\ 509.2 [2M + Na]f.
Synthesis of Benzyl UR. 2R)-N-rerr-butvloxvcarbonvl-trmis-2aminoevcloliexanecarboxvlate (2 -8 )
NHBoc
'COOBn
2-8

Compound 2-8 was prepared from the corresponding free acid by benzylation.
The acid 2-7 (0.2 g, 0.82 mmol) was dissolved in dry benzene. Benzyl bromide (0.1 ml.,
0.82 mmol) was added followed by 1,8-diazabicyclo [5 4 0]unde-7-cne (0.12 mL, 0.82
mmol) and the solution refluxed under N 2 for 24 hours. White solid preeipitated from the
solution in the course of the reaction. The mixture was cooled to room temperature and
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concentrated to obtain a tan solid. The crude product was purified by SiOj flash column
chromatography eluting with 6:1 hexane: ethyl acetate (Rf = 0.24). The product eluted in
fractions 14-30 (10 mL fractions collected) to afford 0.25 g (90% yield) of 2-8 as a white
solid. A sample of this solid was recrystallized from n-hcplunc: m.p. 103-104 °C; 'll
NMR (300 MHz, CDCI3): 6 7.38-7.29 (m, 5H. ArH), 5.12 (s, 2H, ArCH,), 4.52 (br, 1H.
NH), 3.69 (br td. J = 10.4, 9 Hz, 1H. BocHNCH), 2.31 (id, J = 11.7, 3.6 Hz. 1H,
BnOCOCH), 2.10-2.05 (m, 1H), 1.98-1.90 (m. 111), 1.79-1.56 (m, 311), 1.39 (s, 9H, CHj),
1.36 (m, 1H), 1.27-1.11 (m, 2H); ,3C NMR (75 MHz, CDC1,): 8 173.8 (C), 154.8 (C),
136.0 (C), 128.6 (CH), 128.0 (CH), 79.3 (C), 66.2 (CH2), 51.3 (CH), 50.0 (CH), 33.0
(CHj), 28.6 (CH,), 28.3 (CH3), 24.6 (CH,), 24.4 (CH2); MS-ESI m/z 356.1 [M + N a]\
689.3 (2M + N a]\
Synthesis of (IR. 2/0-2-(9//-Fluoren-9-vlmethoxvcarbonvlamino)cvelohcxanecarboxvlie acid 12-9)
.NHFmoc

a

''COOH

2-9

Compound 2-9 was prepared from the corresponding Boc-protcetcd free acid 2-7
by two methods.
Method I
Boc-protected acid 2-7 (1.39 g, 5.72 mmol) was dissolved in 4N HCI/dioxane (10
mL) and the mixture stirred at room temperature for 4 hours. Progress of reaction was
checked by TLC in CH2CI2 : McOH (10:1). The solvent was removed under a stream of
nitrogen and resulting white solid dried under vacuum for 5 hours. The free amine was
dissolved in CH3CN/H2O (4:1, 69ml), followed by addition of DIEA (2.89 mL, 16.6
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mmol) and Fmoc-OSu (1.87 g, 5.54 mmol). The reaction mixture was then stirred at
room temperature for 3.5 hours.
hcxane/cthyl acetate (1:1).

Progress of reaction was monitored by TLC in

The reaction mixture was cooled to 0°C and 1M HCI

(approximately lOmL) added to adjust pH to approximately 7. CH3CN was removed on
a rotary evaporator leaving a white precipitate. Additional 1M HCI was added at 0°C
until more white precipitate formed. The white solid was collected by suction filtration
and washed with dilute aqueous HCI. The white solid was dissolved in large excess of
ethyl acetate and filtered to separate undissolved impurities. The filtrate was washed
once with 1M HCI and once with brine. Organic extracts were dried in MgSO.i and
concentrated on a rotary evaporator at room temperature to obtain bright white solid
which was further dried under vacuum. The TLC of the white solid in ClTCL/MeOH
(9:1) showed a single spot of Rf = 0.40. The crude product was purified by crystallization
from n-hexane/ethyl acetate to afford 1.68g (83%) of the Fmoc-protected ACHC as a
white solid: mp 207-208°C; [a]“3D = -37.8 (c 0.50, acetone); Rf = 0.43, 10:1
CH2Cl2/MeOH; ' l l NMR (300 MHz, CDClj/CDjOD) 5 7.77 (d, J = 7.3 Hz, 2H, Arl-l).
7.62 (d, J = 7.0 Hz, 211. Aril), 7.42-7.29 (m. 4H. ArH), 4.33-4.19 (m, 3H), 3.73-3.67 (m.
1H), 2.35-2.28 (m, 1H), 2.02-1.98 (m. 2H), 1.78-1.73 (m, 2H), 1 63-1.51 (m, 1H), 1.411.22 (m, 3H); UC NMR (75 MHz, CDCI3/CD3OD) 6 180.61 (C), 160.16 (C), 147.69 (C),
147.53 (C), 144.92 (C), 131.26 (CH), 130.67 (CM), 128.69 (CH), 123.47 (CH), 70.23
(CH2), 55.12 (CH), 52.45 (CH), 50.84 (CH), 36.27 (CH2), 32.73 (CH,), 28.35 (CH2),
28.11 (CH2); MS-ESI m/z 388.1 [M + N af, 753.2 [2M + Na]T
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Method 2
Boc-proteeted acid (0.63 g, 2.59 mmol) was dissolved in 4N HCI/dioxane (10
mL) and ihe mixture stirred at room temperature for 4 hours. Progress of reaction was
checked by TLC in CHjCIj : MeOH (10:1). The solvent was removed under a stream of
nitrogen and resulting white solid dried under vacuum for 2 hours.

This solid was

dissolved in acetone/HiO (2:1, SI mL), cooled to 0 "C and Fmoc-OSu (1.04 g, 3.08
mmol) and NaHCOj (1.99 g, 23.7 mmol) were added. The turbid reaction mixture was
stirred at 0 °C for 1 hour and was then allowed to stir at room temperature overnight.
The acetone was removed under reduced pressure. The aqueous residue was diluted with
ITO (27 mL). stirred for 1 hour at room temperature with diethyl ether (109 mL), and the
layers were separated. Separation by extraction was not possible because the bottom
layer contained white solid which would not drain from the separatory funnel. The solid
was isolated by suction filtration and washed subsequently with NaHCOj, IN MCI and
water. The solid was diluted with MCI and a large volume of ethyl acetate used for
extraction. The combined ethyl acetate layers were dried in MgSO,i, concentrated on a
rotary evaporator, and dried under vacuum to obtain a white solid. The crude product
was purified by crystallization from n-hexane/ethyl acetate to afford 0.68 g (72%) of 2-9
as a white solid: mp 206-207°C; [a]J\> = -37.6 (c 0.50, acetone); Rf = 0.45, 10:1
CILCIi/MeOH.
Synthesis of lfthvl 2-1(170-phenvlcthvlaminol-evclolicx-l-cne carboxvlate f2-19)

Ph

2 -1 9
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To a solution of ketoestcr 2-18 (11.0 g, 64.7 mmol) in 100 mL of dry benzene was
added the chiral amine (R)-(+)-a-methylbenzylamine (8.01 g, 66.1 mmol), and a catalytic
amount of p-tolucncsulfonic acid (0.618 g, 3.25 mmol, 5 mole %). The mixture was
refluxed under N2 with continuous removal of water using a Dean-Stark trap for 4 hours.
After the solution was cooled to room temperature, it was washed twice with saturated
aqueous NaHCOj. The organic extracts were dried over MgSOj, concentrated, and dried
under vacuum to obtain a yellow oily residue. The resulting yellow oily residue was
fractionally distilled to give 15.8 g (89%) of 2-19 as a pale yellow oil: bp 160-165°C, 2
mm Hg; Rr = 0.32, 20: l hexane/ ethyl acetate; 'll NMR (300 MHz, CDC1,) 8 9.40 (d. J
= 7.5 Hz, 1H, NH), 7.35-7.20 (m, 5H, Aril), 4.63 (quint, J = 7.2 Hz, 1H), 4.17 (dq, J =
7.2, 1.2 Hz, 2H), 2.36-2.24 (m. 3H), 1.99-1.89 (m, IH), 1.54-1.47 (m. 7H), 1.30 (t. J =
7.2 Hz, 311); 13C NMR (75 MHz, CDCIj) 5 170.74 (C), 158.86 (C), 145.65 (C), 128.47
(CH), 126.58 (CI1), 125.23 (CI1), 90.34 (C), 58.50 (CH2), 51.79 (CH), 26.43 (CI12),
25.16 (CH,). 23.60 (CH2), 22.40 (CH2), 22.22 (CH:), 14.48 (CHi); MS-ESI m/z 274 2
[M + II]*, 296.1 [M + N af, 569.3 [2M + Na]*.
Synthesis of fltlivl (lK.2K)-2-U 1'A’l-Phcnvlethvll- aminoevclohcxane carboxvlatc
hydrochloride (2-20)

JL

Ph^

NH ,HCI

2-20

Sodium borohydridc (3.14 g, 83.0 mmol) was added to isobulyric acid (44 mL,
474.0 mmol) portion wise under N2 at 0°C. This mixture was stirred at room temperature
for 30 minutes and then cooled to 0 ”C. A solution of 2-19 (6.48 g, 23.7 mmol) dissolved
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in dry toluene (26.4 mL) was added drop wise under N; at 0°C. The mixture was stirred
at 0"C for 6 hours, followed by addition of a second portion of sodium borohydride (0.20
g, 5.29 mmol). The reaction mixture was then stirred at 0 °C overnight. The reaction
mixture was quenched by addition of aqueous solution of IN HCI to obtain a pH of
approximately 1. The mixture was further basified to a pH of about 10 using an aqueous
solution of 1 N NaOH followed by extraction with four equal portions of CH jCIj (100

mL each). The combined organic extracts were dried over MgSOj and concentrated
under reduced pressure. The resulting oil was applied to a plug of silica gel and washed
with 1:1 hexane/ethyl acetate. The filtrate was concentrated to obtain a pale yellow oil
(6.01 g, 92%; Rr = 0.22, 4:1 hexane/ethyl acetate), which was dried under vacuum
overnight. To this oil (dried under vacuum, 3.11 g, 11.29 mmol), was added freshly
distilled ethanol (50 mL) under N;. In a separate flame-dried Schlcnk flask outfitted with
a condenser was placed sodium (1.3 g, 56.52 mmol). The flask was cooled to 0°C, and
dry ethanol (100 mL) was added. The mixture was kept under N2 and vented to remove
evolved gases until all of the sodium dissolved. The clear solution of the carboxylatc was
then transferred via cannula to the NaOLt solution. The resulting solution was refluxed
at 80°C under Nj for 15 h. The solvent was removed on a rotary evaporator followed by
addition of brine (100 mL). The resulting mixture was basified to a pH of approximately
10 by addition of aqueous 1 N NaOH and then extracted four times with ethyl acetate
(100 mL each). The combined organic extracts were dried over MgS04 and concentrated
under reduced pressure. The resulting oil was applied to a plug of silica gel and washed
with 3:1 hexane/ethyl acetate. The filtrate was then concentrated to obtain pale yellow
011 (2.62 g, 84%). To this oil was added ethyl acetate (19 mL), followed by dropwise
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addition of 4 N HC1 in dioxane (2.8 mL. 11.2 mmol) at room temperature. The resulting
solution was cooled to 0°C and allowed to stand at 0°C overnight. A white precipitate
was formed during this time. The white solid was Tillered and washed three limes with
20 mL portions of cold ethyl acetate to afford the desired crude material in 84% yield
from 2-19. This crude product was purified by rccrystallization from acetonitrile. The
solid was suspended in acetonitrile (36 ml) and healed to reflux for 1 h. The mixture was
filtered through cotton wool and cooled to 0°C overnight. The resulting precipitate was
isolated by filtration and washed three times with 10 mL portions of cold acetonitrile.
The mother liquor and washings were combined and condensed to about half the original
volume to gel a second crop. The combined crops were dried under vacuum to give 1.28
g of 2-20 as a white crystalline solid (51% yield), 'll NMR of the corresponding free
amine 2-21 indicated the diastereomcric excess to be >99%: mp 210-211°C; Rr = 0.39,
4:1 hcxanc/cthyl acetate; 'll NMR (300 MHz, CDC1,) 6 9.97 (br s, III, NIL), 9.70 (brs,
1H, NH;), 7.84-7.80 (m, 2H. Aril). 7.47-7.30 (m, 311, ArH), 4.64-4.60 (m, 1H), 4.34-4.23
(m, 2H), 3.15-3.12 (m. 2H). 2.21-2.17 (m, IH). 1.96-1.59 (m, 8H), 1.36-1.20 (m, 5H),
0.97-0.93 (m, 1H); l3C NMR (75 MHz, CDC1,) 5 174.14 (C), 136.62 (C), 128.93 (CH),
128.84 (CH), 128.40 (CH), 61.14 (CH;), 59.39 (CH), 56.49 (CH), 45.85 (CH,), 29.92
(CH;). 29.26 (CH;), 23.92 (CH;), 23.72 (CH;), 20.47 (CH), 13.94 (CH,); MS-ESI m/z
276.2 [(M - HC1) + H]*, 298.2 [(M - HCI) + N af, 573.3 |2(M - HCI) + Na]L
Synthesis of Ellivl ( lfl.2)?)-2-f(l Tfl-Phcnvlethvll- aminocvclohcxanc carboxvlale (2-21)

2-21
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A small sample of 2-20 was mixed with an excess of saturated NaHCO, solution
and then extracted into diethyl ether. After drying over MgSOj, the organic extract was
concentrated under reduced pressure to give 2-21 as a colorless oil: Rf = 0.40, 4:1
hexanc/ethyl acetate; 'll NMR (300 M il/. CDCIj) 8 7.30-7.21 (m, 5H, ArH). 4.24-4.13
(m. 2H, CH,Cli;OCO), 3.82 (q, J = 6.6 Hz, IH, ArCHNH), 2.72 (td, J = 10.7, 3.8 Hz.
1H, HNCHCH;), 2.19-2.10 (m, HI. OCOCH), 1.91-1.82 (m, 214), 1.68-1.63 (m, 2H),
1.32-1.11 (m, 10H); n C NMR (75 MHz, CDCI.,) 6 175.50 (C), 146.86 (C), 128.0 (CH),
126.42 (CH), 126.20 (CH), 59.86 (CH;), 55.88 (CH), 55.44 (CH), 51.58 (CH), 32.99
(CH;), 30.03 (CH;), 28.95 (CH:), 24.72 (CH;), 23.64 (CH,), 14.06 (CH,); MS-ES1 m/z
276.2 [M + H]L 298.2 IM + NaJ*, 573.4 [2M + Na]+.
Synthesis of (lR.2fl)-2-(9//-Fluorcn-9-vlmethoxvcarhonvlamino)-cvclohexane
carboxylic acid KIR.2/0-2-91 from B-Ammonium Ester 2-20.
NHFmoc

Compound 2-20 (1.23 g, 3.94 mmol) was dissolved in THF/McOH/H20 (2:1:1,
44 mL), and the solution was cooled to 0 °C. LiOH.H;0 (0.83 g, 19.8 mmol) dissolved
in 4.5 mL H-O was added. The mixture was stirred at 0°C for 20 hours. The solvent was
removed under reduced pressure and the residue was applied to a plug of silica gel and
washed with CH,Cl;/McOH 6:1. The filtrate was concentrated to obtain a white solid (Rf
0.26, 8:1 CH2CI2/MCOH). To a clear solution of this white solid in 88 mL MeOH, Pd/C
(10%, 0.92 g) and ammonium formate (1.24 g, 19.7 mmol) were added under N2 at room
temperature. The mixture was refluxed for 4 hours. After the reaction was complete
(disappearance of starting material, as monitored by TLC), the cool reaction mixture was
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filtered through celite, and the filtrate concentrated to obtain a white solid. This solid
was dissolved in acctone/H20 (2:1, 45 mL), cooled to 0"C and Fmoc-OSu (1.29 g, 3.82
mmol) and Nal 1C02 (3.31 g, 39.4 mmol) were added. The turbid reaction mixture was
stirred at 0°C for 1 hour and was then allowed to stir at room temperature overnight. The
acetone was removed under reduced pressure. The aqueous residue was diluted with H20
(45 mL), stirred for 1 hour at room temperature with diethyl ether (200 mL), and the
layers were separated. The ether phase was washed three times with saturated NallCOj
(100 mL each). The combined aqueous phase was acidified with 1 N aqueous HC1 and
extracted three times with ethyl acetate (100 mL each). The organic extracts were dried
over MgSCL and concentrated to give a white solid. The crude product was purified by
crystallization from n-hexane/chloroform to afford 1.09 g (76%) of 2-9 as a while solid:
mp 205-206”C; [a]23,>= 37.6 (e 0.50, acetone); Rf = 0.43, 10:1 CH 2Cl2/MeOH; ‘ll NMR
(300 MHz, CDCIj/CDjOD) 6 7.77 (d, J = 7.3 Hz, 2H), 7.62 (d, J = 7.0 Hz, 2H), 7.427.29 (m, 4H), 4.33-4.19 (m, 3H), 3.73-3.67 (m. 1H), 2.35-2.28 (m, 1H), 2.02-1.98 (m,
2H), 1.78 1.73 (m, 2H), 1.63-1.51 (m, 1H), 1.41-1.22 (m, 3H; liC NMR (75 MHz,
CDCI3/CD 3OD) 8 180.61 (C), 160.16 (C), 147.69 (C), 147.53 (C), 144.92 (C), 131.26
(CH), 130.67 (CH), 128.69 (CH), 123.47 (CH), 70.23 (CH2), 55.12 (CH), 52.45 (CH),
50.84 (CH), 36.27 (CH2), 32.73 (CH2), 28.35 (CH2), 28.11 (CH2); MS-ESI mJz 36-1.2 [M
- H ]\ 753.2 [2M - H]'.
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Synthesis of Pipcridinc-Enaminc (2-23)

P h '-^'-N H

0
OCH2CH3

k

N
Boc

2-23

The piperidine carboxylate sail 2-22 (15.3 g, 50.5 mmol) was dissolved in
absolute ethanol (480 mL) and ammonium formate (15.7 g, 249 mmol) added. The
mixture was then flushed with N2 continuously while adding Pd/C (10%, 2.40 g, 2.26
mmol). The mixture was refluxed for 2 hours. The reaction mixture was cooled to room
temperature, filtered through celite and through a syringe filter.

The filtrate was

concentrated on a rotary evaporator and dried under vacuum to afford 10.03 g (96%
yield) of a yellowish-white solid. The amine salt was dissolved in chloroform (85 mL)
and sonicated followed by addition of a solution of NaHCOj (4.17 g, 49.6 mmol) in water
(80 mL) and NaCI (8.33 g, 143 mmol).

A solution of Boc:0 (10.4 g, 47.5 mmol)

dissolved in chloroform (30 mL) was slowly added during a 15 minute period, and the
mixture was refluxed for 15 hours. The organic layer was separated and the aqueous
layer was extracted three times with chloroform (150 mL total volume). The organic
extracts were dried over MgSOa, concentrated and dried under vacuum to obtain reddishyellow oil (13.2 g, 95%). The oil was dissolved in dry benzene (150 mL) followed by
addition of a catalytic amount of p-toluenesulfonic acid (451 mg, 2.37 mmol, 5 mole %),
and the chiral amine (R)-(+)-a-methylbenzylaminc (6.44 mL, 49.9 mmol). The mixture
was refluxed under Ni with continuous removal of water using a Dean-Stark trap for 12
hours. The reaction mixture was cooled and then washed twice with saturated aqueous
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Nall CO;, (150 mL).

The organic extract was dried over anhydrous MgSOj and

concentrated on a rotary evaporator.

The resulting yellow oily residue was filtered

through a pad of silica gel and washed with CIliCK until filtrate was colorless. The
filtrate was concentrated to obtain yellow oil. The crude product was purified by Si02
flash column chromatography eluting with hexanc:ethyl acetate 4:1 (Rf = 0.44) to afford
13.12 g (72%) of 2-23 as a pale yellow oil: 'll NMR (300 MHz, CDCIj) 8 9.27 (d, J =
7.2 Hz, 1H, NH), 7.36-7.21 (m, 5H, ArH), 4.61 (quint, J = 6.9 Hz, 111, AlCHNH), 4.18
(q, J = 7.0 Hz, 2H, CH,CH2OCO), 4.08 (s, 2H, CCHjNBoc), 3.45-3.39 (m, 1H,
CHjCHj NBoc), 3.35-3.28 (m, 1H, CH2CH2NBoc), 2.42-2.36 (m, 1H, NHCCH2), 2.072.02 (m, 1H, NHCCH2), 1.53 (d, J = 6.9 Hz, 3H, ArCHCH,), 1.44 (s, 9H), 1.29 (t, J = 7.0
Hz, 3H, OCOCHjCHj); 15C NMR (75 MHz, CDCIj) 6 168.78 (C), 156.89 (C), 154.35
(C), 145.00 (C), 128.45 (CH), 126.85 (CH), 125.38 (CH), 88.33 (C), 79.38 (C), 58.75
(Cl-12). 52.02 (CH), 41.17 (CH2), 39.40 (CH2), 28.17 (CHj), 26.02 (CH2), 24.99 (CH.,),
14.34 (CH,); MS-ESI m/z 375.2 [M + H f, 397.2 [M + N af, 771.3 |2M + Na]+.
Synthesis of (3/C4/?)-l-((V-fm-Butvloxvcarbonvll-3-cthvloxvcarhonvl-4-l(fl)phcnvlcthvlaminolpipcridine hydrochloride (2-24)

2-24

To isobutyric acid (27.1 mL, 291.7 mmol) in an oven-dried round bottom flask
was added sodium borohydride (1,62 g, 42.8 mmol) portionwise under N2 at 0°C. The
mixture was first stirred at room temperature for 30 minutes, followed by the addition of
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5 ml. of freshly distilled toluene and then cooling to OX'. A solution of the cnaminc 2-23
(5.32 g, 14.2 mmol) in dry toluene (13 mL) was added drop wise under Nj at OX. The
mixture was stirred at OX for 2 hours followed by the addition of additional sodium
borohydride (0.12 g, 3.17 mmol). After 8 hours, the reaction was incomplete as judged
by TLC and so another 3.17 mmol of sodium borohydride was added and mixture stirred
overnight. Upon completion of the reaction (24 h), 50 mL of water was added and the
mixture stirred at room temperature for 10 minutes. The mixture was then basified to a
pH of 10 with IN NaOH and extracted three times with ethyl acetate (300 mL total
volume). The organic extracts were dried over MgSCL and concentrated under reduced
pressure. The resulting yellow oil was dried under vacuum and then applied to a plug of
silica gel washing with 2:1 hexane:ethyl acetate. The filtrate was concentrated to obtain a
pale yellow oil. The crude product was purified by SiOj flush column chromatography
eluting with 2:1 hexanc:ethyl acetate (Rf = 0.38). The product was eluted to afford 4.126
g (77% yield) of colorless oil. The oil (3.997 g, 10.6 mmol, vacuum dried overnight) was
dissolved in freshly distilled dry ethanol (36 mL). In a flame-dried Schlenk flask was
added freshly distilled dry ethanol (70 mL) and sodium (0.73 g, 31.8 mmol), and the
mixture was stirred under N2 while venting to remove evolved gases until the sodium
completely dissolved.

The carboxylale solution was then transferred to the NaOEt

solution and the mixture was stirred at 50X under N2 for 21 hours. The mixture was
concentrated under reduced pressure then NaCI and IN NaOH were added until a pH of
10 was obtained. The mixture was then extracted three times with ethyl acetate (300 mL
total volume). The combined organic extracts were dried over MgSCL and concentrated
on a rotary evaporator. The resulting oil was applied to a plug of silica gel and washed
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with 2:1 hexane:ethy! acetate. The filtrate was concentrated and dried under vacuum to
obtain pale yellow oil (2.943 g, 74 % yield from the carboxylute). The oil was then
dissolved in elhy! acetate (31.05 mL), and 4 N HC1 in dioxanc (1.92 mL) was added
dropwise while swirling at room temperature. The resulting solution was cooled to 0"C
and allowed to stand at this temperature overnight during which a white precipitate
formed. The while solid was filtered and washed three times with cold ethyl acetate to
provide the crude material. The crude product was purified by recrystallization from
acetonitrile. The solid was suspended in acetonitrile (40 mL) and heated under reflux for
1 hour. The mixture was then filtered through glass wool and cooled to 0"C overnight.
The resulting white crystalline solid was isolated by filtration, and washed three times
with fresh portions of cold acetonitrile. The mother liquor and washings were combined
and condensed to get a second and third crop. The combined crops were dried under
vacuum to afford 1.29 g (22% yield from 2-23) of 2-24 as a white crystalline solid: m.p.
197-199°C; Rr = 0.37, 4:1 hcxane.ethyl acetate; ’ll NMR (300 MHz, CDC13) 8 10.24 (br
s, 111, NH2), 9.S9 (br s, 1H, NHj), 7.81-7.78 (m, 211, ArH), 7.48-7.40 (m, 3H, Aril), 4.60
(br s, 1H, ArCHNH), 4.28 (q, J = 6.9 Hz, 2H, CH;,CH2OCO), 3.88 (br d, J = 13.2 Hz, 1H,
CH2CHNH2), 3.26-3.20 (m, 2H, CHCHjNBoc). 3.00-2.78 (m, 1H, OCOCH), 2.55 (br s,
111,), 2.06-1.93 (m, 411), 1.74-1.60 (m, 1H), 1.44-1.30 (m. 12H); l3C NMR (75 MHz,
CDCI3) 6 170.75 (C), 158.89 (C), 145.65 (C), 128.47 (CH), 126.59 (CH), 125.22 (CH),
90.33 (C), 58.50 (CH2), 51.78 (CH), 46.44 (CH2), 25.18 (CH3), 23.61 (CH2), 22.39(CH2),
22.00 (CH2), 14.49 (CH3); MS-ESI m/z 377.1 [M-1ICI+ H ]\ 753.3 [2(M-HC1) + H]+.
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Synthesis of (3AV4Af)-l-(iV-/f7V-Buivloxvcarbunvl )-3-cllivlo\\'c;irbonvl-4-lfA’)phcnvlethvlnminolniperidinc (2-25)
Ph '^~ NH 0
r ^ | - " ^ O C H 2CH3

V

Boc

2-25

A sample of the carboxylate salt 2-24 was mixed with excess saturated NaHCOj
solution, and the mixture was extracted with diethyl ether, The extracts were dried over
MgSOj, concentrated under reduced pressure and dried under vacuum to afford 2-25 as a
colorless oil (Rf = 0,31, hc,xane:cthyl acetate 3:1). The diastereomeric excess was shown
to be > .9 9 %

:

' l l NMR (300 MHz, CDCI;,) 6 7.33-7.19 (m, 5H, Aril). 4.24-4.13 (m, 3H),

3.95 (br, 1H), 3.81 (q, J = 0.6 Hz, 1H), 2.88 (td,/ = 10.6. 4.2 Hz, 2H), 2.66 (td, 7 = 12.9,
2.4 Hz, IH), 2.29 (td, J = 10.8, 4.2 Hz, IH), 1.76-1.72 (m, IH), 1.43 (s, 9H), 1.33-1.27
<m, 711), 1.16-1.04 (m. IH); UC NMR (75 MHz, CDCI.,) 5 172.89 (C), 154.22 (C),
146.45 (C), 128.19 (CM), 126.71 (CH), 126.24 (CH), 79.63 (C), 60.46 (CH:), 55.77
(CH), 55.19 (CH). 49.66 (CH). 44.91 (CH2). 42.48 (CH,), 32.00 (CHj), 28.16(CH3),
23.91 (CH3), 14.08 (Cll3); MS-ESI m/z 377.2 [M + H]+, 399.2 [M + N a]\ 753.4 [2M+
l i r , 775.4 [2M+ Na]T
Synthesis of (3/<.4/<)-l-(Ar-terr-butvloxvcarbonvl)-3-hvdroxvcarbonvl-4-(9//-fluoren-9-

Boc
2-26
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The carboxylatc salt 2-24 (0.084 g, 0.204 mmol) was dissolved in
THF/MeOH/H:0 (6:3:1, 9 mL) and the solution cooled to 0°C. LiOH*H:0 (0.045 g,
1.07 mmol) dissolved in 0.4 mL ILO was added. The mixture was stirred at 0 °C for 20
hours. The solvent was removed under reduced pressure to give a while solid (Rf = 0.31,
CHjCli.MeOH 10:1). The white solid was dissolved in McOH followed by addition of
ammonium formate (0,106 g, 1.68 mmol) and Pd/C (10%, 0.049 g) under N2. The
mixture was refluxed for 3 hours. The solution was cooled, filtered through celite and
syringe filter and the filtrate concentrated on a rotary evaporator to afford a white solid.
The solid was dissolved in acetonc/l-LO (2:1, 9 mL) and cooled to 0°C, followed by the
addition of Fmoc-OSu (0.067 g, 0.199 mmol) and NaHCO^ (0.16 g. 1.90 mmol). The
turbid reaction mixture was stirred at 0°C for 1 hour and was then allowed to stir at room
temperature overnight.

Acetone was mostly removed under reduced pressure.

The

aqueous residue was diluted with H..:0 (2 mL), diethyl ether (9 mL) added and the
mixture stirred at room temperature for 1 hour. The layers were separated and the ether
layer was washed three times with saturated NaHCO.i.

The aqueous phases were

combined, acidified with IN HCI and extracted three times with ethyl acetate (75 mL
total volume). The combined organic extracts were dried over MgS04, concentrated on a
rotary evaporator, and dried under vacuum to afford a white solid. The caidc product
was purified by three crystallizations from n-hexane/chloroform to afford 0.05g (53%
yield) of 2-26 as white fluffy crystals: rn.p. 206-208°C; Rr = 0.44, 10:1 CH2C12:McOH;
[a]“ D = -36.0 (e 0.50, acetone); *H NMR (300 MHz, CDClVCD,OD) 8 7.77 (d. J = 7.5
Hz, 211, Aril), 7.62 (d, J = 6.9 Hz, 2H, Aril), 7.43-7.29 (m, 4H. Aril), 4.36-4.22 (m, 3H),
4.07-4.02 (m, 1H), 3.93-3.86 (m. 1H), 3.09-2.82 (m, 2H), 2.44-2.38 (m, 1H), 2.02-1.97
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(m, 1H), 1.50-1.43 (m, 1H), 1.47 (s, 911); 13C NMR (75 MHz, CDCI3/CD3OD) 6 173.38
(C), 155.83 (C), 154.21 (C), 143.23 (C), 140.69 (C), 127.07 (CH), 126.46 (CH), 124.42
(CH), 119.27 (ClI), 80.00 (C), 66.35 (CII2), 49.73 (CH), 47.77 (CH), 46.57 (CH), 44.33
(CH:), 41.68 (CH:), 30.63 (CH:), 27.51 (CH.,); MS-ES1 m/z 243.1 [M - Fmoc], 465.1
1M- HI . 931.2 [2M- H]\
Synthesis of Boc-D-Ala-ACHC-OBn (2-27)

Boc-D-Ala-ACHC-OBn (2-27)

In an oven-dried round bottom flask, Boc-ACHC-OBrt (0.25 g, 0.75 mmol) was
dissolved in 5 mL of HCl/dioxane (4 M) at 0 °C. The mixture was allowed to warm to
room temperature and stirred for 2 hours. The solvent was then removed under a stream
of N2 and under reduced pressure to obtain a white solid. The residue was dried under
vacuum for 1 hour. The HCI salts were used without further purification. In an ovendried round bottom flask, the resulting HCI salt was dissolved in 6 mL of anhydrous
DMF and cooled to 0°C.

After stirring for 5 minutes, HOBt (0.22 g, 1.63 mmol),

EDCHHCI (0.31 g. 1.63 mmol), DIEA (0.15 mL, 0.86 mmol), and a solution of Boc-OAla-OH (0.14 g, 0.75 mmol) in 4 mL of anhydrous DMT were added. The mixture was
allowed to warm to room temperature and stirred for 48 hours under Nj. The mixture
was diluted with 20 mL CH:CI: and solvent evaporated under reduced pressure. The
solid residue was dissolved in 25 mL CH2C1: and washed with 50 mL of 1 N HCI
solution three limes followed by 50 mL of saturated NaHCO, and 50 mL of saturated
NaCI solution. The combined organic phase was dried over anhydrous MgSO, and the
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solvent was evaporated under reduced pressure to obtain yellow oil which was dried
further under vacuum.

The crude product was purified by S i0 2 flash column

chromatography eluting beginning with CH iC12 and increased polarity to 10:1
CHiCliiMeOII (Rr = 0.38). The product was eluted to afford 0.278 g (92% yield) of 2-27
as a yellowish-white solid. Crystals were grown by slow vapor diffusion of ;i-heptane
into a solution of 2-27 in 1,2-dichloroethanc: m.p. 92-93°C; 'H NMR (300 MHz, CDCIj)
8 7.30-7.36 (m, 5H, ArH), 5.97 (br d, J = 9 Hz, 1H, NH), 5.09 (s, 2H, ArCH2), 4.92 (br d,

7 =1 1 Hz. 1H, NH). 4.03-3.93 (m. 2H. BocHNCH and CONHCH). 2.37 (id, J = 13, 4.5
Hz, III, BnOCOCH), 2.08-1.90 (m, 211). 1.80-1.62 (m, 311), 1.50-1.10 (m. 3H). 1.44 (s,
9H), 1.21 (d, J = 8 Hz, 3H, CHj); MS-ES1 m/z 427.2 (M + N af, 831.4 |2M + N a]\
Svnthesis of Boc-D-Phe-ACHC-OBn (2-28)

Boc-D-Phe-ACHC-OBn (2-28)

In an oven-dried round bottom flask, Boc-ACHC-OBn (0.20 g, 0.60 mmol) was
dissolved in 4 mL of HCI/dioxane (4 M) at 0°C. The mixture was allowed to warm to
room temperature and stirred for 2.5 hours. The solvent was then removed under a
stream of N2 and under reduced pressure to obtain a white solid. The residue was dried
under vacuum for 1 hour. The MCI salts were used without further purification. In an
oven-dried round bottom flask, the resulting HCI salt was dissolved in 5 mL of anhydrous
DMF and cooled to 0°C.

After stirring for 5 minutes, HOBt (0.18 g, 1.30 mmol),

EDCHICI (0.25 g, 1.30 mmol), DIEA (0.12 mL, 0.69 mmol), and a solution of Boc-D-
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Phe-OH (0.16 g, 0.60 mmol) in 3 mL of anhydrous DMF were added. The mixture was
allowed to warm to room temperature and stirred for 60 hours under N2. Solvent was
removed under reduced pressure and the solid residue dissolved in 20 mL CH’Cli. The
resulting solution was washed with 40 mL of I N HC1 solution three times followed by
40 mL of saturated NaHCOj and 40 mL of saturated NaCI solution. The combined
organic phase was dried over anhydrous MgSO* and the solvent was evaporated under
reduced pressure to obtain a white solid which was dried further under vacuum. The
crude product was purified by Si02 Hash column chromatography eluting with 70:1
CILCIcMeOH (Rr = 0.29).

The product eluted in fractions 9-13 (10 mL fractions

collected) to afford 0.270 g (94% yield) of 2-28 as a while solid. Crystals were grown by
slow vapor diffusion of n-heptane into a solution of 2-28 in 1 ,2 -dichloroethane: m.p. 181182 °C; *H NMR (300 MHz. CDC13) 8 7.37-7.18 (m. 10H, ArH), 5.87 (br d, J = 8.7 Hz.
1H, NH), 5.04 (app q,

= 8 Hz, 2H, ArCH2OCO), 4.90 (br s, 1H, NH). 4.24-4.17 (m.

1H, BocllNCH), 4.00 (tdd, J = 11.1, 8.7, 4.2 Hz, 1H, CONHCH), 2.98 (d, J = 6.6 Hz,
2H, ArCH-CH), 2.34 (td, J = 11.1, 3.9 Hz. 1H, BnOCOCH), 2.01-1.87 (m, 2H), 1.721.33 (m, 4H), 1.41 (s. 9H), 1.27-1.11 (m, 2H); MS-ESI ni/z 503.2 [M + Na]*, 983.4 [2M
+ N af.
Synthesis of Boc-D-Val-ACHC-OBn (2-29)

H3C

ch3

Boc-D-Val-ACHC-OBn (2-29)

In an oven-dried round bottom flask, Boc-ACHC-OBn (0.53 g, 1.58 mmol) was
dissolved in 3 mL of HCI/dioxanc (4 M) at 0°C. The mixture was allowed to warm to
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room temperature and stirred for 3.5 hours. The solvent was then removed under a
stream of N2 and under reduced pressure to obtain a white solid. The residue was dried
under vacuum for 1 hour. The HC1 salts were used without further purification. In an
oven-dried round bottom flask, the resulting HC1 salt was dissolved in 10 mL of
anhydrous DMF and cooled to 0°C. After stilting for 5 minutes, HOBt (0.47 g, 3.47
mmol), EDCl’HCI (0.67 g, 3.47 mmol), DIEA (0.41 mL, 2.37 mmol), and a solution of
Boc-D-Val-OII (0.34 g, 1.58 mmol) in 6 mL of anhydrous DMF were added. The
mixture was allowed to warm to room temperature and stirred for 48 hours under N2.
Diluted mixture with 25 mL CbLCL and transferred to a larger flask.

Solvent was

removed under reduced pressure and the solid residue dissolved in 30 mL CH2C12. The
resulting solution was washed with 50 mL of 1 N HC1 solution three times followed by
50 mL of saturated NaHCO.i and 50 mL of saturated NaCI solution. The combined
organic phase was dried over anhydrous MgS0 4 and the solvent was evaporated under
reduced pressure to obtain a white solid which was dried further under vacuum. The
crude product was punfied by Si02 flash column chromatography eluting with 30:1
ClLClcMeOII (Ri = 0.28). The product was eluted to afford 0.55 g (80% yield) of 2-29
as a white solid. Crystals were grown by slow vapor diffusion of /(-heptane into a
solution of 2-29 in 1,2-dichloroelhanc: m.p. 138-140°C; 'll NMR (300 MHz, CDCI3) 5
7.40-7.28 (m, 5H, Aril), 5.80 (br d, J = 8.4 Hz, 1H, NH), 5.14-5.09 (m, 3H, ArCHj &
NH), 4.07 (ddd, J = 14.7, 8.4, 3.9 Hz, 1H, BocHNCH), 3.75 (app q, Jm = 6.3, 111,
CONHCH), 2.39 (td, J = 11.4, 3.9 Hz, 1H, BnOCOCH), 2.09-1.94 (m, 3H), 1.76-1.52
(nr, 4H), 1.45 (s, 9H), 1.40-1.15 (m, 2H) 0.89 (t, ./= 6.9, 6H, 2CHj); MS-ESI m/z 455.2
[M + N a]\ 887.4 [2M + N af.
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Synthesis of Boc-D-Val-D-Phe-ACHC-OBn (2-30)
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Boc-D-Val-DiPhe-ACHC-OBn (2-30)

In an oven-dried round bottom flask, Boc-D-Phe-ACHC-OBn (0.227 g, 0.47
mmol) was dissolved in 2 mL of HCI/dioxane (4 M) at 0°C. The mixture was allowed to
warm to room temperature and stirred for 2 hours. The solvent was then removed under
a stream of Nj and under reduced pressure to obtain a white solid.

The residue was dried

under vacuum for I hour. The HC1 salts were used without further purification. In an
oven-dried round bottom flask, the resulting 1ICI salt was dissolved in 3 mL of anhydrous
DMF and cooled to 0°C. After stirring for 5 minutes, 1.42 mmol of D1EA was added via
syringe and the mixture was stirred for 10 minutes. In another oven-dried round bottom
llask. Boc-D-Val-OII (0.102 g, 0.47 mmol) was dissolved in 3 mL of DM1- followed by
addition of HOBt (0.141 g, 1.04 mmol), and HDCI'HCI (0.199 g, 1.04 mmol), and the
mixture was cooled to 0°C. The solution of amine and DIEA was then transferred to the
flask containing Boc-Val-OH, HOBt and EDCI'HCI. The mixture was allowed to warm
to room temperature and stirred for 72 hours under N2. The mixture was diluted with 20
mL CH2CI2 and transferred to a larger flask. The solvent was removed under reduced
pressure and the solid residue dissolved in 25 mL CII2CI2. The resulting solution was
washed with 30 mL of 1 N HCi solution three times followed by 30 mL of saturated
NaHCOj and 30 mL of saturated NaCI solution. The combined organic phase was dried
over anhydrous MgSOj, and the solvent was evaporated under reduced pressure to obtain
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a while solid which was dried further under vacuum. The crude product was purified by
SiO; Hash column chromatography eluting with 30:1 CHiCI2:MeOH (Rf = 0.21). The
product eluted in fractions 9-13 (10 mL fractions collected) to afford 0.233 g (85% yield)
of 2-30 as a tan solid.

Crystals were grown by slow vapor diffusion of 1:1 1,2-

dichloroethane:hexane into a solution of 2-30 in 1,2-dichloroethane and methanol: m.p.
187-189 °C; *11 N\1R (300 MHz, CDCI3) 8 7.37-7.14 (m, 10H, ArH), 6.34 (br d, J = 7.2
Hz, 1H, NH), 6.20 (br d, J = 7.2 Hz, 1H. NH), 5.07 (app q, J,„ = 6.3 Hz, 2H,
ArCHiOCO), 4.76 (br d. J = 4.2 Hz. 1H, NH), 4.59-4.52 (m, IH, ArCH:CH), 4.03 (ddd,
J = 12.6, 10.8, 3.9, HI, BocHNCH), 3.81 (app q, Jm = 5.1, 1H, CONHCH), 3.13-3.04
(in, IH, ArCHj), 2.98-2.88 (m, HI, ArCH>), 2.36 (td, J = 11.4, 3.9 Hz, 1H, BnOCOCH),
2.20-2.09 (m, IH), 1.94-1.87 (m, 2H), 1.69-1.43 (m. 4H), 1.44-1.00 (m, 211), 1.39 (s.
9H), 0.89 (d, J = 6.9 Hz, 3H, CHj) 0.77 (d. J = 6.9 Hz, 3H, CH3); MS-ESI m/z 602.3 [M
+ N a]\ 1181.6 [2M + Na]*.
Synthesis of Boc-ACHC-O-Phe-ACHC-OBn (2-31)

Boc-ACHC-D-Phe-ACHC-OBn (2-31)

In an oven-dried round bottom flask, Boc-D-Phe-ACHC-OBn (0.047 g, 0.097
mmol) was dissolved in 1 mL of HCl/dioxane (4 M) at 0°C. The mixture was allowed to
warm to room temperature and stirred for 2 hours. The solvent was then removed under
a stream of N2 and under reduced pressure to obtain a white solid. The residue was dried
under vacuum for 1 hour. The HCI salts were used without further purification. In an
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oven-dried round bottom flask, the resulting HC1 salt was dissolved in 3 niL of anhydrous
DMF and cooled to 0°C. After stirring for 5 minutes, 0.388 mmol of D1EA was added
via syringe and the mixture was stirred for 10 minutes. In another oven-dried round
bottom flask, Boc-ACHC-OH (0.0236 g, 0.097 mmol) was dissolved in 3 mL of DMF
followed by addition of HOBt (0.016 g, 0.117 mmol), and EDC1*HCI (0.022 g, 0.117
mmol) and the mixture cooled to 0°C. The solution of amine and DIEA was then
transferred to the flask containing Boc-ACHC-OH, HOBt and EDCI'HCl. The mixture
was allowed to warm to room temperature and stirred for 38 hours under Nj. The solvent
was removed under a stream of Na and reduced pressure and the residue was dried under
vacuum.

This residue was washed with 1 N HC1 solution and saturated NaHCOj

solution. The solid that did not dissolve was collected by suction filtration and dried
under vacuum to obtain a brownish-white solid. The crude product was purified by SiOa
flash column chromatography eluting with 30:1 CHClj.MeOH (Rf = 0.30). The product
was eluted to afford 0.031 g (52% yield) of 2-31 as a white solid. Crystals were grown
by slow vapor diffusion of 1:1 l,2-dichloroethane:hexane into a solution of 2-31 in 1,2dichloroethanc and methanol: m.p. 232-235°C; 'l l NMR (300 MHz, CDCI3/CD 3OD) 6
7.46-7.13 (m, 10H, ArH), 5.05 (br s, 2H, ArCHrOCO), 4.53-4.48 (m, 1H, ArClBCH),
4.00-3.98 (m, 1H, BocHNCH), 3.49-3.40 (m, 1H, CONHCH), 3.00-2.94 (m, 1H, ArCH2),
2.80-2.72 (m. 111, ArCH2), 2.39 (td, J = 11.4, 3.6 Hz, 111, BnOCOCH), 2.09-1.90 (m,
4H), 1.77-1.53 (m, 7H), 1.45-1.14 (in, 5H), 1.40 (s, 9H); MS-ESI m/z 628.3 (M + Na]+,
1234.6 [2M + Na]*.
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Synthesis of ACHC-D-Val-ACHC-OBn (2-32)

Boc-ACHC-D-Val-ACHC-OBn (2-32)

In an oven-dried round bottom flask, Boc-D-Val-ACHC-OBn (0.118 g, 0.272
mmol) was dissolved in 2 mL of HCI/dioxane (4 M) at 0°C. The mixture was allowed to
warm to room temperature and stirred for 1.5 hours. The solvent was then removed
under a stream of Nj and under reduced pressure to obtain a white solid.
was dried under vacuum for 1 hour.

The residue

The HCI salts were used without further

purification. In an oven-dried round bottom flask, the resulting HCI salt was dissolved in
3 mL of anhydrous DMF and cooled to 0°C. After stirring for 5 minutes, 1.085 mmol of
DIEA was added via syringe and the mixture was stirred for 10 minutes. In another
oven-dried round bottom flask, Boc-ACHC-OH (0.0661 g, 0.272 mmol) was dissolved in
3 mL of DMF followed by addition of HOBt (0.0441 g, 0.326 mmol), and EDCFHCI
(0.0625 g, 0.326 mmol) and the mixture was cooled to 0°C. The solution of amine and
DIEA was then transferred to the flask containing Boc-ACHC-OH, HOBt and
EDCM1CI. The mixture was allowed to warm to room temperature and stirred for 40
hours under N2. The solvent was removed under a stream of N2 and reduced pressure and
the residue was dried under vacuum. This residue was washed with 1 N HCI solution and
saturated NaHCOa solution. The solid that did not dissolve was collected by suction
filtration and dried under vacuum to obtain a white solid. The crude product was purified
by Si02 flash column chromatography eluting with 30:1 CHCIj:MeOH (Rr = 0.36). The
product was eluted to afford 0.094 g (62% yield) of 2-32 as a white solid. Crystals were
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grown by slow vapor diffusion of 1:1 l,2-dichloroethanc:hexane into a solution of 2-32 in
1,2-dichloroethane and methanol: m.p. 245-247°C; ‘ll NMR (300 MHz, CDCI3/CD3OD)
5 7.48-7.30 (m, 5H, ArH), 5.09 (s. 2H, ArCH;OCO), 4.09-4.00 (m, 2H, BocHNCH &
(CHj),CHCH), 3.58-3.49 (m, 1H, CONHCH), 2.43 (td, J = 11.7, 4.0 Hz, 1H,
BnOCOCH), 2.18 (td, J = 11.7, 4.0 Hz. IH, NHCOCH), 2.10-1.86 (m. 5H), 1.82-1.73
(m, 411), 1.61-1.54 (m. 3H), 1.44-1.13 (m, 511), 1.41 (s, 9H), 0.88 (d, J = 3.9 Hz. 3H,
CHj), 0.86 (d, J = 3.9 Hz, 3H, CH3); MS-ESI m/z 580.3 [M + Na]*, 1138.7 [2M + Na]f.
Synthesis of Boc-D-Lvs(2-CI-Z)-P-Val-ACHC-OBn (2-33)

Cl
Boc-0-Lys(2-CI-Z)-0-Val-ACHC-OBn (2-33)

In an oven-dried round bottom flask, Boc-D-Val-ACHC-OBn (0.186 g, 0.430
mmol) was dissolved in 2 mL of HCI/dioxanc (4 M) at 0°C. The mixture was allowed to
warm to room temperature and stirred for 2 hours. The solvent was then removed under
a stream of N2 and under reduced pressure to obtain a while solid. The residue was dried
under vacuum for 1 hour. The HC1 salts were used without further purification. In an
oven-dried round bottom flask, the resulting HCI salt was dissolved in 3 mL of anhydrous
DMF and cooled to 0"C. After stirring for 5 minutes, 0,642 mmol of DIEA was added
via syringe and the mixture was stirred for 10 minutes. In another oven-dried round
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bottom flask, Boe-D-Lys(2-CI-Z)-OH (0.178 g, 0.430 mmol) was dissolved in 3 mL of
DMF followed by addition of HOBt (0.128 g, 0.950 mmol), and EDC1-HCI (0.181 g,
0.950 mmol), and the mixture was cooled to 0°C. The solution of amine and DIEA was
then transferred to the flask containing Boc-£)-Lys(2-Cl-Z)-OH, HOBt and EDCI'HCl.
The mixture was allowed to warm to room temperature and stirred for 48 hours under Nj.
The solvent was removed under a stream of NS and reduced pressure and the residue w<as
dried under vacuum. This residue was washed with 1 N 11CI solution and saturated
NaHCOj solution. The solid that did not dissolve was collected by suction filtration and
dried under vacuum to obtain a white solid. The crude product was purified by Si0 2
Hash column chromatography eluting with 30:1 CHCfpMeOH (Rr = 0.20). The product
eluted after increasing solvent polarity to CHCfpMeOH 1:1. Product was dried under
vacuum to afford 0.263 g (84% yield) of 2-33 as a white solid. Crystals were grown by
slow vapor diffusion of 1:1 l,2-dichlorocthane:licxane into a solution of 2-33 in 1,2dichloroethane and methanol: m.p. 210-2I2°C; ’ll NMR (300 MHz, CDCI5/CD3OD) 6
7.70 (hr d, J = 4.2, IH, NH) 7.44-7.24 (nt, 9H, ArH), 5.20 (s, 2H, ArCICHj), 5.06 (s, 2H,
ArCLLOCO), 4.06-3.96 (m, 311), 3.39-3.37 (m, III), 3.16 (t, J = 6.3 Hz, 2H), 2.39 (td, J =
12.0, 3.6 Hz, 1H, BnOCOCfj), 2.10-1.90 (m, 3H), 1.76-1.68 (m, 3H), 1.60-1.09 (m, 911),
1.43 (s, 9H), 0.87 (d. J = 3.6 Hz, 3H, CHj), 0.84 (d, J = 3.6 Hz, 3H, CH3); MS-ESI mfz
751.3 [M + N af, 1481.6 [2M + Naf.
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Synthesis of Boc-P-Ala-ACHC-fl-Ala-ACHC-OBn (2-34)
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Boc-D-Ala-ACHC-D-Ala-ACHC-OBn (2-34)

In an oven-dried round bottom flask, Boc-£>-Ala-ACHC-OBn (0.056 g, 0.139
mmol) was dissolved in 1 mL of HCl/dioxane (4 M) at 0°C. The mixture was allowed to
warm to room temperature and stirred for 2 hours. The solvent was then removed under
a stream of Nj and under reduced pressure to obtain a tan solid. The residue was dried
under vacuum for 1 hour. The MCI salts were used without further purification. In an
oven-dried round bottom flask, the resulting HC1 salt was dissolved in 2 mL of anhydrous
DMF and cooled to 0°C. After stirring for 5 minutes, 0.208 mmol of DIEA was added
via syringe and the mixture was stirred for 10 minutes. In another oven-dried round
bottom flask, Boc-D-Ala-ACHC-OH (0.0435 g, 0.139 mmol) was dissolved in 2 mL of
DMF followed by addition of HOBl (0.041 g, 0.305 mmol), and EDCI*HCI (0.058 g,
0.305 mmol), and the mixture was cooled to 0'C. The solution of amine and DIEA was
then transferred to the flask containing Boc-D-Ala-ACHC-OH, HOBt and EDCI’HCl.
The mixture was allowed to warm to room temperature and stirred for 76 hours under N;.
The solvent was removed under a stream of Ni and reduced pressure and the residue was
dried under vacuum. This residue was diluted with CH2CI2 and washed three times with
20 mL 1 N HC1 solution, three times with 20 mL saturated NaHCOj solution and once
with 20 mL aqueous NaCl solution. The organic phase was dried in anhydrous MgSOj
and concentrated on a rotary evaporator. The residue was dried under vacuum to obtain a
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pale yellow solid. The crude product was purified by SiC>2 flash column chromatography
eluting with 20:1 CHiCI;:MeOH (Rf = 0.30). The product was then dried under vacuum
to afford 0.062 g (75% yield) of 2-34 as a white solid. Crystals were grown by slow
vapor diffusion of i:l l,2-dichlorocthane:hcxane into a solution of 2-34 in 1,2dichlorocthane and methanol: m.p. 202-203°C; ' l l NMR (300 MHz, CDCIVCDiOH) 6
7.70 (hr d, 7 = 8.7, 1H, NH), 7.57 (br d, 7 = 8.1. 1H, NH), 7.36-7.28 (nn, 5H, ArH), 6.00
(br d, 7 = 6.9, 1H, NH), 5.08 (s, 2H, AiCH jOCO), 4.18-4.14 (m, 2H, NHCHCO), 4.083.96 (m, 2H, CONHCH ), 2.36 (td, 7 = 11.7, 3.6 Hz, 1H, HNCOCH), 2.30-2.22 (m, 1H,
BnOCOCH), 2.01-1.74 (m, 7H), 1.64-1.25 (m. 9H), 1.44 (s, 9H), 1.20 (d, 7= 6.9 Hz, 3H,
CHi), 1.16 (d, 7 = 6.9 Hz, 3H, CH,); MS-ESI ni/z 623.3 [M + Na)+, 1223.6 [2M + N af.

Boc-O-Phe-ACHC-D-Phe-ACHC-OBn (2-35)

In an oven-dried round bottom flask, Boc-D-Phe-ACHC-OBn (0.0167 g, 0.035
mmol) was dissolved in 1 mL of HCI/dioxane (4 M) at 0°C. The mixture was allowed to
warm to room temperature and stirred for 2 hours. The solvent was then removed under
a stream of N2 and under reduced pressure to obtain a white solid. The residue was dried
under vacuum for 1 hour. The HCI salts were used without further purification. In an
oven-dried round bottom flask, the resulting HCI salt was dissolved in 1 mL of anhydrous
DMF and cooled to 0°C. After stirring for 5 minutes, 0.052 mmol of D1EA was added
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via syringe and the mixture was stirred for 10 minutes. Boc-D-Phe-ACHC-OH (0.0134
g, 0.035 mmol), HOBt (0.0103 g, 0.076 mmol), and EDCI'HCI (0.0147 g, 0.076 mmol)
were added at 0”C. The mixture was allowed to warm to room temperature and stirred
for 53 hours under Nj. The solvent was removed under a stream of Nj and reduced
pressure and the residue was dried under vacuum. This residue was diluted with CH2CI2
and washed three times with 20 mL 1 N HCI solution, three times with 20 mL saturated
NaHCOj solution and once with 20 mL aqueous NaCl solution. The organic phase was
dried in anhydrous MgSOj and concentrated on a rotary evaporator. The residue was
dried under vacuum to obtain a brown solid. The crude product was purified by Si02
flash column chromatography eluting with 30:1 CHCb:MeOH (Rr = 0.29). The product
was dried under vacuum to afford 0.0187 g (72% yield) of 2-35 as a while solid. Crystals
were grown by slow vapor diffusion of 1:1 l, 2 -dichlorocthane:hcxanc into a solution of
2-35 in 1,2-dichlorocthane and methanol: m.p. 244-245°C; 'll NMR (300 MHz,
CDCI3/CD3OD) 7.36-7.15 (m, 15H, ArH), 5.06 (s, 2H, ArCH2OCO), 4.59-4.55 (m, 1H,
N’HCHCO), 4.25-4.22 (m, IH, NHCHCO), 3.87-3.77 (m, 2H), 2.94-2.88 (m, 2H,
A1CH 2), 2.70-2.59 (m. 2H, A1CH 2), 2.30-2.17(m, 2H), 1.99-1.85 (m, 2H), 1.74-1.05 (m,
12H), 1.32 (s, 9H), 0.92-0.85(m, 211); MS-ESI m/z 775.4 [M + Na]f
Synthesis of Boc-D-Val-ACHC-P-Val-ACHC-OBn 12-36)
O
O

Boc-D-Val-ACHC-D-Val-ACHC-OBn (2-36)

In an oven-dried round bottom flask, Boc-D-Val-ACHC-OBn (0.111 g, 0.257
mmol) was dissolved in 3 mL of HCI/dioxanc (4 M) at 0°C. The mixture was allowed to
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warm to room temperature and stirred for 2 hours. The solvent was then removed under
a stream of N? and under reduced pressure to obtain a white solid. The residue was dried
under vacuum for 1 hour. The HCI salts were used without further purification. In an
oven-dried round bottom flask, the resulting HCI salt was dissolved in 3 mL of anhydrous
DMF and cooled to 0°C. After stirring for 5 minutes, 1.03 mmol of D1EA was added via
syringe and the mixture was stirred for 10 minutes. In another oven-dried round bottom
flask, Boc-D-Val-ACHC-OH (0.088 g, 0.257 mmol) was dissolved in 3 mL of DMF
followed by addition of HOBt (0.042 g, 0.311 mmol), and EDCl'HCI (0.059 g, 0.311
mmol), and the mixture cooled to 0°C. The solution of amine and DIEA was then
transferred to the flask containing Boc-D-Val-ACHC-OH, HOBt and EDCEHCI. The
mixture was allowed to warm to room temperature and stirred for 48 hours under N2
during which time a white solid precipitated. The solvent was removed under a stream of
Ni and reduced pressure and the residue was dried under vacuum. This residue was
diluted with CH2CI2 (sparingly soluble) and washed three times with 25 mL 1 N HCI
solution, three times with 25 mL saturated NaHCOi solution and once with 25 mL
aqueous NaCl solution.

The organic phase was dried in anhydrous MgSO* and

concentrated on a rotary evaporator. The residue was dried under vacuum to obtain a
white solid.

The crude product could not be purified by SiCL flash column

chromatography because of poor solubility in organic solvents. The crude product was
purified by washing with acetone and filtering to obtain 0.135 g (80%) of 2-36 as a white
solid. A mini workup for NMR purposes involved taking a sample of the product and
reacting with CF3COOH to obtain the trifluoroacctatc and then dissolving in acetone and
filtered to obtain a white solid (free amine). This white solid could then be dissolved in
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CDCI3/CD3OD for NMR analysis. Crystals were grown by slow vapor diffusion of 1:1
l, 2-dichloroethane:hcxanc into a solution of 2-36 in 1,2-dichloroethane and methanol:
m. p. 254-256°C (free amine); 'l l NMR (300 MHz, CDCI3/CD 3OD) (Free amine) 5 7.397.32 (m, 5H, ArH), 5.08 (app q, J = 12.6 Hz, ArCHj), 4.06-3.95 (m. 2H), 3.61 (td, J =
10.8, 3.3 Hz, 1H, CONHCJ4), 3.40-3.35 (m, 1H, CONHCH), 2.69 (td, J = 11.1, 3.0 Hz,
1H, HNCOCH), 2.44 (td,./ = 11.7, 3.9 Hz, 1H, BnOCOCH). 2.13-1.81 (m, I0H), 1.621.18 (m, 8H), 0.99 (app q, J = 3.3 Hz, 614, 2C.Hj), 0.87 (br d, J = 6 Hz, 6H, 2CH3); MSES1 m/z (Free amine) 557.3 [M + H ]\ 579.3 1M + Na|*. 1135.6 [2M + Na]*; (Bocproduct) 679.4 |M + N a]\ 1335.7 [2M + Na]*.
Synthesis of Boc-Q-Lvs(2-Cl Z)-/J-Val-P-Phc-ACHC-OBii (2-37)

Cl
Boc-D-Lys (2-CI-Z)-D-Val-D-Phe-ACHC-OBn

(2 -3 7 )

In an oven-dried round bottom flask, Boc-/J-Val-D-Phe-ACllC-OBn (0.274 g,
0.473 mmol) was dissolved in 2 mL of HCl/dioxane (4 M) at 0“C. The mixture w'as
allowed to warm to room temperature and stirred for 2 hours. The solvent was then
removed under a stream of 1N2 and under reduced pressure to obtain a white solid. The
residue was dried under vacuum for 1 hour. The HC1 salts were used without further
purification. In an oven-dried round bottom flask, the resulting HCI salt was dissolved in
2 mL of anhydrous DMF and cooled to 0°C. After stirring for 5 minutes, 0.712 mmol of
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D1EA was added via syringe and the mixture was stirred for 10 minutes. In another
oven-dried round bottom flask. Boc-Z?-Lys(2-CI-Z)-OH (0.196 g, 0.473 mmol) was
dissolved in 3 mL of DMF followed by addition of HOBt (0.141 g, 1.04 mmol), and
EDCHICl (0.199 g, 1.04 mmol), and the mixture was cooled to 0°C. The solution of
amine and DIEA was then transferred to the flask containing Boc-D-Lys(2-CI-Z)-OH,
HOBt and EDCHICl. The mixture was allowed to warm to room temperature and
stirred for 48 hours under N2. The solvent was removed under a stream of N2 and
reduced pressure and the residue was dried under vacuum. This residue was washed with
1 N HCI solution and saturated NallCOj solution. The solid that did not dissolve was
collected by suction filtration and dried under vacuum to obtain a tan solid. The crude
product was purified by SiO.> flash column chromatography eluting with 2:1
CIIiCkMeOH (R| - 0.40). The Product was dried under vacuum to afford 0.249 g (60%
yield) of 2-37 as a white solid. Crystals were grown by slow vapor diffusion of 1:1 1,2dichloroethane:hexane into a solution of 2-37 in 1,2-diehloroelhane and methanol: m.p.
192-194 °C: 'H NMR (300 MHz, CDC1/CD30D) 6 7.54 (br d. J = 6.3, 111, NH), 7.457.14 (m, 14H, Aril), 6.50(1,/= 5.4 Hz, 111, NH),5.21 (s, 2H, AtCICHH, 5.03 (appq, Japp
= 12.3 Hz, 2H, ArQHOCO), 4.09 (br d, / = 6.0, 1H), 4.02-3.99 (m, 2H), 3.78-3.72 (m,
1H), 3.19-3.13 (m, 2H), 2.82 (app q, 7W = 8.7 Hz, HI), 2.49-2.42 (m, 1H, BnOCOCH),
2.05-1.88 (m, 311), 1.75-1.16 (m, 14H), 1.44 (s, 911), 0.84 (d, J = 6.9 Hz, 3H, CH3), 0.80
(d, J = 6.9 Hz, 3H, CH3); MS-ESI m/z 898.4 [M + N af.
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Synthesis of Boc-»-Lvs(2-Cl-Zl-ACHC-D-V:il-ACHC-OBn (2-38)
0

oA

»?

H N -C -C —
CHj
ch2
ch2
ch2

I

Boc-D-Lys (2-CI-Z)-ACHC-D-Val-ACHC-OBn (2-38)

In an oven-dried round bottom flask. Boc-O-ACHC-D-Val-ACHC-OBn (0.06S g,
0.122 mmol) was dissolved in 1 raL of HCI/dioxane (4 M) at 0°C. The mixture was
allowed to warm to room temperature and stirred for 2 hours. The solvent was then
removed under a stream of N2 and under reduced pressure to obtain a white solid. The
residue was dried under vacuum for 1 hour. The HCI salts were used without further
purification. In an oven-dried round bottom flask, the resulting HCI salt was dissolved in
2 mL of anhydrous DMF and cooled to 0"C. After slitting for 5 minutes, 0.183 mmol of
D1EA was added via syringe and the mixture was stirred for 10 minutes. In another
oven-dried round bottom flask, Boc-/3-Lys(2-CI-Z)-OH (0.0506 g, 0.122 mmol) was
dissolved in 1 mL of DMF followed by addition of liOBt (0.036 g, 0.266 mmol), and
EDCFHCl (0.051 g, 0.266 mmol), and the mixture was cooled to 0°C. The solution of
amine and DIEA was then transferred to the flask containing Boc-D-Lys(2-CI-Z)-OH,
HOBt and EDCFHCI. The mixture was allowed to warm to room temperature and
stirred for 48 hours under N2. The solvent was removed under a stream of N2 and
reduced pressure and the residue was dried under vacuum. This residue was washed with
1 N HCI solution and saturated NaHCOj solution. The solid that did not dissolve was
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collected by suction filtration and dried under vacuum to obtain a white solid. The crude
product was purified by precipitation. Purification involved dissolving the white solid in
minimum amount of MeOH/TFE/CHClj and sonicationg.

Excess diethyl ether was

added and mixture kept at 0°C for 5 minutes and after centrifuging, the ether layer was
decanted. The process was repeated three times with fresh portions of diethyl ether. The
product was dried under vacuum to afford 0.094 g (90% yield) of 2-38 as a white solid:
m.p. 217-219°C; 'll NMR (300 MIIz, CDCIj/CD^OD) 8 7.53 (br d. J = 4.2, 1H, NH),
7.41 (br d. J = 5.1, 1H, NH), 7.36-7.24 (m, 9H, ArH). 5.20 (app q, Jm = 11.7 Hz, 2H.
ArCH:OCO), 5.07 (s, 2H, ArCICH:), 4.12-3.99 (m. 310, 3.86-3.80 (m, 1H, CONHCH),
3.18-3.12 (m, 211), 2.99-2.88 (m, 1H), 2.44-2.26 (m. 211). 2.05-1.15 (m. 23H), 1.43 (s,
9H), 0.85 (br d. J = 6.3 Hz, 611. 2CH,); MS-ESI mfz 876.4 |M + Nap.
Synthesis of l)oc-ACHC-/J-l.vs(2-CI-/.l-/J-Val ACHC-OBn (2-39)

Boc-ACHC-D-Lys (2-CI-Z)-0-Val-ACHC-OBn (2-39)

In an oven-dried round bottom flask, Boc-D-Lys(2-Cl-Z)-D-Val-ACHC-OBn
(0.239 g, 0.328 mmol) was dissolved in 2 mL of HCI/dioxanc (4 M) at 0°C. The mixture
was allowed to warm to room temperature and stirred for 2 hours. The solvent was then
removed under a stream of N2 and under reduced pressure to obtain a white solid. The
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residue was dried under vacuum for 1 hour. The HCI salts were used without further
purification. In an oven-dried round bottom flask, the resulting HCI salt was dissolved in
1 mL of anhydrous DMF and cooled to 0°C. After stirring for 5 minutes, 0.492 mmol of
DIEA was added via syringe and the mixture was stirred for 10 minutes. In another
oven-dried round bottom flask, Boc-ACHC-OH (0.08 g, 0.328 mmol) was dissolved in 2
mL of DMF followed by addition of HOBt (0.097 g, 0.721 mmol), and EDCPHCI (0.138
g, 0.721 mmol) and the mixture was cooled to 0°C. The solution of amine and DIEA was
then transferred to the flask containing Boc-ACHC-OH, HOBt and EDCI'HCI. The
mixture was allowed to warm to room temperature and stirred for 48 hours under Nj.
The solvent was removed under a stream of N2 and reduced pressure and the residue was
dried under vacuum. This residue was washed with 1 N HCI solution and saturated
NallCOj solution. The solid that did not dissolve was collected by suction filtration and
dried under vacuum to obtain a white solid.

The crude product was purified by

precipitation. Purification involved dissolving the white solid in minimum amount of
MeOH/TFE/CHCI3 and sonicating. Excess diethyl ether was added and mixture kept at 0
°C for 5 minutes and after centrifuging, the ether layer was decanted. The process was
repeated three times with fresh portions of diethyl ether. The product was dried under
vacuum to afford 0.210 g (75% yield) of 2-39 as a white solid: m.p. 288-290°C; 'H NMR
(300 MHz, CDClj/CDjOD/TFE) 8 7.47-7.23 (m, 9H, ArH), 5.19 (s, 2H, ArCICHi), 5.06
(s, 2H, AiCH jOCO), 3.66-3.57 (m, 2H), 3.52-3.41 (m, HI), 3.17-3.10 (m, 3H), 2.46-2.37
(m, IH, N'HCOCH), 2.27-2.15 (m, 1H, BnOCOCH), 1.97-1.17 <m, 23H), 1.40 (s, 9H),
0.87 (d, J « 5.0 Hz, 3H, CH3), 0.85 (d, J = 5.0 Hz, 3H, CH3); MS-ESI m/z 876.4 [M +
N af.
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Synthesis of Ac-ACHC-O-Lvs-ACHC-D-Tvr-ACHC A L ys-N IT (2-40)
NH,

0

A

NH2

,OH

o

K

Ac-ACHC-0Tys-ACHC-D-Tyr-ACHC-O-Lys-NH2 (2-40)

The synthesis was performed as described under the General Procedures for Solid
Phase Peptide Synthesis on the automated peptide synthesizer. A 75 /tmol scale for each
residue was used for coupling. Cleavage of the peptide and simultaneous side chain
deprotection was performed as described under the General Procedures.

Extended

deprotection and extended coupling (2 hours) were employed. The crude peptide was
dissolved in the HPLC A solvent and purified by reverse phase IIPLC employing a linear
gradient from 15% to 75% solvent B over 40 minutes. MALD1-TOF-MS m/z ealed for
(C44H71N .A ) IM] 854.09, found 854.0 [M], 855.0 [M + H f , 877.0 [M + N a]\ 892.9 [M
+ K]T
Synthesis of Ac-ACMC-E-Lvs-ACllC-T-Tvr-ACHC-f--Lvs-NfT12-41)

Ac-ACHC-t--Lys-ACHC-C-Tyr-ACHC-t--Lys-NH2 (2-41)

The synthesis was performed as described under the General Procedures for Solid
Phase Peptide Synthesis on the automated peptide synthesizer. A 75 /tmol scale for each
residue was used for coupling. Cleavage of the peptide and simultaneous side chain
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deprolection was performed as described under the General Procedures.

Extended

deprotection and extended coupling (2 hour) were employed. The crude peptide was
dissolved in the HPLC A solvent and purified by reverse phase HPLC employing a linear
gradient from 17% to 47% solvent B over 60 minutes. MALDI-TOF-MS mJz ealed for
(C44H71 NqOr) [M] 854.09. found 854.0 |M], 855.0 [M + HP, 877.0 [M + Na]+, 893.0 [M
+ K]*.
Synthesis of Ac-ACHC-D-Lvs-ACHC-P-Tvr-ACHC-D-Lvs-ACHC-D-Tvr-NH? (2-42)

O

2=7 ; f r

nh.

OH

NH,

01

0
Y

o

K

.

n

_

X2==rH

2

Ac-ACHC-D-Lys-ACHC-D-Tyr-ACHC-D-Lys-ACHC-D-Tyr-NHj (2-42)

The synthesis was performed as described under the General Procedures for Solid
Phase Peptide Synthesis on the automated peptide synthesizer. A 75 jmiol scale for each
residue was used for coupling. Cleavage of the peptide and simultaneous side chain
deprotection was performed as described under the General Procedures.

Extended

deprotection and extended coupling (2 hour) were employed. The crude peptide was
dissolved in the HPLC A solvent and purified by reverse phase HPLC employing a linear
gradient from 35% to 95% solvent B over 40 minutes and 20% to 45% solvent B over 30
minutes. MALDI-TOF-MS m/z ealed for (CWH,,;NnO,,) [M] 1142.43, found 1142.1
[M], 1180.1 [(M-H) + K f.

with permission of the copyright owner. Further reproduction prohibited without permission.

215

Synthesis of Ac-ACHC-Z.-Lvs-ACHC-/J-Tvr-ACHC-/,-Lvs-ACHC-£-Tvr-NH? (2-43)
OH

Ac-ACHC-GLys-ACHC-l.-Tyr-ACHC-/.-lys-ACHC-f.-Tyr-NH2 (2-43)

The synthesis was performed as described under the General Procedures for Solid
Phase Peptide Synthesis on the automated peptide synthesizer. A 75 pmol scale for each
residue was used for coupling. Cleavage of the peptide and simultaneous side chain
deprotection was performed as described under the General Procedures.

Extended

deprotection and extended coupling (2 hour) w'ere employed. The crude peptide was
dissolved in the HPLC A solvent and purified by reverse phase IIPLC employing a linear
gradient from 25% to 40% solvent B over 30 minutes. MALDI-TOF-MS m / z ealed for
(CsoHEiNnOii) [M] 1142.43, found 1142.3 [M], 1I43.1[M + H]*, 1165.4 [M + N a]\
1181.4 [M + K]*.
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CHAPTER 4

MODELING HETEROGENEOUS OLIGOMERS

4.1 Introduction
Homogeneous and heterogeneous backbone oligomers are modeled with the
intention of predicting, qualitatively, the helical secondary structures adopted by
oligomers based on the hydrogen-bonding pattern. The experimental data available for
homogeneous backbone oligomers ate used as standards to validate the modeling method.
Among p-amino acid homo-oligomers, different helical conformations have been
reported, specified by the number of atoms involved in hydrogen bonding. p-Peptides
constructed from cycloalkane based residues have been shown to adopt stable helical
conformations, characterized by 12- and 14-mcmbercd ring hydrogen bonds.710'14'4 '41*
Helical conformations have also been reported for P-peptides built from acyclic
residues.12-1632
Homogeneous backbone oligomers are oligomers containing residues of the same
kind (for example cither only a- or P-amino acids) as monomer units. Heterogeneous
backbone oligomers are oligomers containing both a- and P-amino acids as the monomer
units. Three cx-amino acids Ala, Pile and Val and two P-amino acids, amino cyclohexane
carboxylic acid (ACHC) and amino cyclopcntanc carboxylic acid (ACPC) were used to
build various oligomers (hexamers) and molecular modeling studies performed on these
oligomers.
216
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It was logically thought to begin modeling studies with homogeneous backbone
oligomers of Ala, Phe and Val. In building the homo-oligomers of a-peptides, both the
L- and D-forms of Ala, Phe and Val were used. In building the homo-oligomers of (Jpcptidcs. the (R, Reconfiguration of ACHC and ACPC were used.

The (R. R)-

configuration of ACHC and ACPC and the D-form of the a-amino acids were used to
build the heterogeneous backbone oligomers.
To determine what kind of conformation the oligomers had and to view any
particular hydrogen bonding arrangement, a combination of Monte Carlo (MC)
conformational

search,

energy

minimization

and

dynamics

were

performed.

Representative sequence of each of the homogeneous and heterogeneous backbone
oligomers are shown in Figures 4.1 and 4.2.

Boc-[3-D-Ala-P-D-Ala-p-D-Ala-|V-D-Ala-t)-D-Ala-p-D-Ala-OBn
Boc-ACHC-ACHC-ACHC-ACHC-ACHC-ACHC-OBn

j Boc-ACPC-ACPC-ACPC-ACPC -ACPC-ACPC-OBn
Homogeneous Oligomers

Figure 4.1 Homogeneous oligomers.
Boc-D-Ala-ACHC-D-Ala-ACHC-D-Ala-ACHC-OBn
Boc-O-Phe-ACHC-0-Phe-ACHC-D-Phe-ACHC-OBn
Boc-D-Val-ACHC-D-Val-ACHC-D-Val-ACHC-OBn
Heterogeneous Oligomers

Figure 4.2 Heterogeneous oligomers.
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In each sequence, the N-terminus is protected by a fert-butyloxycarbonyl group (Boc)
and the C-terminus by a benzyloxy group (OBn). Residues are numbered from the Ntemnnus towards the C-terminus.
4.2 Methods
The starting models, for the oligomers of a-amino acids, were built using
standard parameters for amino acid residues supplied with the INSIGHT II (MSI, San
Diego) software package.

For the oligomers of (5-amino acids, of which standard

parameters are not supplied with the INSIGHT II software package, a short input/output
program was written enabling the addition of such parameters into the Aminos library of
INSIGHT II.

With the (5-amino acid residues added, it was then possible to build

homogeneous peptides containing (5-amino acids and heterogeneous peptides containing
both a- and (5-amino acids. Preliminary energy minimization, first with 500 steps of
steepest descent and then 1000 steps of conjugate gradient (CG), were performed to
refine the starting models. Except in the case of the homogeneous backbone oligomers
where both the /^-configuration and /.-configuration of a-amino acids were used for the
modeling, all other oligomers contained a-amino acids in the ^-configuration. Because
all the a-amino acid residues in the residue library are natural amino acids with Lconfiguration, the stereochemistry had to be inverted to ascertain that oligomers had the
desired stereochemistry (all D). Similarly, the stereochemistry for the p-amino acid
(ACHC) was maintained as (R,R). Due to the flexibility inherent in the oligomers, with
many degrees of freedom it was desirable to carry out an extensive conformational search
in order to locate the lowest energy conformation (global minimum).
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Because an extensive conformational search such as Monte Carlo (MC) can not
be carried out in INSIGHT II, the models were exported to PC Spartan Pro
(Wavefunction, Inc.) where the search was performed. MC Spartan conformer program
was used to carry out the conformational search using the SYBYL72 force field and
generating low energy conformations. Starting with an initial temperature of 5000K, the
molecule is gradually cooled down until the conformational search is complete when the
temperature stabilizes at 300K. MC conformational search was carried out in vacuo, as
this is the only condition available in PC Spartan Pro. At the end of the conformational
search, the low energy conformations were saved, and were opened on a spreadsheet
permitting the conformations to be compared. All structures within 5.0 kcal/mol of the
lowest energy conformation were further saved in a protein data bank (pdb) format.
These structures were then exported back to Insight II where energy minimization and
dynamics were performed.
Minimization and molecular dynamics (MD) simulations were performed on a
Silicon Graphics workstation using the DISCOVER program (version 97.0, Molecular
Simulations Inc.) using the Amber73 force field and the Consistent Valence force field
(Cvff).74'76 In minimization, the Conjugate Gradient (CG) algorithm was used and the
number of iterations were set to 10,000 with a derivative of 0.001. Cross term and
Morse term were added with the Cvff force field, but not with the Amber force field. In
performing MD, the structures were equilibrated at 100 steps for a total of 10,000
iterations and the History file was written every 100 steps. All simulations were carried
out at 300K with a time step of 1.0 fs. At the end of the MD simulations, a total of 102
conformations were generated for each starting structure, and each of these
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conformations was examined for the H-bonding arrangement. Hydrogen bonding was
assigned on the basis of the N-H- • -0 angle and the H- • -0 distance. In all cases
examined, the N-H- • -O angle was close to linearity and the H- • -O distance was
approximately 2

A.

Calculations in INSIGHT II were carried out at dielectric constants

of 1.00 and 32.63, the gaseous and methanol dielectrics respectively.
4.3 Results
Results are presented in the sections that follow, based on the type of oligomer
and starting with simple homo-oligomers of a-amino acids. Results are classified based
on the type of force field and dielectric constant.
4.3.1 Homo-Oligomers of Ala. Phe. Val
The a-amino acids, in both the D-configuration and L-configuration, were used to
build oligomers in -INSIGHT II, and after minimization and dynamics the resulting
structures were analyzed by comparing the hydrogen bonding patterns. It should be
noted that except for the case of Phe, where a difference was observed in the H-bond
pattern upon varying the configuration (D or L), no difference was observed in the
hydrogen bonding pattern when either the D- or L-configuration of Ala and Val was used
to build oligomers. Because the goal of this study was to model 3-amino acid oligomers,
not much time was spent on analyzing the a-amino acid oligomers. Only one force field
was used (Amber force field) and a dielectric of 1.00 was used in all calculations. For
purposes of explaining the position of the H-bonds, the protective groups Boc and OBn
were counted as residues making a total of 8 residues.
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For the oligomers of Ala (D- and /.-configurations), three 13-membered ring Hbonds were found between the following residues as shown below.
(Res 1) C =0----------H-N (Res 5)
(Res 2) C =0----------H-N (Res 6)
(Res 3) C=0----------H-N (Res 7)
Two different H-bonding patterns were observed in the oligomers of Phe
depending on the configuration of Phe. In the hexamer containing the L-configuration of
Phe, three H-bonds (all 13-membered rings) were observed as follows.
(Res 1) C=0----------H-N (Res 5)
(Res 2) C=0............. H-N (Res 6)
(Res 3) C =0----------H-N (Res 7)
In the hexamer containing the /^-configuration of Phe, two prominent H-bonds were
observed as shown below. It should be noted that unlike in the other cases, where the Hbonds were regular in which case a fixed number of residues per H-bond were seen, here
the number of residues per H-bond varied.
(Res 2) C =0--------- H-N (Res 4) 7-membered ring
(Res 3) C=0--------- H-N (Res 6) 10-membered ring
For the oligomers of Val (D- and /.-configurations), three 13-membered ring Hbonds were found between the following residues as shown below.
(Res 1) C=0-— ......H-N (Res 5)
(Res 2) C=0-— -— H-N (Res 6)
(Res 3) C -O ...... - —H-N (Res 7)
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4.3.2 Homo-Oligomers of (3-Amino Acids
Homo-oligomers of (3-Ala, ACPC, and ACHC were modeled at dielectric
constants of 1.00 and 32.63 using the Amber and Cvff force fields.
4.3.2.1 Boc-fB-AlaW-OBn at dielectric of 1.00
(i) Amber Force Field
In all the structures examined after MD, single intra-residue hydrogen bonded
structures were common. Predominant intra-residue hydrogen bonds, 6-membered rings,
were observed for residues 3, 4, 5, and 7. This is a rare occurrence in conventional
peptides.

Some inter-residue single hydrogen bonded structures were also observed

either toward the C- or N-terminus.

Among these, a prominence of 10-membered

hydrogen bonded ring structure toward the N-terminus was observed. The other single
hydrogen bonded structures contained 8-membered and 20-membered hydrogen bonded
rings all towards the C-terminus.
(ii) Cvff Force Field
Here, more inter-residue hydrogen bonded structures were observed with only a
few intra-residue hydrogen bonded structures.

Hydrogen bonded structures observed

include single, double and triple hydrogen bonded structures.

Among the single

hydrogen bonded structures, 8-membered ring structures towards the C-terminus, 10- and
14-membered ring structures towards the N-terminus were observed. 8-membered and
14-membered rings oriented towards the C- and N-terminus respectively dominated the
2-hydrogen bonded structures observed. The 3-hydrogen bonded structures included 6and 10-membered rings towards the N-terminus and an 8-membered ring towards the Cterminus.
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4.3.2.2 Boc-(B-AlaWOBn at dielectric of 32,63
(i) Amber Force Field
Only a few H-bonded structures were observed and all were 1-hydrogen bonded
structures with some intra-residue hydrogen bonded structures. The 1-hydrogen bonded
structures observed included 8-membered and 16-membered rings towards the Cterminus and 26-membered ring towards the N-terminus.
(ii) Cvff Force Field
Only a few hydrogen-bonded structures were observed, and all were single
hydrogen bonded structures.

No intra-residue hydrogen bonded structures were

observed. Among the single hydrogen bonded structures, the most prominent was an 18membered ring structure between residues 3 and 6, and this hydrogen bond was oriented
towards the N-terminus. Others included 10-, 14- and 22-membered rings all towards the
N-terminus.
4.3.2.3 Boc-(ACPCyOBn at dielectric of 1.00
(i) Amber Force Field
Hydrogen bonded structures observed ranged from single to multiple hydrogen
bonded structures with no intra-residue hydrogen bonded structures.

All the single

hydrogen bonded structures were 8-membered ring structures oriented towards the Cterminus. Among the 2-hydrogen bonded structures, the most common was 8-membered
ring between residues 1 and 3 and then 3 and 5 all towards the C-terminus. Among the 3hydrogen bonded structures, two prominent hydrogen-bonding arrangements were
observed. In one case, it involved all 8-membered ring structures oriented towards the Cterminus between residues (1,3), (2,4), and (3,5). The other included two 8-membered
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rings and a 12-membered ring all oriented towards the C-terminus between the following
residues, (2,4), (3,5), and (3,6). In the case of the 4-hydrogen bonded structures, the most
prominent structure was observed between the following residues, (1,3), (2,4), (3,5), and
(5,7) and involved all 8-membered rings towards the C-terminus. A 5-hydrogen bonded
structure was also observed and contained all 8-membered rings towards the C-terminus,
between the following residues, (1,3), (2,4), (3,5), (4,6), and (5,7).
(ii) Cvff Force Field
Hydrogen bonded structures observed ranged from only one to four hydrogen
bonded structures with no intra-residue hydrogen bonded structures noticed.

Single

hydrogen bonded structures included 8-, 12-, and 16-membered ring structures all
towards the C-terminus and 14-membered ring towards the N-terminus. The 2-hydrogen
bonded structures observed involved 8-, 12- or 16-membered ring all towards the Cterminus. The most common involved all 12-membered rings between residues (1,4) and
(2.5) . The 3-hydrogen bonded structures also involved 8-, 12-, 16-membered rings
oriented towards the C-terminus. The most common and prominent around a particular
region being an all 12-membered ring structure between the following residues, (1,4),
(2.5) , and (3,6). The 4-hydrogen bonded structures included 8- and 12-membered ring
hydrogen bonds oriented towards the C-terminus. The most prominent structure involved
12-membered ring hydrogen bonds between residues (1,4), and (2,5) and 8-membered
ring hydrogen bonds between residues (4,6), and (5,7).
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4.3.2.4 Boc-(ACPCyOBn at dielectric of 32.63
(i) Amber Force Field
Hydrogen bonded structures were rarely observed.

Only a total of twelve

hydrogen bonded structures, from the hundred and two structures examined after
molecular dynamics, were observed. For the 1-hydrogen bonded structures, 8-, 18-, and
22-membered ring hydrogen bonds were observed with the 8-membered ring oriented
towards the C-terminus and the 18- and 22-membered rings towards the N-terminus. The
18-membered ring structure was the most common. Also observed were 2-hydrogen
bonded structures, one of which involved all 8-membered rings oriented towards the Cterminus and the other a 14-membered ring and a 22-membered ring oriented towards the
N-terminus.
(ii) Cvff Force Field
A total of only eleven hydrogen-bonded structures were observed and all were 1hydrogen bonded structures. All these 1-hydrogen bonded structures were 8-membered
ring hydrogen bonded structures oriented towards the C-terminus.
4.3.2.5 Boc-fACHCV'-OBn at dielectric of 1.00
(i) Amber Force Field
Hydrogen bonded structures observed ranged from 1-, 2- and 3-hydrogen bonded
structures oriented either towards the C- or N-terminus.

The 1-hydrogen bonded

structures observed were either 8-membered, 10-membered or 16-membered ring
hydrogen bonded structures.

Both the 8- and 16-membered ring hydrogen bonded

structures were oriented towards the C-terminus, while the 10-membered ring structure
was oriented towards the N-terminus.

The 10-membered ring 1-hydrogen bonded
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structures were more common.

The 2-hydrogen bonded structures contained a

combination involving any two of the following, 6-, 8-, 10-, 12-, or 16-membered ring
hydrogen bonded structures. The most common structure contained an 8-membered ring
oriented towards the C-terminus and a 10-membered ring oriented towards the Nterminus. In the case of the 3-hydrogen bonded structures examined, a combination
involving any three of the following, 6-, 8-, 10-, 16-, and 18-membered ring hydrogen
bonded structures was observed. The most common structure contained an 8-membered
ring and a 16-membered ring both oriented towards the C-terminus, and a 10-membered
ring oriented towards the N-terminus.
(ii) Cvff Force Field
Structures observed ranged from 1- to 4-hydrogen bonded structures with no
intra-residue hydrogen bonds evident.

The 1-hydrogen bonded structures observed

contained 10-, 16- or 18-membered ring oriented towards the C- or N-terminus. The
most common structure was an 18-membered ring hydrogen bonded structure. Among
the 2-hydrogen bonded structures, the most common contained a 10-membered ring
oriented towards the N-terminus and a 16-membered ring oriented towards the Cterminus. The 3-hydrogen bonded structures observed contained a combination of any
three of the following, 8-, 10-, 16- or 18-membered ring oriented either towards the Cterminus or N-terminus. The most common 3-hydrogen bonded structure contained a 10and 18-membered ring both oriented towards the N-terminus and a 16-membered ring
oriented towards the C-terminus.

A 4-hydrogen bonded structure was observed

containing two 10-membered rings, an 18-membered ring all oriented towards the Nterminus and a 16-membered ring oriented towards the C-terminus.
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4.3.2.6 Boc-(ACHCV,-OBn at dielectric of 32.63
(i) Amber Force Field
Among the structures examined, 1-, 2-, and 3-hydrogen bonded structures were
observed with the 1-hydrogen bonded structures being more common. The hydrogen
bonds were oriented either towards the C- or N-terminus.

The 1-hydrogen bonded

structures contained 10-, 16- or 18-membered ring hydrogen bonds with the 10membered ring, oriented towards the N-terminus, being the most common.

The 2-

hydrogen bonded structures observed contained a combination of two of the following,
10-, 16-, 18-, 20-membered ring. The most common structure contained a 10-membered
ring oriented towards the N-terminus and a 16-membered ring oriented towards the Cterminus.

A 3-hydrogen bonded structure was also observed containing two 10-

membered rings oriented towards the N-terminus and a 16-membered ring oriented
towards the C-terminus. A few intra-residue hydrogen bonds were also observed but
nothing really significant.
(ii) Cvff Force Field
Only a few hydrogen-bonded structures, a total of seven were observed with no
intra-residue hydrogen bonds. Most of the structures were 1-hydrogen bonded structures
containing either 10- or 16-membered ring hydrogen bonds. Of these, the 10-membered
ring hydrogen bonded structures were the most prominent and were oriented towards the
N-terminus while the 16-membered H-bonded structures were oriented towards the Cterminus. A 2-hydrogen bonded structure was observed containing a 10-membered ring
hydrogen bond oriented towards the N-terminus and a 16-membered ring hydrogen bond
oriented towards the C-terminus.
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4.3.3 Heterogeneous Backbone Oligomers
Heterogeneous backbone oligomers were also modeled at the dielectric constants
of vacuum and methanol at two different force fields. Results are presented for both the
Amber and Cvff force fields.
4.3.3.1 Hexamer of Phe and ACHC at dielectric of 1.00
(i) Amber Force Field
Upon examination of all the structures obtained after molecular dynamics, 1-, 2-,
3- and 4-hydrogen bonded structures were observed. The 1-hydrogen bonded structures
were all oriented towards the C-terminus and all contained 7-membered hydrogen bonded
rings.

Some intra-residue hydrogen bonds were observed.

The 2-hydrogen bonded

structures observed were all oriented towards the C-terminus and contained 7-membered
ring hydrogen bonds. All 3-hydrogen bonded structures observed were oriented towards
the C-terminus and contained 7-membered ring hydrogen bonds. The most common
structure contained hydrogen bonds formed between the following residues, (1,3), (3,5),
and (5,7). A 4-hydrogen bonded structure was also observed between the following
residues, (1,3), (2,4), (3,5), (5,7) and all hydrogen bonds were oriented towards the Cterminus.

Three of these hydrogen bonds contained 7-membered rings while one

contained an 8-membered ring.
(ii) Cvff Force Field
Structures containing 1-, 2- and 3-hydrogen bonds were observed.

The 1-

hydrogen bonded structures either contained 7-membered ring hydrogen bonds or 8membered ring hydrogen bonds all oriented towards the C-terminus. The 7-membered
ring hydrogen bond structure is more common.

The 2-hydrogen bonded structures
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contained a combination of two of the following; 7- and 8-membered ring hydrogen
bonds. The most common structure contained two 7-membered ring hydrogen bonds.
The most common 3-hydrogen bonded structure observed contained hydrogen bonds
formed between the following residues, (1,3), (3,5), and (5,7).
4.3.3.2 Hexamer of Phe and ACHC at dielectric of 32.63
(i) Amber Force Field
Among the structures examined, 1-, 2-, 3- and 4-hydrogen bonded structures were
observed. Hydrogen bonds were either oriented towards the C- or N-terminus. Among
the 1-hydrogen bonded structures, a 7-membered ring oriented towards the C-terminus
was the most common. The 2-hydrogen bonded structures were dominated by a structure
having a 7-membered ring hydrogen bond oriented towards the C-terminus and a 16membered ring hydrogen bond towards the N-terminus.

The 3-hydrogen bonded

structures were dominated by a structure having 9- and 16-membered ring hydrogen
bonds oriented towards the N-terminus and 7-membered ring oriented towards the Cterminus. A 4-hydrogen bonded structure was observed containing two 7-membered
hydrogen bonded rings oriented towards the C-terminus, a 9-membered ring and 16membered ring hydrogen bonds oriented towards the N-terminus.
(ii) Cvff Force Field
Most of the structures observed in this case were 1-hydrogen bonded structures
with a few 2-hydrogen bonded structures. All structures were oriented towards the Cterminus.

The 1-hydrogen bonded structures include 7-, 8- and 11-membered ring

hydrogen bonds with the 7-membered ring being the most common. All 2-hydrogen
bonded structures observed contained 7-membered ring hydrogen bonds.
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4.3.3.3 Hexamer of Ala and ACHC at dielectric of 1.00
(i) Amber Force Field
Upon examination of all the structures obtained after molecular dynamics, 1-, 2-,
3-, 4- and 5-hydrogen bonded structures were observed.

The 1-hydrogen bonded

structures were all oriented towards the N-terminus and all contained 13-membered
hydrogen bonded rings. Some intra-residue hydrogen bonds were observed. The 2hydrogen bonded structures observed were oriented either towards the C-terminus or the
N-terminus with the most common containing 7-membered ring hydrogen bonds and 11membered ring hydrogen bonds both towards the C-terminus. Among the 3-hydrogen
bonded structures observed the most common contained two 7-membered hydrogen
bonds and an 11-membered hydrogen bond all oriented towards the C-terminus. The
most common 4-hydrogen bonded structure was observed between the following
residues, (1,3), (1,4), (3,5), (5,7) and all hydrogen bonds were oriented towards the Cterminus.

Three of these hydrogen bonds contained 7-membered rings while one

contained an 11-membered ring. A 5-hydrogen bonded structure was observed between
the following residues, (1,3), (1,4), (3,5), (3,6), and (5,7) all of which were oriented
towards the C-terminus. Three of these structures contained 7-membered ring hydrogen
bonds and two contained 11-membered ring hydrogen bond.
(ii) Cvff Force Field
Only 1-hydrogen bonded structures were observed and all were oriented towards
the N-terminus. The most common of these structures contained a 9-membered ring
hydrogen bond between residues 6 and 7.
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4.3.3.4 Hexamer of Phe and ACHC at dielectric of 32.63
(i) Amber Force Field
Among the structures examined, mostly 1-hydrogen bonded structures were
observed with some 2- and 3-hydrogen bonded structures. Hydrogen bonds were either
oriented towards the C- or N-terminus. Among the 1-hydrogen bonded structures, a 16membered ring oriented towards the N-terminus was the most common. The 2-hydrogen
bonded structures were dominated by a structure having a 7-membered ring hydrogen
bond oriented towards the C-terminus and a 16-membered ring hydrogen bond towards
the N-terminus.

Two 3-hydrogen bonded structures were observed.

One of these

structures had 7- and 11-membered ring hydrogen bonds oriented towards the C-terminus
and a 6-membered ring hydrogen bond towards the N-terminus. The other 3-hydrogen
bonded structure had 6- and 16-membered ring hydrogen bonds oriented towards the Nterminus and an 8-membered ring towards the C-terminus.
(ii) Cvff Force Field
Only 1-hydrogen bonded structures were observed and all were oriented towards
the N-terminus.

These structures were either a 9-membered ring hydrogen bonded

structure or a 12-membered ring hydrogen bonded structure.
4.3.3.5 Hexamer of Val and ACHC at dielectric of 1.00
(ii) Amber Force Field
Analysis of all the structures obtained after molecular dynamics showed the
presence of 1-, 2-, and 3-hydrogen bonded structures. The 1-hydrogen bonded structures
were all oriented towards the C-terminus and all contained either 7-, or 8-membered ring
hydrogen bonds. Some intra-residue hydrogen bonds were observed. The 2-hydrogen
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bonded structures observed were oriented either towards the C-terminus or the Nterminus with the most common containing 7-membered ring hydrogen bonds and 8membered ring hydrogen bonds both towards the C-terminus. Among the 3-hydrogen
bonded structures observed, the most common contained two 7-membered hydrogen
bonds and an 8-membered hydrogen bond all oriented towards the C-terminus.
(ii) Cvff Force Field
Structures containing 1-, 2- and 3-hydrogen bonds were observed. The hydrogen
bonded structures were either oriented towards the C-terminus or N-terminus. Among
the 1-hydrogen bonded structures, a structure containing a 21-membered ring hydrogen
bond was most common. This was observed between the carbonyl oxygen of residue one
and the hydrogen of residue seven.

Other 1-hydrogen bonded structures observed

contained 8-, 9-, 11- or 18-membered ring.

The most common 2-hydrogen bonded

structure observed contained a 9-membered ring towards the N-terminus and a 21membered ring towards the C-terminus. Only one 3-hydrogen bonded structure was
observed and this contained a 9- and an 11-membered ring hydrogen bond towards the Nterminus and a 21-membered ring hydrogen bond towards the C-terminus.
4.3.3.6 Hexamer of Val and ACHC at dielectric of 32.63
(i) Amber Force Field
Among the structures examined, mostly 1-hydrogen bonded structures were
noticed with a few 2-hydrogen bonded structures. Hydrogen bonds were either oriented
towards the C- or N-terminus. Among the 1-hydrogen bonded structures, a 7-membered
ring oriented towards the C-terminus was the most common. The 2-hydrogen bonded
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structures were dominated by 7-and 8-membered ring hydrogen bond structures oriented
towards the C-terminus
(ii) Cvff Force Field
Only 1-hydrogen bonded structures were observed and all were oriented towards
the C-terminus. These structures contained either 7-, 8- or 21-membered ring hydrogen
bonds.
4.4 Discussion
The attempt at using molecular modeling in predicting the structure of
homogeneous and heterogeneous peptides has not been successful. The method is based
on predicting structure using the hydrogen-bonding pattern.

The hydrogen-bonding

pattern, from experiment, for the homogeneous peptides of ACHC and ACPC was used
as a reference to validate the molecular modeling method.

Several factors may be

responsible for the failure of this method such as the nature of the force field, the
dielectric constant and the lack of structural NMR parameters.

Structural NMR

parameters such as interproton distances from NOE or hydrogen bonds from temperature
coefficients can only be obtained from experiments.

However, because the

heterogeneous peptides, for which our interest in this study is geared towards, do not
have any experimental data available we could not rely on constraints. Also the force
fields available in Insight II, Amber and Cvff, have been parameterized for natural amino
acids (a-amino acid) and when these force fields are used to model |3-amino acid
containing peptides, provision is not made to account for the introduction of additional
atoms. The use of a force field specifically design for P-amino acids may be necessary.
To determine the presence or absence of ordered secondary structure in solution, it may
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be necessary to perform molecular dynamics using solvent conditions that may best
represent experimental conditions.

A closer look at all the structures obtained after

molecular dynamics shows that for the most part there is no regular pattern of hydrogen
bond arrangement.
4.5 Summary
The goal of this study was to carry out basic modeling that might allow a
qualitative prediction of ordered oligomer conformations based on the hydrogen bonding
tendencies. The modeling method, however, was not successful as it was not able to
reproduce experimental results. Some potential explanations can be given for the failure.
Firstly, the method was carried out with no inclusion of solvent conditions which is not a
good representation of experimental conditions. Secondly, the force fields used, Amber
and Cvff incorporated in Insight II, have not been parameterized for p-amino acids. In
addition, no constraints were applied to make sure the residues in each oligomer were at
the right conformations (lowest energy conformations). A more systematic approach will
be to start from a dipeptide model and then by a combination of molecular mechanics and
quantum mechanics method, the geometry can be optimized and energy evaluated. A
more thorough conformational search can be performed using MacroModel. 7 7 The effect
of solvent on relative stabilities of various conformers can also be approximated using the
GB/SA solvation model7 8 available in MacroModel. There is still prospect therefore, in
the use of molecular modeling in predicting structures of heterogeneous oligomers if the
right force field and right computer package is used.
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CHAPTER 5
COMPUTER SIMULATION OF LINKERS BETWEEN a- AND (3-PEPTIDE HELICES

5.1 Background and Significance
Fos and Jun are products of the nuclear oncogenes that are known to bind to DNA
79 80

and modulate transcription through the formation of heterodimers. '

The structural

feature common in these proteins that is important for heterodimer formation is the
presence of the leucine zipper region.

The leucine zipper region is defined as the region

containing five leucine residues in which any two adjacent leucine residues are separated
by six residues. 81

Jun proteins can both homodimerize and heterodimerize with Fos

proteins, while Fos proteins do not homodimerize but require heterodimer formation to
bind DNA. 8 0
Both Fos and Jun family proteins serve as dimeric transcription factors that bind
to AP-1 transcription response elements of a variety of mammalian genes. 8 0 The cellular
transcription factor Jun usually exists as a homodimer which moderately activates the
AP-1 transcription response element (left, Figure 5.1). The Fos oncoprotein, when over
expressed, leads to cancer by heterodimerizing with Jun and over activating AP-1 (center,
Figure 5.1) . 8 0 Blocking this leucine zipper interaction with a synthetic oligomer (right.
Figure 5.1) could have wide-ranging biomedical applications.

Synthetic (3-peptides,

possessing numerous biological activities, 1 8 ' 2 2 have been reported in the literature. They
also adopt stable secondary structures at lengths much shorter than do a-peptides.
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Normal
(Low Fos)

Cancer
(High Fos)

Putative
Intervention

Figure 5.1 Model for the interaction of Fos and Jun dimers with DNA.
In particular, oligomers of /ram-2-aminocyclopentanecarboxylic acid (ACPC) or trans-2aminocyclohexanecarboxylic acid (ACHC) adopt distinct helical structures in the solid
and solution states. 8’9
To systematically explore the structure-activity relationship of (3-peptide
sequences binding to Fos or Jun, it would be desirable to link helical (3-peptide segments
to an a-peptide biasing element. Chimerae of a- and (3-peptides, however, are largely
unexplored; the basic question of how such a linkage should be constructed has, to my
knowledge, not been addressed in theory or practice.

Figure 5.2 Structures of amino acid residues and representative structures of a- and (3peptides.

roduced with permission of the copyright owner. Further reproduction prohibited without permission.

237
Herein, theoretical studies of such chimerae with the a- and P-peptide helices
linked by the flexible amino acids glycine (Gly) or P-alanine (P-Ala) (Figure 5.2) are
described. P-Peptides, constituting of the cyclic amino acid ACPC (Figure 5.2) residues,
were used in the studies. The two end moieties of the linkers, N- and C-terminus, should
provide hydrogen bonding groups that serve to continue the helical conformation of the
individual modules.
5.1.1 Study Goal and Objectives
In performing computational simulations on the flexible linkers, it is important to
understand how, in a chimera of a- and p-peptide helices, various linkers constrain the
spatial relationship between the segments. In this light, the objectives were defined: (a)
determine low-energy conformations for chimeric peptides linked by Gly or P-Ala; (b)
determine, for each system, whether conformations where the helices are roughly
collinear (“unkinked” conformations) are particularly favored or disfavored; (c) estimate
how much enthalpic strain is required to “unkink” each chimeric peptide; (d) estimate, as
an entropic measure, the flexibility or rigidity of the low energy and “unkinked”
conformations.
5.2 Methods
All computations were performed on a Silicon Graphics Octane workstation using
the molecular modeling package Insight®II (Accelrys, San Diego, CA). Conformational
searches and energy minimizations were done using the DISCOVER module with the
AMBER force field. 7 3 A dielectric constant of 1.0 was assumed in all calculations.
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5.2.1 Atomic Models
The a- and p-peptide helical segment models were derived from crystal structures
of the Fos/Jun complex (RCSB Protein Data Bank, structure 1A02, residues 167-192 of
Fos and 285-310 of Jun) and the previously published ACPC oligomer crystal structure. 8
In the original crystal structure of Fos, residue number 175 was modified from glutamate
to Lysine (E to K), while residue number 310 in the original crystal structure of Jun was
modified from methionine to alanine (M to A). The sequence of the helical modules of
Fos and Jun are shown in Figure 5.3. The p-Ala linker was constructed by addition of
one methylene to a Gly residue (Figure 5.2).
Fos = E T D Q L E D K K S A L Q T E I A N L L K E K E K
167

192

Jun = R I A R L E E K V K T L K A Q N S E L A S T A N A
285

310

Figure 5.3 Sequence of Fos and Jun helical modules.
5.2.2 Conformational Search
The conformational space was mapped by calculating the conformational energy
at 36° intervals for the torsion angles <j), \|/ of Gly and P-Ala. The co angles were fixed at
180°. For the Gly linker, conformational search at 36° increments for the two dihedral
angles (p and\)/ translates to calculation of 100 structures. For the P-Ala, a systematic
conformational search with 36° increments for the three dihedral angles <J), 0, and \)/
would mean the calculation of 1,000 structures. This is impractical since each structure
has to be visualized for the presence or absence of kinks. Therefore, instead of exploring
the whole potential energy surface, energy maps were computed for the P-Ala linker at
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five 0 angles: 180°, -60°, 60°, -120°, 120° . 8 2 This selection of angles is supported by the
average 0 angles found in the literature for (3-Ala residues. 8 3 ' 8 5
5.2.3 Energy minimization
Minimum-energy conformations were obtained in the low-energy regions of the
conformational search (torsional drive). Each energy minimization consisted of 1,000
steps of steepest descent followed by

1 ,0 0 0

steps of conjugate gradient minimization.

Conformational energies are expressed as AE = E - E 0 with E0 being the energy of the
most stable conformation.
5.2.4 Data Processing
Filled contour plots were generated using SigmaPlot 2000 (SPSS, Chicago, IL).
Data were truncated at 0 kcal/mol to avoid graphing errors arising from extremely high
values when the peptide segments overlapped. Color scaling on the figures was adjusted
so that the red-blue range would be

1 2

kcal/mol, with blue being the global energy

minimum for the molecule. This method sacrifices information on barrier heights in
order to present more detailed depictions of energy wells. Unkinked conformations are
shown as white dots.
5.3 Glycine Linker
The energies of the low-energy conformations from the rigid rotor maps for Gly
linker between Fos and ACPC are shown in Table 5.1, while the energies of the lowenergy conformations for Gly between Jun and ACPC are given in Table 5.2. Rigid rotor
(cj), y) maps for Gly linker between Fos and ACPC and between Jun and ACPC are
shown in Figures 5.4 and 5.5 respectively, with the dots indicating unkinked
conformations.
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Table 5.1 Low Energy Conformations for Gly Linker between Fos and ACPC.
V(°)

AE (kcal/mol)

36

-36

0 .0 0

36

-72

0.43

72

-36

0 .6 8

-36

36

1.57

36

0

1.61

-36

0

1.61

Table 5.2 Low Energy Conformations for Gly Linker between Jun and ACPC.
<t>(°)

V(°)

AE (kcal/mol)

36

-36

0 .0 0

-180

36

0.17

36

-72

0.32

-180

72

0.61

72

-36

0.90

36

0

0.90

5.3,1 Glv Linker between Fos and ACPC
The lowest minimum energy conformation corresponds to a structure with <j) and
V values of 36° and -36° respectively (Table 5.1). Other low energy conformations were
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within a reasonable and close energy range from the lowest energy conformation and
might be accessible. The Ramachandran plot shows a single, broad energy minimum
around <() = 36°, i|/ = -36°. No unkinked conformations were observed for this linker
(Figure 5.4).

Fos Glycine Linker
-1 8 0

14 4

10 8
R e la t iv e
E n e rg y

72

( k c a l/m o l)

36

5-

0
-3 6

-7 2

-1 0 8

-1 4 4

-1 8 0
-1 8 0

-1 4 4

-1 0 8

-7 2

-3 6

0

36

72

10 8

14 4

-1 8 0

<i>

Figure 5.4 Rigid rotor map for Gly between Fos and ACPC.

5.3.2 Glv Linker between Jun and ACPC
Again there is a single broad energy minimum around <(>= 36°,

= -36° (Table

5 .2 ) , although here the potential well is even shallower (Figure 5 .5 ). Other low energy
conformations are much closer in energy to the lowest energy conformation than was
observed for Fos and ACPC (Tables 5.1 and 5.2).

Several unkinked conformations

([<t>> M
y] = [36°, 0°]; [-180°, 0°]; [-180°, 36°]), have strain energy of less than 2 kcal
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compared to the lowest energy conformation (Figure 5.5). Unkinked conformations at
(<)>, i)/) values of (0°, -108°) and (108°, -36°) have strain energy of more than at least 4
kcal compared to the lowest energy conformation (Figure 5.5).
Jun Glycine Linker
-1 8 0
14 4
10 8
72
36

3-

0
-3 6
-7 2
-10 8
-1 4 4
-1 8 0
-1 8 0

-1 4 4

-1 0 8

-7 2

-3 6

0

36

72

10 8

14 4

-1 8 0

<t>
Figure 5.5 Rigid rotor map for Gly between Jun and ACPC.

5.4 p*Alanine Linker
The energies of the low energy conformations from the rigid rotor maps for P-Ala
linker between Fos and ACPC and between Jun and ACPC are shown in Tables 5.3 and
5.4 respectively. Rigid rotor (<J), i|/) maps for 0 angles of 180°, 120°, -120°, 60°, and -60°
for p-Ala linker between Fos and ACPC are shown in Figure 5.6 with the dots
representing unkinked conformations. Rigid rotor (<|), vj/) maps for 0 angles of 180°, 120°,
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-120°, 60°, and -60° for (3-Ala linker between Jun and ACPC are shown in Figure 5.7,
again with the dots representing unkinked conformations.
Table 5.3 Low Energy Conformations for [3-Ala Linker between Fos and ACPC.
AE (kcal/mol)

(°)

V(°)

36

60

-72

0 .0 0

0

60

-72

1.49

72

-60

0

1.72

72

180

72

6.49

-36

1 2 0

-72

6.52

72

-1 2 0

72

7.42

<t>(°)

0

5.4.1 B-Ala Linker between FOS and ACPC
The lowest energy conformation occurs at 0 = 60° for <)) = 36° and \j/ = -72°
(Table 5.3). The difference in energy between 0 = 60°, <j) = 72°, \j/ = 0° and 0 = 60°, <|) =
0°, y = -72° is not great but moving to 0 = 180°, 120°, and -120°, there is a big jump in
energy making these conformations less favorable compared to the lowest energy
conformation (Table 5.3). Examination of the truncated rigid rotor maps shows that
among the conformations studied, the Fos chimera has three narrow energy wells, at (<j>,
0, V|r) = (-72°, 60°, -72°); (-72°, 60°, 36°); (36°, 60°, -72°); and (72°, -60°, 72°) (Figure
5 .6 ). M o s t o f th e u n k in k e d c o n fo r m a tio n s h a v e e n th a lp y at le a s t

8

k c a l/m o l a b o v e th e s e

minima. The lowest energy unkinked conformations occur at 0 = 60°, <() = -180° and \\i =
0°, 36°, 72° or 144° (Figure 5.6). AE for this set of unkinked conformations is
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and these conformations seem to be at the edge of a broad shelf of low energy connecting
them to the wells at (-72°, 60°, -72°) and (-72°, 60°, 36°) (Figure 5.6).
Fos-ACPC 0=180

FosACPC 0=120

180

180

144

144

108

108

72

72

36

5-

36

0

>

-36

0
-36

-72

-72

-108

108

-144

-144
•180

-180
-180-144-108-72 -36

0

-180-144-108-72 -36

36 72 108 144 180

0

36 72 108 144 180

4>

♦

FOS-ACPC 0= -120

F O S _ A C P C 0=60

-180-144-108-72 -36

4>

0

36 72 108 144 180

♦

F O S -A C P C 0 = -6 0
180

Relative
Energy
(kcal/mol)

144
108
72
36

>

0
-38
-72
-108
-144
180
-180-144-108 -72 -36

0

36

72 108 144 180

4>

Figure 5.6 Rigid rotor maps for p-Ala linker between Fos and ACPC with 0 = 180°, 120°,
- 1 2 0 °, 60°, and -60°.
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Thus, these conformations represent the best possibility for an accessible unkinked
conformation for (ACPC)s-p-Ala-Fos.
5.4.2

p-Ala Linker between Jun and ACPC

The lowest minimum energy conformation corresponds to a structure with 0 =
60°,

<J) =

144° and \j/= -108° (Table 5.4). A relatively smaller energy difference exist

between the conformation at

0

= 60°, <j) = -180°, \|f = -108° and the lowest energy

conformation (Table 5.4). However at 0 values of -60°, 180°, 120°, and -120° there is
greater energy difference between the conformations and the lowest energy conformation
(Table 5.4).
Table 5.4 Low Energy Conformations for P-Ala Linker between Jun and ACPC.

AE (kcal/mol)

<M°)

en

V(°)

144

60

-108

0 .0 0

-180

60

-108

1.03

-144

-60

-36

2.37

144

180

72

4.09

-72

1 2 0

-72

5.04

108

-1 2 0

72

5.09

The truncated energy maps for (ACPQs-P-Ala-Jun show two relatively narrow
p o te n tia l w e lls , at (<)>, 0 , y ) = (144°, 60°, -108°) and (-144°, -60°, -12 °) (F ig u r e 5 .7 ).
Several other unkinked conformations exist at 0 values of 180°, 120°, -120°, and -60°,
but AE >

8

kcal/mol for all of these (and, in most cases, AE »

12 kcal/mol).
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36
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0
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-72
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-144
-180

-180-144-108-72 -36
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72 108 144-180

-180-144-108-72 -36

0

36

72 108 144-180

♦

6 = 60

0 = -120
-180
144
108
72
36

>

0
-36
-72
-108
-144
-180

-1 8 0-144-108-72 -36

0

36

72 108 1 4 4 -180

<i>

-1 8 0 -1 4 4 -1 0 8 -7 2 -36

0

36

72 108 1 4 4 -1 8 0

<i>

0 = -60

Relative
Energy
(kcal/mol)

♦

Figure 5.7 Rigid rotor maps for (3-Ala linker between Jun and ACPC with 0 = 180°, 120°,
- 1 2 0 °, 60°, and -60°.
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The energy well at 0 = 60° seems to have greater conformational freedom for the <J>angle
than the \|/angle, but the high-energy area at

0

= 180° appears to be defined by the

<|) angle (Figure 5.7). A single unkinked conformation at <}>= -108°, 0 = 60°,

= -108°

(Figure 5.7) has relatively low AE of 5 kcal/mol; this is the most promising unkinked
conformation for this sequence.
5.5 Comparing Linkers
The energy wells for the Gly linker are, surprisingly, much broader than those for
the p-Ala linker. Perhaps the P-Ala linker’s greater torsional freedom allows it to adopt a
wider variety of conformations, permitting it to find isolated low-energy pockets that are
inaccessible with only two free-rotating bonds.
This flexibility of the P-Ala linker, on the other hand, seems to work against the
goal of favoring unkinked conformations. Because specific low-energy conformations
are available to the p-Ala-linked chimerae and not to the Gly-linked chimerae, the
enthalpic strain required to force the p-Ala-linked structures into an unkinked
conformation is significantly greater. At least 5-6 kcal/mol worth of binding interactions
appear necessary to counterbalance the less favorable linker conformation for these
chimerae.

On the other hand, the Gly-linked Jun chimera has several unkinked

conformations which would require less than

2

kcal/mol of binding energy to overcome

linker-derived strain.
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5.6 Summary
Although attempt at locating low energy conformations of two linked peptides, el
and (3-helices, in which the helical axis is continuous without kinks, has not been
completely successful, some interesting conclusions can be made. Whereas linkage with
glycine produces the broad energy wells seen in a typical Ramachandran plot for Gly,
linkage with (3-Ala gives narrow and deep energy minima. The (3-Ala energy wells seem
to leave more conformational freedom for the \j/ angle than the <J) angle. Although some
promising unkinked conformations were seen, for the most part these flexible linkers
favor conformations in which the helices are not aligned to allow tandem binding to a
common a-helical target. Under these conditions, at least for Jun, the glycine linker
appears superior to the (3-Ala linker. A possible solution could be to further control the
linker conformation by strategic substitution at the a- and/or p-carbons.
Possible future direction of this project may involve generating control
Ramachandran plots of linkers by themselves, and then determine the effect of the helical
segments on linker conformation. The simulations can be carried out at higher dielectric
constant, incorporating solvent conditions. The simulations can also be repeated at finer
resolution, such as 5° intervals, although this will mean dealing with thousands of
structures, which may be cumbersome.

Another possibility will be to repeat the

simulations by interchanging the a- and P-peptide segments. The simulations can be
repeated with P-peptide segments made from ACHC or with P-substituted P-amino acids
(P-homoamino acids). Lastly, the simulations may be carried out with substituted linkers.
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SELECTED 'H NMR, COSY AND UV SPECTRA
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Figure 1A 300 MHz ‘H NMR spectrum of 2-3 in CDC13.
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Figure 2A 500 MHz 'H NMR spectrum of 2-4 in C D C I 3 .
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Figure 3A 300 MHz 'H NMR spectrum of 2-5 in CDCI3 .
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Figure 4A 300 MHz 'H NMR spectrum of 2-6 in DMSO.
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Figure 5A 500 MHz ‘H NMR spectrum of 2-7 in DMSO.
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Figure 6 A 500 MHz 'H NMR spectrum of 2-8 in CD O 3 .
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Figure 7A 300 MHz lH NMR spectrum of 2-9 in CDC13.
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Figure 8A 500 MHz ‘H NMR spectrum of 2-10 in CDCl^.
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Figure 9A 500 MHz 'H NMR spectrum of 2-11 in CDCI3 .
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Figure 10A 500 MHz 'H NMR spectrum of 2-12 in CDCI3 .
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Figure 11A 500 MHz ‘H NMR spectrum of 2-13 in CDCI3 .
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Figure 12A 500 MHz 'H NMR spectrum of 4-3 in CDCI3 .
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Figure 13A 500 MHz 'H NMR spectrum of 4-7 (mono-adduct) in CDCI3 .
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Figure 14A 500 MHz 'H NMR spectrum of 4-7 (bis-adduct) in CDCI3 .
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Figure 15A 500 MHz COSY spectrum of Bis-adduct 4-7 in CDC13.
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Figure 16A UV spectrum of 4-3 in MeOH.
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Figure 17A UV spectrum of 4-7 (mono-adduct) in MeOH.
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Figure 18A UV spectrum of 4-7 (bis-adduct) in MeOH.
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Figure 19A 500 MHz 'H NMR spectrum of 5-2 in CDCI3 .
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Figure 21A 500 MHz ‘H NMR spectrum of 5-4 in C D C I 3 .
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Figure 23A 500 MHz ’H NMR spectrum of 5-6 in C D C I 3 .
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Figure 24A 500 MHz *H NMR spectrum of 5-7 in CDCI3 .
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Figure 25A 500 MHz 'H NMR spectrum of 5-10 in CDCI3 .
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APPENDIX B (Part Two)
SELECTED *H AND 13C NMR SPECTRA
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Figure IB 300 MHz *H NMR spectrum of 2-2 in CDCI3
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Figure 2B 300 MHz ‘H NMR spectrum of 2-3 in C D O 3 .
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Figure 3B 75 MHz 1 ’C NMR spectrum of 2-3 in CDQ 3 .
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Figure 4B 300 MHz !H NMR spectrum of 2-5 in CDCI3 .

279

iroduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 5B 300 MHz 'H NMR spectrum of 2-6 in CDCI3 .
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Figure 6 B 75 MHz 13C NMR spectrum of 2-6 in CDCI3 .
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Figure 7B 300 MHz ‘H NMR spectrum of 2-7 in CDC13.

CL
_ CL

roduced with permission of the copyright owner. Further reproduction prohibited without permission.

roduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 8 B 300 MHz ‘H NMR spectrum of 2-8 in CDCI3 .
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Figure 10B 300 MHz 'H NMR spectrum of 2-19 in CDCI3 .
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Figure 1IB 75 MHz 13C NMR spectrum of 2-19 in CDC13.
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Figure 12B 300 MHz 'H NMR spectrum of 2-20 in CDCI3 .
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Figure 13B 75 MHz l3C NMR spectrum of 2-20 in CDC13.
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Figure 14B 300 MHz ‘H NMR spectrum of 2-21 in CDCI3 .
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Figure 15B 75 MHz l3C NMR spectrum of 2-21 in CDC13.

290

reduced with permission of the copyright owner. Further reproduction prohibited without permission.

iroduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 16B 300 MHz 'H NMR spectrum of 2-23 in CDCIj.
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Figure 17B 300 MHz ’H NMR spectrum of 2-24 in CDCI3 .
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Figure 18B 300 MHz 'H NMR spectrum of 2-25 in CDCI
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Figure 20B 300 MHz 'H NMR spectrum of 2-27 in CDCI3 .
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Figure 2 IB 300 MHz 'H NMR spectrum of 2-28 in CDCF,
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Figure 22B 300 MHz *H NMR spectrum of 2-29 in CDC13.
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Figure 23B 300 MHz *H NMR spectrum of 2-30 in CDC13.
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Figure 24B 300 MHz 'H NMR spectrum of 2-31 in CDCI3 /CD 3 OD.
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Figure 25B 300 MHz 'H NMR spectrum of 2-32 in CDCU/CD3 OD.
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Figure 26B 300 MHz 'H NMR spectrum of 2-34 in CDCI3 /CD 3 OH.
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Figure 27B 300 MHz
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Figure 28B 600 MHz 'H NMR spectrum of 2-40 in CD3 OD.
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Figure 29B 600 MHz !H NMR spectrum of 2-40 in CD3 OD, expansion of amide region.

304

reduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 30B 600 MHz 'H NMR spectrum of 2-41 in CD3 OD.
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Figure 3 IB 600 MHz 'H NMR spectrum of 2-41 in CD3 OD, expansion of amide region.
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Figure 32B 600 MHz 'H NMR spectrum of 2-42 in C D 3 O D .
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Figure 33B 600 MHz 'H NMR spectrum of 2-42 in CD3 OD, expansion of amide region.
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